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Shelterin is a multiprotein complex that prevents DNA damage signaling at 
chromosome ends. In its absence, DNA repair pathways are activated that can 
promote the fusion of dysfunctional telomeres resulting in chromosomal 
instability. The work presented here aims to understand how telomeres are 
protected from these pathogenic repair pathways. 
The first part of this thesis is focused on the DNA damage response factor 
53BP1, a key regulator in double strand break (DSB) repair pathways in 
mammalian cells. By influencing key regulatory events at and near DNA ends, 
53BP1 plays an important role in the decision between non-homologous end-
joining (NHEJ) and homologous recombination (HR). Telomeres lacking the 
shelterin protein TRF2 have proven a versatile system for studying 53BP1 in 
DSB repair since 53BP1 protects dysfunctional telomeres from resection and 
promotes their mobility. Analysis of separation of function mutants of 53BP1 has 
identified the domain that is responsible for promoting the mobility of DSBs. Cells 
expressing 53BP1ΔMOB showed reduced levels of NHEJ at dysfunctional 
telomeres and damage foci roamed a smaller part of the nucleus. But which 
53BP1 interacting factors are responsible for mediating the increased mobility 
remains unclear. 
The second part of this thesis aims to elucidate the DNA repair pathways 
that are activated when the shelterin component TRF1 is absent. The results 
provide tantalizing evidence that sister telomeres can fuse via the alternative-
NHEJ (a-NHEJ) pathway when replication forks reach the end of the 
chromosome in cells that are deficient in TRF1. To prevent chromosome 
instability, mammalian cells appear to employ the Holliday Junction resolvase 
Gen1, which is capable of cleaving cruciform DNA structures that can be formed 
when telomeres fuse. The deletion of Gen1 from TRF1 null cells resulted in the 
accumulation of chromatin bridges and isochromosomes, indicative of genomic 
instability. The results presented here are of relevance to studies of human 
cancer cells since the presence of critically short telomeres induces sister 
telomere fusions via a-NHEJ. It is possible that replication stress underlies these 
fusion events and that Gen1 has evolved as a mechanism to counteract the 
consequences of chromosomal fusion events at telomeres. 
iii 
Acknowledgements 
I would first of all like to express my gratitude to my advisor, Titia de Lange. I 
joined your lab late into the program and I am very grateful for your guidance and 
support. I am impressed with your dedication to science and have learned a lot 
during the past three and a half years from your rigorous, distinctive and 
inspirational approach to solving scientific problems, which will be helpful in any 
future career. I would also like to thank Tarun Kapoor, Robert Roeder, and John 
Petrini for serving on my thesis committee. I also thank the Deans office for their 
continuous support and help over the years. Finally, I would like to thank Daniel 
Mucida and Sasha Tarakhovsky for being great mentors during my first years in 
the program. 
My experience in the de Lange lab would not have been the same without 
Francisca, who is an amazing teacher, mentor and friend. I am grateful for all 
your help and advise and I am so excited that there will soon be a Lottersberger 
lab! Hiro, thank you for being my bay mate and for sharing your vast knowledge 
about the lab with me. And I will certainly miss chatting with you about running 
and climbing mountains! John, I would also like to thank you for our scientific 
discussions, but even more for all the fun afternoon runs and crazy bike rides that 
we did (I’ll always be terrified of dogs!). I furthermore thank all other members of 
the de Lange lab for scientific support. I particular Adriana, Stew and Rosie, who 
do an amazing job making the lab run efficiently. 
iv 
I have been supported by a fellowship from the Boehringer Ingelheim foundation, 
which not only provided financial assistance but also scientific support in the form 
of symposia and workshops. I was also the recipient of a fellowship from the 
Women & Science initiative at the Rockefeller University. 
I also want to thank all the friends that have been there for me over the years, 
both in New York and back at home. Lianne, Lieke, Lidwien, Sara, Michiel, 
Evelien, Boaz’s, Carlien – your support has meant a lot to me. Special thanks go 
to my running friends, who kept me sane over the years with our weekly runs, 
dinners, brunches, crazy races and vacations. Kristina, Lauren, Deirde, Kat, 
Shin, Dara, Burke, Pete, Will, Kate, Mike, Dima, Andel, Chacko, Laura, Rachel, 
Nick, Jimmy, I would not have made it to this particular finish line without you. 
Importantly, I would like to thank my family, Nico, Ina, Leendertjan and Peter. 
You have supported me unconditionally over the years for which I am very 
grateful. I am not the first in our family with a PhD and probably not the last; this 
would not be possible without your enthusiasm, support and trust in us. Finally, I 
want to thank Johannes. We met during my first weeks in New York and I have 
benefited immensely from your love, encouragement, scientific curiosity and 
patience. Thank you for believing in me no matter what. I am looking forward to 
spending the next chapter of our lives together. 
v 
Table of Contents 
Acknowledgements ........................................................................................... iii 
Table of Contents ................................................................................................ v 
List of Figures ..................................................................................................... ix 
List of Abbreviations .......................................................................................... xi 
Chapter 1: Introduction ....................................................................................... 1 
1.1 Mammalian DNA damage response pathways ............................................... 2 
1.1.1 DNA damage ................................................................................................... 2 
1.1.2 ATM kinase and DSB repair ............................................................................ 5 
1.1.3 Classical and Alternative NHEJ ....................................................................... 7 
1.1.4 Homologous Recombination .......................................................................... 10 
1.1.5 ATR kinase activation and replication stress ................................................. 13 
1.1.6 ATR regulates origin firing ............................................................................. 14 
1.1.7 Fork stabilization by ATR ............................................................................... 15 
1.1.8 Crosstalk between the ATM and ATR pathway ............................................. 15 
1.2 The role of 53BP1 in the DNA damage response pathway ............................. 17 
1.2.1 53BP1 is a key regulator in the DNA damage response pathway ................. 17 
1.2.2 Structure of 53BP1 ......................................................................................... 19 
1.2.3 Recruitment of 53BP1 .................................................................................... 21 
1.2.4 Regulation of end-resection in mammalian cells ........................................... 24 
1.2.5 53BP1 mediated chromatin mobility .............................................................. 27 
1.3 The structure and function of telomeres ......................................................... 29 
1.3.1 Telomeres protect the end of linear chromosomes ........................................ 29 
1.3.2 Telomerase counteracts the end-replication problem .................................... 31 
1.3.3 Shelterin protects against the end-protection problem .................................. 32 
1.3.4 TRF2 prevents ATM activation and NHEJ ..................................................... 35 
1.3.5 TRF1 is required or telomere replication ........................................................ 37 
vi 
1.3.6 Fragile sites .................................................................................................... 38 
1.3.7 Fragile site cleavage prevents anaphase bridges .......................................... 39 
1.3.8 TRF1 recruits BLM to prevent fragile telomeres ............................................ 40 
1.3.9 TRF1 prevents the formation of sister associations ....................................... 41 
1.3.10 Dysfunctional telomeres as a model for DNA damage response pathways 42 
Chapter 2: 53BP1 dissociation of function mutants ...................................... 44 
2.1 Introduction ......................................................................................................... 45 
2.2 Results ................................................................................................................. 46 
2.2.1 Generation of 53BP1 mutants ........................................................................ 46 
2.2.2 Rif1 is the only factor downstream of 53BP1 controlling resection ................ 52 
2.2.3  53BP1 mutant alleles promote varying levels of telomere fusions ................ 56 
2.2.4 Identification of the 53BP1 mobility domain ................................................... 60 
2.2.5 No interaction detected between Sun1 and 53BP1 ....................................... 64 
2.2.6 Exploring a role for known 53BP1 interacting partners in chromatin mobility 70 
2.2.7 Oligomerization domain of 53BP1 ................................................................. 73 
2.3 Summary of findings .......................................................................................... 81 
Chapter 3: The nature of telomere sister associations formed upon loss of 
TRF1 ................................................................................................................... 84 
3.1 Introduction ......................................................................................................... 85 
3.2 Results ................................................................................................................. 92 
3.2.1 PARP1 is required for Sister Associations ..................................................... 92 
3.2.2. Ligase 3 is involved in the formation of Sister Associations ......................... 95 
3.2.3 Ku does not affect Sister Associations ........................................................... 99 
3.2.4 Anaphase bridges are seen upon deletion of TRF1 .................................... 101 
3.2.5 PICH localizes to DNA bridges upon deletion of TRF1 ................................ 104 
3.2.6 The role of 53BP1 at sites of replication stress ............................................ 111 
3.2.7 Rif1 acts downstream of 53BP1 to promote Sister Associations ................. 120 
3.2.8 A enigmatic role for Exo1 in the formation of Sister Associations ................ 125 
3.3 Summary of findings ........................................................................................ 128 
vii 
Chapter 4: Gen1 cleaves fused sister telomeres ......................................... 131 
4.1 Introduction ....................................................................................................... 132 
4.2 Results ............................................................................................................... 136 
4.2.1 Gen1 loss induces chromatin bridges after TRF1 loss ................................. 136 
4.2.2 Aphidicolin does not induce chromatin bridges ............................................ 143 
4.2.3 Gen1 loss does not affect the frequency of SAs or telomere fragility ........... 145 
4.2.4 Gen1 loss increases the frequency of isochromosomes .............................. 147 
4.2.5 TRF1F/FGen1-/- cells display increased mitotic failure .................................. 154 
4.2.6 Overexpression of mutant Gen1 alleles in TRF1F/FGen1-/- MEFs ................ 156 
4.2.7 Chromatin bridges are not an SV40 artifact ................................................. 160 
4.2.8 PARP1 deletion rescues chromatin bridge formation .................................. 164 
4.2.9 Mus81 depletion aggravates the Gen1-/- effect ............................................ 167 
4.3 Summary of findings ........................................................................................ 176 
Chapter 5: Discussion .................................................................................... 179 
5.1 Dissociation of function mutants of 53BP1 ................................................... 180 
5.1.1 Rif1 is the only factor downstream of 53BP1 inhibiting resection ................ 180 
5.1.2 The connection between 53BP1 and the LINC complex ............................. 182 
5.1.3 The function of chromatin mobility in response to damage .......................... 186 
5.2 The fusion of sister telomeres by a-NHEJ and cleavage by Gen1 .............. 188 
5.2.1 Telomeres are prone to a-NHEJ in absence of TRF1 .................................. 188 
5.2.4 Telomere entanglements in yeast ................................................................ 194 
5.2.6 The role of Ku in preventing a-NHEJ at telomeres ...................................... 202 
5.2.7 Gen1 cleaves SAs ....................................................................................... 204 
5.2.8 Critically short telomeres in human cells fuse via a-NHEJ ........................... 207 
Chapter 6: Materials and Methods ................................................................. 210 
6.1 Cell culture techniques .................................................................................... 211 
6.1.1 Mammalian cell culture ................................................................................ 211 
viii 
6.1.2 Calcium phosphate precipitation transfection of 293T and Phoenix cells .... 212 
6.1.3 Retroviral gene delivery ............................................................................... 212 
6.1.4 Lentiviral gene delivery of shRNAs .............................................................. 213 
6.1.5 Cre mediated gene deletion ......................................................................... 214 
6.1.6 Generation of CRISPR/Cas9 knockout cell lines ......................................... 214 
6.1.7 PARPi treatment of cells .............................................................................. 216 
6.2 Molecular techniques ....................................................................................... 216 
6.2.1 Cloning techniques ...................................................................................... 216 
6.2.2 Co-immunoprecipitation in 293T cells .......................................................... 219 
6.2.3 Co-immunoprecipitation of endogenous Sun1 from MEFs .......................... 221 
6.2.4 Western blotting ........................................................................................... 222 
6.2.6 Chromatin immunoprecipitation (ChIP) ........................................................ 223 
6.2.7 Telomere overhang analysis ........................................................................ 224 
6.2.8 Quantitative PCR analysis ........................................................................... 226 
6.3 Imaging techniques .......................................................................................... 227 
6.3.1 IF and IF-FISH ............................................................................................. 227 
6.3.2 Chromatin bridge analysis ........................................................................... 228 
6.3.3 Metaphase telomeric FISH .......................................................................... 229 
6.3.4 Isochromosome analysis ............................................................................. 230 
6.3.5 Live-cell imaging for chromatin mobility analysis ......................................... 230 
6.3.6 Live-cell imaging for mitotic abnormalities ................................................... 231 
6.4 Lists of cell lines used ..................................................................................... 232 
6.5 List of shRNA used ........................................................................................... 233 
References ....................................................................................................... 235 
ix 
List of Figures 
Figure 1.1 ATM and ATR activation ................................................................................................ 4 
Figure 1.2 Pathways for c-NHEJ and a-NHEJ ................................................................................. 9 
Figure 1.3 Homologous recombination .......................................................................................... 12 
Figure 1.4 Functions of 53BP1 ...................................................................................................... 20 
Figure 1.5 Structure of 53BP1 ....................................................................................................... 20 
Figure 1.6 Recruitment of 53BP1 to DSBs .................................................................................... 23 
Figure 1.7 Shelterin protects chromosome ends ........................................................................... 30 
Figure 2.1 Gibson cloning of 53BP1 mutant alleles ....................................................................... 47 
Figure 2.2 53BP1 mutant alleles ................................................................................................... 48 
Figure 2.3 Rif1 recruitment to 53BP1 ............................................................................................ 50 
Figure 2.4 53BP1 mutant alleles localize to telomeres .................................................................. 51 
Figure 2.5 Schematic of telomere overhang assay ....................................................................... 54 
Figure 2.6 53BP1ΔRif1 cannot protect telomeres from end resection .............................................. 55 
Figure 2.7 Analysis of telomere fusions in cells expressing mutant 53BP1 alleles. ...................... 57 
Figure 2.8 Analysis of telomere fusions in cells deficient for the LINC complex ............................ 58 
Figure 2.9 53BP1ΔMOB is deficient in stimulating chromatin mobility .............................................. 62 
Figure 2.10 Interaction between 53BP1 and Sun1 is not consistently detected ............................ 65 
Figure 2.12 Telomere fusions upon depletion of potential 53BP1 and Sun1 interaction partners . 71 
Figure 2.13 Telomere CHIP ........................................................................................................... 72 
Figure 2.14 53BP1 oligo mutants .................................................................................................. 75 
Figure 2.15 Telomere fusions in MEFs expressing oligo mutants ................................................. 77 
Figure 2.16 Localization of 53BP1 oligo mutants to telomeres is affected .................................... 79 
Figure 3.1 TRF1 deletion phenotype ............................................................................................. 87 
Figure 3.3 PARP1 is required for the formation of SAs ................................................................. 93 
Figure 3.4 Depletion of Lig3 reduces SAs ..................................................................................... 96 
Figure 3.5 Lig1 and Lig4 do not affect the frequency of SAs ......................................................... 97 
Figure 3.6 Ku does not affect SAs ............................................................................................... 100 
Figure 3.7 Mitotic abnormalities after TRF1 loss ......................................................................... 103 
Figure 3.8 PICH localizes to anaphase bridges .......................................................................... 106 
Figure 3.9 PICH localizes to bridges after deletion of TRF2 ........................................................ 109 
x 
Figure 3.10 Phosphorylation of 53BP1 upon TRF1 or TRF2 deletion ......................................... 112 
Figure 3.12 Telomere overhang gel in TRF1F/F53BP1-/- cells ...................................................... 115 
Figure 3.13 53BP1 S/TQ sites affect the frequency of SAs ......................................................... 117 
Figure 3.14 53BP1 S/TQ sites affect SAs in two additional cell lines .......................................... 118 
Figure 3.15 CRISPR/Cas9 editing of 53BP1 in TRF1F/FRif1F/F MEFs .......................................... 121 
Figure 3.16 Analysis of SAs and fragility in TRF1F/FRif1F/F53BP1-/- MEFs ................................... 122 
Figure 3.17 Analysis of SAs and fragility upon deletion of Exo1 or BLM ..................................... 126 
Figure 4.1 A cruciform DNA structure from a telomere fusion and pathways of Holliday Junction 
resolvases in mammalian cells .................................................................................................... 133 
Figure 4.2 CRISPR/Cas9 editing of Gen1 in TRF1F/F MEFs ........................................................ 137 
Figure 4.3 Growth curve .............................................................................................................. 138 
Figure 4.4 Gen1 null cells display increased chromatin bridges after deletion of TRF1 .............. 139 
Figure 4.5 CRISPR/Cas9 editing of Gen1 in TRF1F/F cell line 9.3 ............................................... 141 
Figure 4.6 Aphidicolin treatment does not induce chromatin bridges in TRF1F/FGen1-/- MEFs ... 144 
Figure 4.7 SAs and telomere fragility in TRF1F/F20.6Gen1-/- clones ............................................ 146 
Figure 4.8 Faith of a sister fusion in absence of Gen1 ................................................................ 148 
Figure 4.9 Verification of isochromosome analysis ..................................................................... 149 
Figure 4.10 Isochromosomes are increased in Gen1 null cells ................................................... 153 
Figure 4.11 Anaphase bridges in TRF1F/FGen1-/- cells persist longer .......................................... 155 
Figure 4.12 TRF1F/FGen1-/- cells with overexpressed Gen1 ........................................................ 158 
Figure 4.13 CRISPR/Cas9 editing of Gen1 in TRF1F/Fp53-/- MEFs ............................................. 162 
Figure 4.14 Knockdown of PARP1 reduces chromatin bridge formation in TRF1F/FGen1-/- cells 165 
Figure 4.15 Quantification of Mus81 knockdown by qPCR ......................................................... 169 
Figure 4.16 Growth curve of Gen1 clones after depletion of Mus81 ........................................... 170 
Figure 4.17 Chromatin bridges are increased after depletion of Mus81 ...................................... 171 
Figure 4.18 Telomere SAs, fragility and isochromosomes after Mus81 depletion ....................... 174 
Figure 5.1 Models for the interaction between 53BP1 and Sun1 ................................................ 184 
Figure 5.2 Proposed function of 53BP1-dependent mobility of DSBs ......................................... 187 
Figure 5.3 Model for the fork stabilization in absence of TRF1 ................................................... 198 
Figure 5.4 Model for the formation of sister telomere fusions upon TRF1 loss ........................... 201 
Figure 5.5 Model for the role of Gen1 at telomeres fused by a-NHEJ. ........................................ 205 
xi 
 List of Abbreviations 
53BP1    p53 binding protein 1 
ATM       Ataxia telangiectasia mutated 
ATR      ATM- and Rad3- related 
BLM     Bloom’s syndrome helicase 
BRCA1   Breast cancer (early onset) 1 
BRCT     BRCA1 C-terminal 
CDK     Cyclin-dependent kinase 
CFS     Common fragile site 
ChIP Chromatin    
immunoprecipitation 
co-IP     Co-immunoprecipitation 
CO     Crossover 
CSR     Class switch recombination 
DDR     DNA damage response 
dHJ     Double Holliday Junction 
DSB     Double strand break 
Exo1     Exonuclease 1 
FISH Fluorescence in situ     
hybridization 
G4     G-quadruplexes 
HR     Homologous recombination 
IF     Immunofluorescence 
INM     Inner nuclear membrane 
IP     Immunoprecipitation 
IR     Ionizing radiation 
Ku     Ku70/80 
LINC Linker of Nucleoskeleton and 
Cytoskeleton 
Lig(x) Ligase (1,3 or 4) 
MDC1  Mediator of DNA damage 
checkpoint 1 
MEF Mouse embryonic 
fibroblast 
MRN Mre11-Rad50-Nbs1 
NCO Non crossover 
NHEJ Non-homologous end 
joining 
c-NHEJ Classical NHEJ 
a-NHEJ lternative NHEJ 
ONM Outer nuclear membrane 
PARP1 Poly [ADP-ribose] 
polymerase 1 
PARPi PARP inhibitor 
Rif1 Rap1 interacting factor 1 
RPA Replication protein A 
SA Sister Association 
S/TQ       Serine or Threonine  
and Glutamine 
SSB        single stranded break 
UDR        Ubiquitin dependent 
recruitment 
UFB Ultrafine Bridge 
WRN        Werner syndrome 
helicase
     1 
Chapter 1: Introduction 
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1.1 Mammalian DNA damage response pathways 
1.1.1 DNA damage 
The integrity of the DNA in each cell in the human body is under constant attack 
from thousands of DNA insults every day (Hoeijmakers, 2009). These lesions can 
block transcription and replication and can lead to mutations and large 
chromosomal aberrations if not accurately repaired (Jackson and Bartek, 2009). 
To counteract the consequences of DNA damage, cells have developed complex 
repair mechanisms to safeguard the integrity of the genome. Defects in these 
pathways leave cells highly sensitive to DNA damaging agents and are linked to 
different types of human disease. Furthermore, genome instability resulting from 
defective DNA repair pathways forms the basis for nearly all types of cancer. A 
good understanding of the different DNA damage response pathways and their 
interplay is therefore essential. 
Cells are subject to different types of DNA damage including nicks, gaps, 
single stranded breaks (SSBs), double-stranded breaks (DSBs) and base 
modifications. Distinct DNA repair mechanisms have evolved to sense and repair 
each of these lesions. Small base modifications such as deamination or 
depurination can be repaired through mismatch repair (MMR) or base excision 
repair (BER). More bulky DNA adducts are repaired via nucleotide-excision repair 
(NER) whereas SSBs can be repaired via distinct single-strand break repair 
pathways (SSBR).  Ionizing radiation (IR), replication fork collapse or reactive 
oxygen species (ROS) can form DNA DSBs which can be repaired via 
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nonhomologous end-joining (NHEJ) or homologous recombination (HR) 
depending on the stage of the cell cycle. 
Key to orchestrating these different DNA repair pathways are members of 
the phosphatidylinositol 3-kinase-like family of protein kinase (PIKKs) family 
(ATM kinase, ATR kinase and to a lesser extend DNA-PK), which coordinate 
rapid and potent signal transduction pathways to initiate repair (Harper and 
Elledge, 2007). ATM, ATR and DNA-PK are threonine/serine kinases that 
recognize a common motif, which is their target threonine or serine followed by a 
glutamine residue (S/TQ site). While this consensus target motif might indicate 
redundancy, each kinase has a specific function and a different but overlapping 
set of substrates (Matsuoka et al., 2007). Moreover, ATM and DNA-PK respond 
to DSBs whereas ATR kinase is activated upon single-stranded DNA formed 
during replication stress and upon resection of DSBs (Fig. 1.1). Phosphorylation 
of S/TQ sites in specific target proteins results in the recruitment of a variety of 
effector proteins that together orchestrate repair of the DNA lesion or activate 
apoptotic and senescent pathways if the damage is too severe. Activation of ATM 
and ATR also triggers cell-cycle checkpoints through activation of Chk1 and 
Chk2 (Sanchez et al., 1997; Matsuoka et al., 1998; Chaturvedi et al., 1999; Liu et 
al., 2000; Matsuoka et al., 2000). These kinases phosphorylate the Cdc25 family 
of phosphatases thereby preventing their activity. This leads to cell-cycle arrest in 
G1 or G2/M as Cdc25 proteins are responsible for activation of cyclin-dependent 
kinases (CDKs) which control cell cycle progression 
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Figure 1.1 ATM and ATR activation 
(A) ATM is activated by the MRN complex, which rapidly binds to DSBs. Upon activation, ATM 
phosphorylates histone H2AX recruiting MDC1 which propagates the γH2AX signal. MDC1 itself 
further stimulates ATM activation, resulting in signal amplification. (B) A crucial step for ATR 
activation is RPA binding to ssDNA resulting in the recruitment of ATR via its binding partner 
ATRIP. An additional step is needed to activate ATR. The most studied factor is TopBP1, which is 
recruited to the ssDNA/dsDNA junction via the 9-1-1 complex. A second pathway occurs via 
ETAA1, which directly binds RPA away from the ssDNA/dsDNA junction and has a similar ATR 
activating domain as TopBP1. 
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(Sanchez et al., 1997; Costanzo et al., 2000; Mailand et al., 2000). The delay in 
cell cycle progression ensures damaged DNA is not transmitted to daughter cells 
by allowing time for accurate repair.  ATM and ATR also activate the p53 tumor 
suppressor gene to further halt cell-cycle progression and activate proapoptotic 
or senescence pathways when the DNA damage is extensive (Tibbetts et al., 
1999; Shieh et al., 2000). 
1.1.2 ATM kinase and DSB repair 
DSBs are generated when both strands of the double helix are broken in close 
proximity. DSBs can arise inadvertently when replication forks collapse or by 
DNA damage inducing agents such as ionizing radiation or radiomimetic drugs 
(Jackson and Bartek, 2009). But DSBs are also formed during normal 
physiological processes such as programmed immune receptor rearrangements 
in lymphocytes during V(D)J recombination and class switch recombination 
(CSR) events (Dudley et al., 2005). 
An initiating step for DSB repair is sensing of the lesion by the Mre11-
Rad50-Nbs1 (MRN) complex. MRN is a multifaceted complex that is required for 
several DNA repair pathways and its widespread functions are not yet fully 
understood on a molecular level (Stracker and Petrini, 2011). Among its many 
functions, MRN can act as DSB sensor, tether broken ends together and provide 
nucleolytic processing of the DNA ends (Lee et al., 1998; Nelms et al., 1998; de 
Jager et al., 2001; Mirzoeva and Petrini, 2001; Hopfner et al., 2002; Mimitou and 
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Symington, 2008; Zhu et al., 2008). Importantly, MRN is essential for the 
recruitment and activation of ATM at DSBs by promoting monomerization and by 
acting as cofactor for the catalytic activity of ATM  (Carney et al., 1998; Stewart 
et al., 1999; Lim et al., 2000; Uziel et al., 2003; Lee and Paull, 2004; Lee and 
Paull, 2005; Paull, 2015). 
The Mre11 nuclease forms the core of the MRN complex and harbors both 
exonuclease and endonuclease activity to initiate resection, the latter of which is 
stimulated by interaction with CtIP (Sartori et al., 2007; Mimitou and Symington, 
2008; Zhu et al., 2008; Wang et al., 2013). The directionality of the exonuclease 
activity however is towards the break in the 3’-5’ direction, opposite of polarity 
required for resection. The MRN complex therefore only performs the resection 
initiation step but its activity is thought to be important for the clearance of 
adducts and blockages from DNA ends, such as topoisomerases or Ku (Mimitou 
and Symington, 2008; Zhu et al., 2008; Hartsuiker et al., 2009; Garcia et al., 
2011; Stracker and Petrini, 2011; Deshpande et al., 2016). 
Once MRN has activated ATM kinase, the DNA damage response 
pathway is activated at DSBs (Fig. 1.1). A key initial function of ATM is 
phosphorylation of histone variant H2AX on serine 139, which rapidly spreads 
over a large chromatin domain surrounding the DBS site (Rogakou et al., 1998; 
Burma et al., 2001). Key to propagating the γH2AX signal is Mediator of DNA 
damage Checkpoint 1 (MDC1), which directly binds γH2AX as well as ATM and 
the MRN complex thereby further stimulating their activation (Stewart et al., 2003; 
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Lee et al., 2005; Lou et al., 2006; Chapman and Jackson, 2008). Besides 
propagating the γH2AX signal, MDC1 recruits the E3 ubiquitin ligase RING finger 
8 (RNF8) and other proteins that eventually result in the recruitment of 53BP1 
and other DNA repair proteins, which will be discussed in more detail in Chapter 
1.2.  
1.1.3 Classical and Alternative NHEJ 
Repair of DSBs occurs mainly via two repair pathways in eukaryotic cells: 
classical NHEJ (c-NHEJ) and HR (Fig. 1.2 and 1.3). The prevailing model in 
mammalian cells is that most clean, blunt breaks are rapidly repaired by NHEJ in 
all stages of the cell cycle, in a process that depends on binding of DNA ends by 
Ku70/80 (Ku) and ligation by DNA ligase VI (Lig4). In S/G2, repair switches to 
HR, which uses the newly replicated sister chromatid as template for accurate 
repair. The decisive factor between these two pathways is resection of the 5’ 
ends since HR requires annealing to a homologous template strand. 
C-NHEJ is a rapid, reliable, error-free repair mechanism when executed 
properly and is initiated by loading of Ku onto broken ends (Fig. 1.2)(Lieber, 
2010). Ku is a highly abundant ring-shaped heterodimer (Ku70 and Ku80) with 
high affinity for duplex DNA and the complex rapidly slides onto both ends of the 
break. There, it serves as docking site for core repair factors such as DNA-PKcs, 
XRCC4, DNA Lig4, Artemis, XRCC4-like factor (XLF) and PAXX, which help 
stabilize the repair complex and ligate the broken ends together (Lieber, 2010; 
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Waters et al., 2014; Ochi et al., 2015; Xing et al., 2015). Not all DNA ends are 
directly compatible for end-joining by c-NHEJ due to chemical modifications at 
the break site originating from the source of damage. Therefore several 
accessory proteins, such as the Artemis nuclease, are recruited to remove 
damaged bases, hairpins or other obstructions. This allows c-NHEJ to function 
on a wide range of DNA end substrates (Chang et al., 2016). 
C-NHEJ has long been considered an error-prone repair pathway because 
it does not rely on a homologous sister template to repair the lesion and small 
deletions at the junction can occur. However, more recently a different 
mammalian NHEJ pathway has been attributed to mutagenic repair that does not 
rely on Ku or Lig4. This pathway employs Poly[ADP-ribose] polymerase 1 
(PARP1) and DNA Ligase III (Lig3), relies on extensive microhomology at the 
break site and is known as alternative NHEJ (a-NHEJ) (Fig. 1.3)(Boboila et al., 
2010; Simsek et al., 2011; Frit et al., 2014; Pannunzio et al., 2014). This pathway 
operates when core components of the c-NHEJ machinery are missing, such as 
Ku or Lig4 (Kabotyanski et al., 1998; Verkaik et al., 2002; Wang et al., 2003; 
Weinstock et al., 2007). Mechanistically, a DSB is recognized by PARP1 in the a-
NHEJ pathway, a step normally inhibited by Ku (Wang et al., 2006). End-
resection by MRN, CtIP and Exonuclease1 (Exo1), DNA2 and Bloom’s syndrome 
helicase (BLM) are then thought to expose sufficient microhomology to allow a-
NHEJ to take place, although the precise mechanism remains unclear. The 
Werner syndrome protein (WRN) has also been implicated in resection together 
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Figure 1.2 Pathways for c-NHEJ and a-NHEJ 
c-NHEJ is initiated by Ku loading onto the DNA ends, where it serves as docking sites for 
additional proteins such as DNK-PKcs, XRCC4 and Artemis that help with end-processing steps if 
required. The final ligation step is done by DNA ligase 4.  
a-NHEJ occurs in absence of cNHEJ components and requires microhomology surrounding the 
DSB (in red). The break is recognized by PARP1, followed by limited end-resection by the MRN 
complex and CtIP. Upon annealing of the exposed microhomology domains, Polθ fills in any gaps 
while Lig3 performs the final ligation step. 
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with DNA2 (Sturzenegger et al., 2014). However, it is thought that WRN limits the 
a-NHEJ pathway by suppressing MRN and CtIP although the precise 
mechanisms are not well understood (Shamanna et al., 2016).  Importantly, a-
NHEJ has been linked to pathological repair of DSBs resulting in large deletions, 
insertions and whole chromosomal translocations (Yan et al., 2007; Simsek and 
Jasin, 2010; Simsek et al., 2011).  
There is significant controversy whether a-NHEJ represents a distinct 
back-up repair pathway or merely pathological processing that occurs when c-
NHEJ fails (Deriano and Roth, 2013; Frit et al., 2014; Pannunzio et al., 2014). 
The reason behind this controversy is that a-NHEJ is highly versatile regarding 
the proteins involved in the process. For example, DNA ligase 1 (Lig1) can 
replace Lig3 when the latter is absent (Paul et al., 2013). Furthermore, no 
physiological relevant function has been uncovered for a-NHEJ, except as 
backup where others fail. However, given the importance of a-NHEJ in 
pathological situations, a better understanding of both NHEJ pathways remains 
important, whether a-NHEJ represents a physiological pathway or not. 
1.1.4 Homologous Recombination 
Errors during DNA replication give rise to DSBs in S/G2 of the cell cycle that are 
preferentially repaired using the homologous template to ensure accurate repair 
without loss of genetic information (Fig. 1.3). Central to HR is end-resection, 
which is initiated by the MRN complex together with CtIP followed by more 
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extensive resection by Exo1, and DNA2 together with BLM and WRN (Sartori et 
al., 2007; Mimitou and Symington, 2008; Nimonkar et al., 2008; Zhu et al., 2008; 
Sturzenegger et al., 2014).  Replication Protein A (RPA) rapidly binds the 
resulting long 3’ single-stranded overhang and has a stabilizing and protective 
function. For HR to proceed, RPA has to be displaced by Rad51 in a process 
stimulated by BRCA2 (Baumann et al., 1996; Wong et al., 1997; Davies et al., 
2001; Jensen et al., 2010). The Rad51 coated filament catalyzes homology 
search and strand invasion into a homologous region forming a D-loop, where it 
forms a primer for new DNA synthesis from using the homologous template to 
initiate repair. 
Completion of HR can proceed via two pathways ending in crossover (CO) 
or non-crossover (NCO). First, synthesis dependent-strand annealing (SSDA) 
allows the extended ssDNA to dissociate from the D-loop and anneal back to the 
other ssDNA end resulting in NCO (Nassif et al., 1994). In a separate pathway 
called double-strand break repair (DSBR), the other end of the DSB end is 
captured in the D-loop forming an intermediate structure with a double Holliday 
junction (dHJ) (Szostak et al., 1983). Processing of this dHJ can involve 
dissolution by the BLM helicase resulting in harmless NCO. However, the dHJ 
can also be cleaved by resolvases such as SLX1/SLX4 and Mus81 or Gen1 
resulting in NCO or CO. This potential for CO events is toxic for cells as it can 
lead to loss of heterozygosity (Moynahan and Jasin, 2010). Presumably, 
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Figure 1.3 Homologous recombination 
In S/G2, DSB are preferentially repaired via HR since a homologous template is available. Central 
to HR is extensive resection by the MRN complex together with CtIP, Exo1, BLM and DNA2. The 
ssDNA is coated by RPA, which is replaced by Rad51 in a process dependent on BRCA2. Rad51 
catalyzes strand invasion into the homologous template forming a D-loop structure, and DNA 
synthesis from the homologous template occurs. From here, two separate pathways can occur. In 
SDSA, the newly synthesized strand dissociates from the D-loop and anneals back to the other 
ssDNA yielding a NCO. In DSBR, the second end of the DSB is captured in the D-loop creating 
an intermediate structure with a dHJ. Dissolution can take place by the BLM helicase (not shown). 
Alternatively, resolution can occur if resolvases cleave the dHJ resulting in either NCO or CO 
depending on orientation of the cleavage. 
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SSDA or dissolution by BLM is more prevalent as CO events are suppressed in 
mitotic cells (Stark and Jasin, 2003). 
1.1.5 ATR kinase activation and replication stress 
Whereas ATM is dispensable for cell viability, deletion of ATR kinase is lethal, 
signifying its broad contribution to the DNA damage response (Brown and 
Baltimore, 2000; Cortez et al., 2001; Brown and Baltimore, 2003). ATR is 
activated in every S-phase to respond to stalled and collapsed replication forks 
and regulates origin firing as well as checkpoint activation to prevent premature 
mitosis in presence of damage (Costanzo et al., 2003; Pichierri and Rosselli, 
2004; Woodward et al., 2006). The binding of RPA to ssDNA is a crucial step in 
the activation process of ATR (Fig. 1.1). RPA is a highly conserved heterotrimeric 
complex consisting of 70, 32 and 14 kDa subunits that bind ssDNA with high 
affinity using four OB (oligonucleotide/oligosaccharide binding) folds. The role of 
RPA is to stabilize the unwound ssDNA, prevent and remove secondary 
structures and interact with DNA processing proteins to form an appropriate 
response to ssDNA (Wold and Kelly, 1988; Wold, 1997; Chen et al., 2013). ATR 
recognizes ssDNA bound RPA together with its interaction partner ATR-
interacting protein (ATRIP) (Cortez et al., 2001; Zou and Elledge, 2003). But this 
interaction alone is not sufficient to activate ATR, as it requires an ATR-activating 
domain (AAD) containing protein to accomplish this (MacDougall et al., 2007). 
The most studied ATR activating protein is TopBP1, which is recruited to the 
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junction of ssDNA and dsDNA via the Rad9-Rad1-Hus1 (9-1-1) complex and 
RHINO (Bermudez et al., 2003; Kumagai et al., 2006; Delacroix et al., 2007; 
Cotta-Ramusino et al., 2011). Recently, a second pathway for ATR activation 
was described in mammalian cells with the discovery of a second AAD-
containing protein ETAA1 (Bass et al., 2016; Haahr et al., 2016). In contrast to 
TopBP1, ETAA1 binds RPA directly and activates ATR in response to replicative 
stress but not in response to DSB-inducing agents. Furthermore, activation of 
ATR by ETAA1 causes phosphorylation of distinct ATR substrates as in 
response to TopBP1, indicative of parallel pathways. The ability of ETAA1 to 
activate ATR away from the ssDNA/dsDNA junction might signify an ability to 
propagate the activation of ATR over long stretches of ssDNA although concrete 
evidence for this idea is lacking. 
1.1.6 ATR regulates origin firing 
Once activated at a DNA lesion or a stalled replication fork, ATR phosphorylates 
a multitude of substrates (Matsuoka et al., 2007). Most notably, ATR activates 
Chk1 via phosphorylation of Ser317 and Ser345, often used as a marker of ATR 
activation (Walworth and Bernards, 1996; Liu et al., 2000). Chk1 phosphorylates 
CDC25 to prevent entry into mitosis. Chk1 activation also slows replication by 
limiting global dormant origin firing (Tercero and Diffley, 2001). However, near 
the stalled fork the ATR pathway has an opposite effect and promotes dormant 
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origin firing via activation of PLK1 and CDC45 (Woodward et al., 2006; Ge et al., 
2007; Ibarra et al., 2008). 
1.1.7 Fork stabilization by ATR 
 An important function of ATR lies in its ability to stabilize the replication fork, 
preventing its collapse and the formation of a DSB (Lopes et al., 2001; Tercero 
and Diffley, 2001). The precise mechanism through which ATR stabilizes the 
replication fork is still poorly understood. It may involve retaining components of 
the replisome at the replication fork since DNA polymerases alpha (Pol α) and 
epsilon (Pol ε ) are lost in absence of ATR signaling (Cobb et al., 2003; Lucca et 
al., 2004). 
After stabilizing the fork, DNA repair and restart of the replication fork 
takes place. Depending on the type of damage, ATR phosphorylates and recruits 
different DNA repair enzymes that regulate phosphorylation of H2AX and 
recruitment 53BP1, the RecQ helicases BLM and WRN, BRCA1 and many 
others. Together these enzymes repair the DNA lesion and reinitiate DNA 
replication at the fork. 
1.1.8 Crosstalk between the ATM and ATR pathway 
Although ATM and ATR respond to different DNA structures and have many 
distinct substrates, there is some redundancy between the pathways such as 
checkpoint activation and H2AX phosphorylation (Ward and Chen, 2001; 
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Matsuoka et al., 2007). Furthermore, there is significant crosstalk between the 
pathways as ATM can be activated at DSBs generated at collapsed replication 
forks and ATR is activated by ssDNA after end-resection at DSBs. What appears 
to be a defining factor in the cellular response to damage is the kinetics of 
activation of either pathway. 
ATM is rapidly activated at DBSs but resection in S/G2 causes a switch 
from ATM to ATR activation as a result of ssDNA formation. Interestingly, several 
studies showed that ATR activation in response to IR induced DSBs requires 
ATM and the MRN complex (Cuadrado et al., 2006; Jazayeri et al., 2006; Myers 
and Cortez, 2006). Absence of either ATM or MRN reduces the levels of RPA foci 
formation indicative of limited end-resection. A key step by which ATM activates 
ATR is by stimulating initial CtIP dependent resection to form ssDNA. 
Additionally, ATM recruits and phosphorylates TopBP1, the ATR activating 
protein (Yoo et al., 2007). Once activated, ATR phosphorylates CtIP at T818, a 
modification that stabilizes chromatin bound CtIP and promotes robust resection 
(Peterson et al., 2013). Secondly, ATR mediated activation of Chk1 is essential 
to activate the G2/M checkpoint and prevents cells from entering mitosis with 
damaged DNA (Brown and Baltimore, 2003). Chk2 also enforces the G2/M 
checkpoint, but regulates a more immediate effect whereas long-term arrest is 
maintained more by Chk1 (Brown and Baltimore, 2003; Rainey et al., 2008). 
 Conversely, the role of the ATM kinase at stalled replication forks is less 
understood. Mostly, ATM is activated when ATR signaling is compromised and 
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replication forks collapse to form DSBs (Chanoux et al., 2009). The role of ATM 
might be similar to its general DSB repair functions to promote repair of the 
collapsed replication fork (Cimprich and Cortez, 2008). Interestingly, replication 
stress results in the formation of 53BP1 nuclear bodies in the next G1, in a 
process that depends on the activation of ATM kinase (Harrigan et al., 2011; 
Lukas et al., 2011). The function of these structures remains elusive but they are 
thought to shield broken or unreplicated DNA from the previous S-phase allowing 
their repair before the next S-phase. They are present at low frequency in 
unperturbed cells and often form at Common Fragile Sites (CFS), regions of the 
genome that are difficult to replicate, further indicating that these 53BP1 nuclear 
bodies are the result of aberrant replication. 
1.2 The role of 53BP1 in the DNA damage response pathway 
1.2.1 53BP1 is a key regulator in the DNA damage response pathway 
53BP1 was initially discovered as a p53 interacting protein required for activation 
of the tumor suppressor protein (Iwabuchi et al., 1994; Iwabuchi et al., 1998). 
However, 53BP1 is much better known for its key role in regulating c-NHEJ and 
HR at DSBs (Panier and Boulton, 2014; Zimmermann and de Lange, 2014). The 
role of 53BP1 in regulating DSB repair emerged from work on immunoglobulin 
gene rearrangements, damaged telomeres and DSB repair defects in BRCA1-
deficient cells (Ward et al., 2003; Ward et al., 2004; Difilippantonio et al., 2008; 
Dimitrova et al., 2008; Bunting et al., 2010; Bothmer et al., 2011; Lottersberger et 
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al., 2013). Collectively, the data revealed 53BP1 as a multifaceted protein that 
controls the choice between c-NHEJ and HR by influencing key regulatory events 
at and near DNA ends. In particular, 53BP1 promotes c-NHEJ and contributes to 
lethal mis-repair of DSBs in BRCA1-deficient cells by inhibiting 5’ end resection 
(Fig. 1.4). The results also suggested that 53BP1 promotes c-NHEJ by 
increasing the mobility of damaged telomeric chromatin and by mediating 
synapsis of DNA ends in CSR (Difilippantonio et al., 2008; Dimitrova et al., 2008). 
The role of 53BP1 in c-NHEJ is evident in BRCA1-deficient cells. Upon 
inhibition of PARP1, transient nicks in DNA primarily resulting from base-excision 
repair (BER) are not repaired resulting in DSBs in S phase. In BRCA1-deficient 
cells, HR does not repair these breaks because BRCA1 promotes the 5’ 
resection needed for HR. Instead, 53BP1-dependent c-NHEJ leads to aberrant 
chromosome structures such as radials (Moynahan et al., 1999; Snouwaert et al., 
1999; Cao et al., 2009). Evidence from several systems revealed that the 
mechanism by which 53BP1 acts is through inhibition of DNA resection by 
CtIP/MRN (Bouwman et al., 2010; Bunting et al., 2010). Absence of 53BP1 can 
rescue the embryonic lethality of BRCA1-deficiency and represses the formation 
of radial chromosomes in PARPi-treated cell lacking BRCA1 (Bothmer et al., 
2011). 
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1.2.2 Structure of 53BP1 
53BP1 is a large 1972 amino acids protein that has no enzymatic activity of its 
own. Instead, 53BP1 functions as a scaffold to recruit DNA repair proteins to 
damaged chromatin. 53BP1 contains several functional domains as shown in 
Figure 1.5. The C-terminus of 53BP1 contains a Tudor domain and an ubiquitin 
dependent recruitment (UDR) motif responsible for binding damaged chromatin 
through interaction with H4K20me2 and H2AK15ub respectively (Huyen et al., 
2004; Fradet-Turcotte et al., 2013). The C-terminus also contains tandem BRCT 
domains that are important for DNA repair in heterochromatin and for the 
interaction with p53, but not for the promotion of NHEJ (Noon et al., 2010; 
Bothmer et al., 2011; Lottersberger et al., 2013; Cuella-Martin et al., 2016). The 
C-terminus of 53BP1 furthermore contains an oligomerization domain that 
contributes to optimal recruitment of 53BP1 to chromosome internal DSBs but is 
dispensable for recruitment to telomeres (Bothmer et al., 2011; Lottersberger et 
al., 2013). Nuclear localization of 53BP1 is promoted by the NLS signal in the 
center of the protein. 53BP1 also contains a PRMT1-methylated, glycine-arginine 
rich (GAR) domain and a dynein light chain 8 (LC8) binding motif, but the function 
of these domains is still unknown (Adams et al., 2005; Lo et al., 2005).  
Importantly, the N-terminus of 53BP1 contains 29 S/TQ sites that are 
phosphorylated by ATM and ATR in a DNA damage responsive fashion. While 
the S/TQ sites are not needed for 53BP1 recruitment to DSBs, its has been 
shown that phosphorylation is required for all of its known functions since they 
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Figure 1.4 Functions of 53BP1 
The main role of 53BP1 is to promote NHEJ. It does so via distinct methods. First, 53BP1 recruits 
Rif1 to block end resection in G1. BRCA1/CtIP counteracts Rif1 in S/G2 to allow for HDR to 
occur. 53BP1 also promotes NHEJ by stimulating the mobility of damaged chromatin through the 
LINC complex and cytoplasmic microtubules. Finally, 53BP1 recruits PTIP although the precise 
function of this interaction is not well understood. Possibly, PTIP is required for end-trimming of 
incompatible ends for NHEJ. 
Figure 1.5 Structure of 53BP1 
53BP1 binds to chromatin with its Tudor and UDR domain. It contains an NLS signal for nuclear 
localization and two BRCT domains in the very C-terminus. The LC8 domain binds dynein and 
the oligo domain is required for oligomerization. The C-terminus furthermore contains a GAR 
domain with an unknown function. Importantly, the N-terminus contains 28 S/TQ sites (red) that 
can be phosphorylated by ATM or ATR kinase and recruit proteins such as PTIP and Rif1 to 
DSBs.  
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serve as docking sites for interacting proteins such as Rif1 and PTIP (Anderson 
et al., 2001; Rappold et al., 2001; Bothmer et al., 2011; Lottersberger et al., 2013; 
Zimmermann et al., 2013). While the function of some interaction partners is 
known, the role of most binding proteins remains poorly defined. 
1.2.3 Recruitment of 53BP1 
The precise molecular mechanisms by which 53BP1 accumulates at sites of DNA 
damage has only recently been defined. It was long known that 53BP1 
recognizes H4K20me2 with its tandem Tudor domain (Botuyan et al., 2006). 
However, this chromatin mark is constitutive and does not distinguish damaged 
sites from the rest of the genome. How 53BP1 forms foci specifically near DSBs 
was shown recently by the identification of the UDR motif that binds ubiquitylated 
H2K15. The signaling cascade that is initiated by ATM mediated phosphorylation 
of H2AX establishes this mark (Fig. 1.6). MDC1 is recruited to phosphorylated 
H2AX, which in turn recruits the E3 ubiquitin ligase RNF8/UBC13 complex (Huen 
et al., 2007; Mailand et al., 2007). The major substrates for RNF8 and UBC13 
were long unknown. Recently it was discovered that RNF8 and UBC13 catalyze 
K63-linked polyubiquitylation of the linker histone H1 at DSB sites (Thorslund et 
al., 2015). This mark is recognized by yet another E3 ubiquitin ligase, RNF168, 
which is responsible for the ubiquitylation of H2A at K13/K15, the latter of which 
is recognized by 53BP1 (Doil et al., 2009; Stewart et al., 2009; Mattiroli et al., 
2012; Fradet-Turcotte et al., 2013). Thus, 53BP1 functions as a bivalent reader of 
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histone modifications and is recruited through a multistep signaling cascade that 
allows for signal amplification or modification when needed. 
Another determinant for recruitment of 53BP1 to sites of damage is the 
oligomerization domain of 53BP1. A 53BP1 mutant lacking this domain is 
incapable of foci formation at IR induced DSBs and is defective in CSR in 
lymphocytes (Ward et al., 2006; Zgheib et al., 2009; Bothmer et al., 2011). 
However, this mutant localizes to dysfunctional telomeres and is capable of 
partially promoting c-NHEJ at these sites (Lottersberger et al., 2013). Likely, the 
primary function of the oligomerization domain is to form dimers of 53BP1 as it 
can be replaced by an ectopic dimerization or tertramerization domain without 
loss of foci formation (Zgheib et al., 2009; Wilson et al., 2016). 
Interestingly, the pathway recruiting 53BP1 is suppressed during mitosis 
(Giunta et al., 2010; Orthwein et al., 2014). MDC1 is still bound to γH2AX but 
RNF8 is no longer recruited due to phosphorylation of RNF8 at Thr198 by CDK1 
(Orthwein et al., 2014). In support of this model, a RNF8 T198A mutant is 
insensitive to CDK1 activity and is able to form foci throughout mitosis whereas 
the phosphomimetic T198E mutant is incapable of foci formation in interphase 
cells or mitosis. However, although the T198A mutant restores RNF8 recruitment 
to DSBs in mitosis, it fails to recruit 53BP1. A second inhibitory pathway acts 
directly on 53BP1 to suppress its localization to DSBs. Specifically, CDK1 and 
PLK1 phosphorylate T1609 and S1618 in mitosis, two sites located in the UDR 
motif of 53BP1 (Orthwein et al., 2014). Thus, 53BP1 focus formation is inhibited 
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Figure 1.6 Recruitment of 53BP1 to DSBs 
53BP1 is recruited in response to a signaling cascade that starts with MRN accumulation at a 
DSB. MRN activates ATM kinase, which phosphorylates H2AX. This γH2AX forms a docking site 
for MDC1, which in turn recruits the ubiquitin ligaseRNF8 and UCB13. RNF8 catalyzes 
ubiquitylation of H1 resulting in the recruitment of RNF168. This ubiquitin ligase induces 
ubiquitylation of lysine15 on H2A, which is recognized by the UDR domain of 53BP1. The Tudor 
domain of 53BP1 furthermore binds the H4K20me2 group that is constitutively present on H4 
independent of DNA damage. 
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in mitosis by inhibitory phosphorylation of both RNF8 and 53BP1 itself. Why does 
53BP1 need to be so strictly suppressed during mitosis? Interestingly, restoring 
53BP1 foci formation in mitosis by using phosphomutants resulted in genome 
instability. These cells were highly sensitive to low dose of IR and showed high 
rates of micronuclei formation. Furthermore, these cells were prone to sister 
telomere fusions suggesting spontaneous DSB repair at telomeres. It was 
speculated that telomeres are transiently uncapped during mitosis thus requiring 
the inactivation of DSB repair to mitigate this threat to genome integrity (Orthwein 
et al., 2014). 
1.2.4 Regulation of end-resection in mammalian cells 
One of the mechanisms by which 53BP1 promotes c-NHEJ is by blocking 5’ end 
resection at broken ends in a cell-cycle dependent manner (Fig. 1.4) (Bothmer et 
al., 2010; Bunting et al., 2010). Resection is initiated in mammalian cells upon 
ATM activation by the MRN complex together with the CtIP (Sartori et al., 2007; 
Buis et al., 2008; Wang et al., 2013). In absence of CtIP, RPA foci do not form 
after IR and ATR is no longer recruited to DSBs indicating resection is inhibited 
(Sartori et al., 2007). CtIP is thought to activate the endonuclease activity of MRN 
to create a nick upstream of the DSB site. The 3’-5’ exonuclease activity of MRN 
towards the DNA end then creates a substrate for more extensive resection by 
Exo1 or DNA2 with BLM/WRN (Gravel et al., 2008; Nimonkar et al., 2008; 
Nimonkar et al., 2011; Tomimatsu et al., 2012; Sturzenegger et al., 2014). This 
initial processing step my MRN and CtIP is especially important with chemically 
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blocked ends, such as those arising after IR, whereas at clean ends MRN mainly 
functions to recruit other factors of the resection machinery (Buis et al., 2008; 
Nimonkar et al., 2011). 
The function of 53BP1 to block extensive resection by CtIP and Exo1 was 
first shown in CSR in lymphocytes (Bunting et al., 2010; Bothmer et al., 2011; 
Bothmer et al., 2013). Subsequent studies from several groups identified Rif1 as 
the effector, which is recruited to 53BP1 in an ATM/ATR phosphorylation 
dependent manner. Rif1 was shown as to be the main factor by which 53BP1 
blocks CtIP-initiated resection at DSBs in G1 therefore promoting c-NHEJ while 
blocking HR (Chapman et al., 2013; Di Virgilio et al., 2013; Escribano-Diaz et al., 
2013; Feng et al., 2013; Zimmermann et al., 2013). In S/G2, this inhibition of 
resection is counteracted by BRCA1, which displaces 53BP1, to allow resection 
and HR with the sister template to occur. Elegant studies revealed the 
mechanisms by which this cell cycle depended block to resection is achieved 
(Escribano-Diaz et al., 2013). In G1, when c-NHEJ is the pathway of choice, 
53BP1/Rif1 inhibit binding of BRCA1 at DSBs. Upon entry into S/G2, CDK1 
phosphorylates CtIP creating a CtIP/BRCA1 complex that displaces 53BP1/Rif1 
from damage foci to allow resection to take place. In absence of BRCA1 or when 
the interaction between CtIP and BRCA1 is lost, 53BP1/Rif1 form foci in S/G2 
and inhibit resection and repair via HR. Conversely, in absence of 53BP1, 
BRCA1 and CtIP locate to DBSs in G1 thereby promoting resection and inhibiting 
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c-NHEJ. As such, this regulatory circuit between 53BP1 and BRCA1 controls 
repair pathway choice. 
The importance of pathway choice can easily be seen in BRCA1 deficient 
cells treated with PARP1 inhibitors (PARPi). Upon treatment, nicks in the DNA 
are not repaired causing DSBs in S-phase. In BRCA1 deficient cells, these DBSs 
are repaired by c-NHEJ resulting in aberrant chromosome structures such as 
radials (Moynahan et al., 1999; Snouwaert et al., 1999; Cao et al., 2009). 
Deletion of 53BP1 rescues the lethality of PARPi and restores HR, suggesting 
that the main function of BRCA1 is displacement of 53BP1 in S/G2 (Bunting et 
al., 2010; Chapman et al., 2013; Di Virgilio et al., 2013; Escribano-Diaz et al., 
2013; Feng et al., 2013; Zimmermann et al., 2013). 
How Rif1 blocks resection or competes with BRCA1 is still unclear. 
Genetic screens aimed to find factors that alleviate the synthetic lethality of 
PARPi and BRCA1 recently discovered MAD2L2 (also called REV7) as a protein 
that functions downstream of Rif1 to block resection (Boersma et al., 2015; Xu et 
al., 2015). MAD2L2 is a component of the translesion polymerase Zeta (Polζ) but 
its role in blocking end resection was found to be independent of this function. 
MAD2L2 localizes to sites of DNA damage in an ATM/53BP1/Rif1-dependent 
manner but a direct interaction could not be found. The N-terminal HEAT repeats 
of Rif1 were shown to be required for localization of MAD2L2 to DSBs. This is 
consistent with the fact that this domain is necessary for the interaction of Rif1 
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with 53BP1, confirming that MAD2L2 functions downstream of 53BP1/Rif1 
(Escribano-Diaz et al., 2013; Boersma et al., 2015). 
Another factor implicated downstream of 53BP1 in resection control is 
PTIP (Fig. 1.6). The N-terminal S25 of 53BP1 is phosphorylated in an ATM 
dependent manner and required for the interaction with PTIP (Munoz et al., 
2007). However, the importance of the interaction with 53BP1 is poorly 
understood and PTIP does not require 53BP1 to localize to sites of damage 
(Gong et al., 2009; Wu et al., 2009). Furthermore, PTIP has been suggested to 
play a role in HR since loss of PTIP results in cell cycle arrest in S-phase due to 
unrepaired DSBs (Wang et al., 2010). The function of PTIP is even more 
complex with regards to c-NHEJ. While loss of PTIP had no effect on CSR in B 
cells, radial formation in PARPi-treated BRCA-/- cells was diminished in absence 
of PTIP (Callen et al., 2013). Perhaps this phenotype reflects an S-phase specific 
role for the interaction of PTIP with 53BP1 as PARPi results in nicks during DNA 
replication whereas CSR occurs in G1. 
1.2.5 53BP1 mediated chromatin mobility 
Although loss of Rif1 suppresses NHEJ at dysfunctional telomeres and in CSR, 
the effect is not as severe as loss of 53BP1, indicating that other factors 
downstream of 53BP1 are required. A second function for 53BP1 in regulating c-
NHEJ is promotion of chromatin mobility upon DNA damage (Fig. 1.4) (Dimitrova 
et al., 2008). Live-cell imaging has shown that telomeres become more mobile 
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and occupy larger territories when TRF2 is removed, which renders telomeres 
dysfunctional and activates ATM kinase. This increase in mobility is dependent 
on the N-terminal S/TQ sites of 53BP1, as a phosphorylation mutant (53BP1Δ28) 
was unable to promote mobility. However, neither Rif1 nor MAD2L2 is required 
for this effect (Zimmermann et al., 2013; Boersma et al., 2015). The effect of 
53BP1 on mobility is not limited to dysfunctional telomeres as IR-induced DSBs 
show an ATM dependent increase in mobility in G1 as well (Krawczyk et al., 
2012; Neumaier et al., 2012; Becker et al., 2014).  However, other studies have 
shown that I-SceI induced DSBs are immobile unless Ku is removed (Soutoglou 
et al., 2007). 
Preliminary data from the de Lange lab had pointed to the possibility that 
53BP1 acts through the LINC (Linker of Nucleoskeleton and Cytoskeleton) 
complex and uses kinesin-mediated movement on microtubules to increase the 
mobility of damaged telomeres. The LINC complex is composed of Sun proteins 
(including Sun1 and Sun2 in mammals) that span the inner nuclear membrane 
(INM) and associate with KASH (Klarsicht, Anc-1, Syne1 homology) domain 
containing proteins situated in the outer nuclear membrane (ONM) (Mejat and 
Misteli, 2010). Mammalian KASH proteins include the nesprins and the KMS 
proteins, which can link to microtubules with kinesins and dynein. Experiments 
suggest the involvement of Sun1, Sun2, Nesprin-4, and the kinesin components 
KIF3A, KIF5B, and Klc1. Using shRNAs against these proteins, telomere fusions 
are diminished by 30-50%. Importantly, the mobility of damaged chromatin is 
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diminished in a Sun1/2 deficient background to the same extent as in the 
absence of 53BP1. How 53BP1 connects to the LINC complex and which S/TQ 
sites are required remains unknown. 
1.3 The structure and function of telomeres 
1.3.1 Telomeres protect the end of linear chromosomes 
Telomeres are nucleoprotein structures containing of short tandem repetitive 
sequences that cap the natural ends of linear eukaryotic chromosomes. In 
mammalian cells, telomeres consist of 5’-TTAGGG-3’ repeats that can be 10-15 
kb (human) to 20-50 kb (mouse) in length, ending with a 3’ overhang (de Lange 
et al., 1990; Lejnine et al., 1995). Electron microscopy has shown that telomeres 
are organized in large lariat-like t-loop structures that are formed by strand 
invasion by the 3’ overhang (Griffith et al., 1999; Nikitina and Woodcock, 2004). A 
telomere specific protein complex, shelterin, together with telomerase protects 
the telomere from two threats that arise at chromosome ends: the end-replication 
and end-protection problem (Fig. 1.7). 
The end-replication problem arises due to the inability of the DNA 
replication machinery to fully replicate the 3’ ends of linear DNA. Replicative 
polymerases function in the 5’ to 3’ direction and require a free 3’ hydroxyl group 
to initiate synthesis of nascent DNA.  At the leading-strand the DNA polymerase 
move in the same direction as the replication fork allowing the replication until the 
end. At the lagging-strand, the DNA is synthesized in opposite direction of the 
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Figure 1.7 Shelterin protects chromosome ends 
(A) The six protein shelterin complex binds telomeric DNA via TRF1 and TRF2. The function of 
each shelterin in blocking DNA damage pathways is shown on the right. (B) Shelterin and 
particularly TRF2 keep the telomeric DNA in a T-loop configuration. This physically hides the DNA 
end from recognition by the MRN complex and protects against ATM activation. Loss of TRF2 
results in T-loop unwinding and activation of ATM kinase and NHEJ at the chromosome end. 
Adapted from Doksani and de Lange 2014 (Doksani and de Lange, 2014). 
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replication fork resulting in short stretches of nascent DNA, Okazaki fragments, 
which are initiated at RNA primers that provide the free 3’ hydroxyl group. The 
RNA primers are subsequently removed and the Okazaki fragments ligated 
together. Yet, the removal of the very last RNA primer produces a gap at the end 
of the lagging strand, incompletely replicating the 3’ end. This causes telomeres 
to gradually shorten during every cell division, eventually resulting in loss of 
genetic information thus limiting the replicative potential of the cell (Hayflick, 
1965; Watson, 1972; Olovnikov, 1973). Additionally, nucleolytic processing of the 
3’ overhang adds to the end-replication problem. Leading end DNA synthesis 
results in blunt ends that require processing by Apollo and CST to produce the 3’ 
overhang (Wu et al., 2010; Wu et al., 2012). 
The end-protection problem refers to the possibility of the chromosome 
end to be recognized as a DSB that could initiate apoptosis or inappropriate 
repair via the DDR pathway. 
1.3.2 Telomerase counteracts the end-replication problem 
To counteract telomere erosion, most eukaryotic cells possess a specialized 
enzyme called telomerase. The presence of a specialized enzyme capable of 
replicating the terminal TTAGGG repeats was first shown and isolated in 
Tetrahymena (Greider and Blackburn, 1985). Subsequent studies revealed 
telomerase as a ribonucleoprotein that uses a catalytic subunit with reverse 
transcriptase activity (TERT) to synthesize TTAGGG repeats from an RNA 
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primer, TERC (Greider and Blackburn, 1987; Greider and Blackburn, 1989; 
Lingner et al., 1997; Nakamura et al., 1997). Telomerase is highly regulated 
during development, being active in germline tissue but not somatic cells (Kim et 
al., 1994). This ensures a limited lifespan of normal somatic cells, with telomeres 
shortening every cell division. The inactivation of telomerase in somatic cells 
represents an important tumor suppressor pathway to limit immortalization of 
cells. Indeed, about 90% of tumor biopsies tested have reactivated telomerase 
(Kim et al., 1994). The remaining 10% of tumors may either lack telomere 
maintenance or rely on a recombination based mechanism, Alternative 
Lengthening of Telomeres (ALT), to prevent loss of telomeric sequences (Bryan 
et al., 1997; Dunham et al., 2000). The fact that all tumor cells possess some 
mechanisms to prevent telomere attrition illustrates the importance of telomeres. 
1.3.3 Shelterin protects against the end-protection problem 
The end-protection problem emerged from landmark studies by Herman Muller 
and Barbara McClintock in the 1930’s and 1940’s (Muller, 1938; McClintock, 
1941). First, Muller observed that induced chromosomal translocations and 
rearrangements never occurred at chromosomes ends, which he called 
telomeres. He concluded that the terminal “gene” must have a protective function 
by sealing the chromosome end. Barbara McClintock independently found that 
broken chromosomes are prone to fusions and rearrangement, but that the 
natural ends of chromosomes are somehow protected from this genetic 
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instability. We now know that a protective telomere specific protein complex, 
shelterin, associates with chromosome ends (Palm and de Lange, 2008). 
Shelterin associates with telomeres through TRF1 and TRF2, which bind 
specifically to double stranded TTAGGG repeats. POT1 (POT1a and POT1b in 
mice) binds the single stranded TTAGGG repeats that are present in a 50-400 nt 
TTAGGG repeat 3’ overhang at the telomere terminus. POT1 is connected to 
TRF1 and TRF2 through two other shelterin components, TIN2 and TPP1. A 
sixth component, Rap1, binds to TRF2. 
Studies using telomeres lacking components of shelterin or the entire 
complex revealed how shelterin represses different deleterious damage 
pathways that are activated at unprotected DNA ends (Fig. 1.7a) (Palm and de 
Lange, 2008; Sfeir and de Lange, 2012; Doksani and de Lange, 2014). TRF2 
represses ATM activation and c-NHEJ by sequestering telomeres in a t-loop 
configuration (van Steensel et al., 1998; Griffith et al., 1999; Karlseder et al., 
1999; Celli and de Lange, 2005; Doksani et al., 2013). This conformation is 
proposed to inhibit loading of Ku70/80 and the MRN complex onto DNA ends, 
steps that are essential for initiation of c-NHEJ and ATM signaling, respectively 
(Lieber, 1999; Walker et al., 2001; Lee and Paull, 2004). TRF2 has long been 
implicated in t-loop formation, but only recent STORM imaging techniques have 
enabled direct evidence for this in vivo (Doksani et al., 2013). These experiments 
have shown that TRF2 is the sole shelterin component involved in t-loop 
formation. 
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TRF1 has similar domain architecture as TRF2 but its main function lies in 
promoting telomere replication (Sfeir et al., 2009; Zimmermann et al., 2014). The 
telomeric TTAGGG sequence poses a problem for the replication machinery, 
similar to common fragile sites (CFS) elsewhere in the genome. Upon deletion of 
TRF1, multiple telomeric signals are observed at a single chromatid end, 
indicative of replication problems and fork stalling in the telomeric DNA can be 
observed by DNA combing. Furthermore, ATR kinase is activated at telomeres 
lacking TRF1 in a process that requires progression through S-phase, consistent 
with a role for TRF1 in replication. The mechanism by which TRF1 supports 
replication is not completely understood, but involves recruitment of BLM and 
Rtel1 helicases to unwind G-quadruplexes that are formed by telomeric TTAGGG 
sequences (Sfeir et al., 2009; Vannier et al., 2012; Zimmermann et al., 2014).  
In contrast to TRF1 and TRF2, POT1 binds the single stranded DNA in the 
telomeric overhang. Interestingly, humans and mice differ with regards to POT1. 
Where mouse telomeres require two distinct paralogs, POT1a and POT1b, the 
function of these proteins is carried out by one POT1 protein in human cells 
(Hockemeyer et al., 2006). POT1 has several functions at telomeres. First of all it 
shields the single stranded overhang from RPA binding and unwanted ATR 
activation (Hockemeyer et al., 2005; Hockemeyer et al., 2006; Denchi and de 
Lange, 2007; Gong and de Lange, 2010). Furthermore, POT1 (POT1b) is 
required for postreplicative processing of telomeres by blocking excessive 
resection by the Apollo nuclease (Wu et al., 2012). Leading-strand DNA 
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synthesis results in blunt ended telomeres that are at risk for ATM activation and 
NHEJ. TRF2 recruits Apollo to process the leading ends into minimal overhang 
that enables the t-loop configuration. In absence of POT1b, resection by Apollo 
and also Exo1 is extreme (Wu et al., 2010). Besides its inhibitory effect on Apollo, 
POT1 (POT1b) recruits CST to regulate the overhang length at the telomere end. 
CST-mediated fill-in synthesis corrects the extended overhang created by Exo1 
(Wu et al., 2012; Takai et al., 2016). Another role for POT1 lies in telomere length 
control as POT1 is thought to block access of telomerase to single stranded 
overhangs (Loayza and de Lange, 2003). POT1 is therefore a negative regulator 
of telomere length. 
Rap1 binds TRF2 but unlike TRF2 it has no role in the repression of ATM or 
c-NHEJ. However, deletion of Rap1 in a Ku70/80-/- background revealed a role 
for Rap1 in repressing HR, similarly as seen previously seen for POT1a and 
POT1b (Palm et al., 2009; Sfeir et al., 2010). Shelterin as well Ku70/80 thus 
block HR at telomeres, perhaps to ensure greater protection. 
1.3.4 TRF2 prevents ATM activation and NHEJ 
By sequestering telomeres in the t-loop configurations, TRF2 is thought to inhibit 
loading of Ku and MRN at the end. Indeed, when TRF2 is deleted from mouse 
embryonic fibroblasts (MEFs), ATM is rapidly activated as indicated by Chk2 
phosphorylation and accumulation of 53BP1, MDC1 and γH2AX in foci that 
overlap with telomeres called telomere dysfunction induced foci (TIFs) (Karlseder 
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et al., 1999; Takai et al., 2003; Celli and de Lange, 2005; Dimitrova and de 
Lange, 2006; Denchi and de Lange, 2007). NHEJ is unleashed when TRF2 is 
missing causing telomere end-to-end fusions that are visible as chromosome 
trains on metaphase spreads. These chromosome fusions occur mostly in G1 
and are fully dependent on ATM, Lig4 and Ku, supporting their dependency on 
NHEJ and DNA damage signaling (Smogorzewska et al., 2002; Celli and de 
Lange, 2005; Celli et al., 2006; Konishi and de Lange, 2008). Furthermore, 
53BP1 mediated mobility of chromatin and inhibition of end resection are 
required for these telomere fusions, which are drastically reduced in absence on 
53BP1 (Dimitrova et al., 2008; Lottersberger et al., 2013; Zimmermann et al., 
2013). The resection that occurs at telomeres when TRF2 is deleted in absence 
of 53BP1 is dependent on ATM and CtIP (Lottersberger et al., 2013). Similar to 
chromosome internal DSBs, 53BP1 recruits Rif1 and MAD2L2 to suppress 
extensive end-resection (Zimmermann et al., 2013; Boersma et al., 2015). 
TRF2 binds specifically to telomeric DNA through a C-terminal SANT/Myb 
domain and forms homodimers with its N-terminal TRFH domain (Palm and de 
Lange, 2008). TRF2 furthermore contains a Gly/Arg rich domain Basic domain in 
its N-terminus that can bind and stabilize dHJs that can be formed at the base of 
the t-loop by branch-migration (Fouche et al., 2006; Poulet et al., 2009). While 
the t-loop is required for protection against NHEJ and ATM activation, the dHJs 
can be cleaved by Holliday junction resolvases resulting in excision of the t-loop 
and loss of telomeric DNA (Wang et al., 2004). Expression of a TRF2 mutant 
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lacking the Basic domain results in t-loop excision and telomere shortening, while 
NHEJ is still suppressed (Wang et al., 2004; Saint-Leger et al., 2014). 
1.3.5 TRF1 is required or telomere replication 
Studies in yeast and mammals have shown that telomere replication mostly 
originates from the subtelomeric regions (Makovets et al., 2004; Sfeir et al., 
2009). Therefore, leading-strand replication produces the G-rich strand whereas 
the C-rich strand is made by lagging-strand synthesis. However, the repetitive 
telomeric sequence poses a problem for the replication machinery as the G-rich 
DNA can form G-quadruplexes (G4), a secondary structure held together by G-G 
Hoogsteen base-pairing (Henderson et al., 1987). Fork stalling is frequently 
observed in telomeric sequences and treatment of cells with G4-stabilizing drugs 
induces ATR activation and telomeric aberrations (Miller et al., 2006; Salvati et 
al., 2007; Rizzo et al., 2009; Sfeir et al., 2009). Interestingly, fork stalling also 
occurs when the telomeric sequence is located internally in chromosomes, 
further indicating that the DNA sequence itself forms a problem for the replication 
machinery (Miller et al., 2006; Bosco and de Lange, 2012). 
TRF1 is required to aid replication fork progression through telomeric DNA 
(Martinez et al., 2009; Sfeir et al., 2009). Deletion of TRF1 from MEFs results in 
frequent fork stalling in telomeric sequences and activation of an ATR signaling 
cascade, and the appearance of fragile telomeres. The fragile telomeres are 
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reminiscent of fragile sites that arise at other genomic regions that are 
challenging to replicate.  
 
1.3.6 Fragile sites 
 Two different types of fragile sites have been described in human cells. Rare 
fragile sites are only present in certain individuals that have expansions of 
genomic repeat regions such as Fragile X syndrome (Kremer et al., 1991). In 
contrast, all individuals have common fragile sites (CFSs), which represent 
regions of the genome that are late to replicate or have a low density of 
replication origins. As a result, CFSs are often incompletely replicated at the 
onset of mitosis. Fragile sites manifest as breaks and gaps on metaphase 
chromosomes, especially upon treatment with drugs that affect replication such 
as aphidicolin, which blocks DNA synthesis by inhibiting polymerase alpha. The 
inherent genetic instability of CFSs is thought to be a driving force in the onset of 
cancer because many chromosome translocations and rearrangements in tumors 
originate from CFSs (Hecht and Glover, 1984; Hellman et al., 2002; Le Tallec et 
al., 2011; Ozeri-Galai et al., 2012). The mechanisms of genetic instability at 
CFSs are not very well understood. Secondary structure formation at CFSs could 
be a causative factor for their instability (Durkin and Glover, 2007). Upon 
replication stress, single stranded DNA formed ahead of the DNA polymerase 
upon uncoupling from the replicative helicase could form a secondary structure 
resulting in fork stalling and breakage. Consistent with this model, loss of 
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enzymes that remove secondary structures, such as the RecQ helicases BLM 
and WRN, increases fragile site expression (Pirzio et al., 2008). More recent 
studies challenged this model and postulated that it is the lack of replication 
origins that cause CFSs instability (Ozeri-Galai et al., 2011). CFSs are thought to 
replicate late in S-phase and additional delay upon treatment with aphidicolin 
results in incomplete replication (Le Beau et al., 1998; Pelliccia et al., 2008). 
Another contributing factor to CFS expression is thought to be a collision 
between transcription and replication forks (Helmrich et al., 2011). Likely, all 
these pathways play a varying role in CFS expression, which could explain why 
expression levels of CFSs differ between cell types. One unifying factor in CFSs 
expression is the observation that replication is not finished at these sites, 
yielding DNA structures with replication intermediates at the onset of mitosis. 
1.3.7 Fragile site cleavage prevents anaphase bridges 
Cleavage of CFSs was long thought to cause genetic instability, but this view was 
recently challenged by two studies indicating that cleavage by Mus81-Eme1 is 
actually protective (Naim et al., 2013; Ying et al., 2013). The structure-specific 
endonuclease Mus81-Eme1 was shown to localize to CFSs at the onset of 
mitosis and cleave replication intermediates, triggering the appearance of the 
characteristic breaks and gaps associated with CFSs. Unexpectedly however, 
depletion of Mus81-Eme1 caused more severe genetic instability due to 
accumulation of anaphase bridges and mitotic failure. Thus, cleavage of under-
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replicated DNA by Mus81-Eme1 appears to be beneficial to cells as it helps sister 
chromatid disjunction and prevents the formation of anaphase bridges. The gaps 
and breaks in DNA caused by Mus81-Eme1 cleavage are protected in 53BP1 
nuclear bodies in the next G1 to allow for their repair (Lukas et al., 2011).  
 The anaphase bridges that appear at CFSs, especially when Mus81 is 
missing, are not always detectable with conventional DNA dyes. These bridges 
are called ultrafine bridges (UFBs) and can be visualized by immunofluorescent 
staining of either BLM or PICH (Chan et al., 2009; Naim and Rosselli, 2009). The 
presence of BLM on these UFBs is dependent on PICH and provides cells with a 
final attempt to resolve unrepaired DNA intermediates before anaphase (Chan et 
al., 2007).  
 
1.3.8 TRF1 recruits BLM to prevent fragile telomeres 
It is not completely understood how TRF1 promotes faithful telomere replication. 
TRF1 lacks enzymatic activity and is assumed to function by recruiting additional 
proteins to aid fork progression. Two proteins of interest are BLM and RTEL1, 
since telomere fragility is seen upon shRNA mediated depletion of these proteins 
(Ding et al., 2004; Lillard-Wetherell et al., 2004; Sfeir et al., 2009). Recent studies 
have shown that BLM interacts with TRF1 and that this interaction is required to 
prevent telomere fragility, specifically on the telomere replicated by lagging 
strand DNA synthesis (Zimmermann et al., 2014). The lagging-strand TTAGGG 
template is particularly prone to G-quadruplex formation. Since BLM possesses 
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G-4 unwinding activity, it is likely that TRF1 recruits BLM to unwind Hoogsteen 
bonding between guanines in the lagging-strand template and thus prevents 
telomere fragility (Sun et al., 1998; Huber et al., 2002). How TRF1 prevents 
leading-strand telomere fragility remains unknown but might require RTEL1. 
1.3.9 TRF1 prevents the formation of sister associations 
A separate phenotype that emerges upon deletion of TRF1 are sister 
associations (SA), which are visible as fused sister telomeres in metaphase 
spreads. However, the molecular nature of SA is not yet known. They are not 
fused by c-NHEJ, as deletion of Lig4 has no effect on their prevalence (Sfeir et 
al., 2009). SAs are also not dependent on the interaction of TRF1 with BLM and 
therefore likely form through a mechanism distinct from fragile telomeres 
(Zimmermann et al., 2014). The only known contributing factor to the formation of 
SAs is the activation of ATR kinase. When ATR is depleted from TRF1 null cells, 
the frequency of SAs is significantly reduced (Sfeir et al., 2009). Supporting this 
model, it was shown that TRF1 uses the interaction with TIN2/TPP1 and POT1 to 
prevent sister associations (Zimmermann et al., 2014). POT1a is thought to 
compete with RPA for binding single-stranded TTAGGG repeats and thereby 
prevent ATR activation. However, activation of ATR alone is not sufficient to form 
SAs as deletion of TPP1 or POT1 by itself results in only low levels of SAs 
(Hockemeyer et al., 2006; Kibe et al., 2010). Thus, TRF1 deletion combined with 
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ATR activation is required for the formation of SAs indicating that it requires an 
activity that occurs at a stalled replication fork. 
1.3.10 Dysfunctional telomeres as a model for DNA damage response pathways 
All six shelterin protein repress different components of the DNA damage 
response, from c-NHEJ and HR to ATM and ATR activation (Sfeir and de Lange, 
2012). Conditional deletion of shelterin proteins has therefore emerged as useful 
model system to study DNA damage response pathways. There are several 
advantages of using shelterin depletion over traditional drug or irradiation 
induced DNA damage. First, the defined location of the DNA damage allows for 
separation of the damaged DNA from the rest of the chromatin. This allows the 
use of molecular techniques such as telomere overhang assays, ChIP and other 
physical assays to study the effect of DNA damage. Secondly, the highly specific 
function of shelterin components allows studying DNA damage pathways 
separately from one each other, a feat difficult to accomplish with drugs or 
irradiation which often stimulate a more complex response. However, care should 
be taken before extrapolating results from telomere specific studies to other sites 
in the genome without appropriate controls. 
For the purpose of this thesis, telomeres lacking TRF2 will be used to 
study the role of 53BP1 in promoting chromatin mobility. Telomeres devoid of 
TRF2 were previously successfully used to shown the role of 53BP1 in the c-
NHEJ pathway and in blocking extensive end-resection (Dimitrova et al., 2008; 
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Lottersberger et al., 2013; Zimmermann et al., 2013). Furthermore, deletion of 
TRF1 will be used to analyze the role of 53BP1 at sites of replication stress and 
to analyze the molecular activities underlying sister telomere associations. 
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Chapter 2: 53BP1 dissociation of function mutants 
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2.1 Introduction 
It is known that 53BP1 is a key regulator in the decision between NHEJ and HR 
at DSBs. However, specifically how 53BP1 promotes NHEJ is not completely 
understood. One mechanism by which 53BP1 stimulates NHEJ is via inhibition of 
end-resection using its interaction with Rif1. However, loss of Rif1 does not 
reduce NHEJ to the same extend as loss of 53BP1 indicating other factors are 
involved (Zimmermann et al., 2013). We also know that 53BP1 promotes NHEJ 
by stimulating the mobility of damaged chromatin but the molecular mechanisms 
are not well understood (Dimitrova et al., 2008). Preliminary data from the de 
Lange lab has shown that the 53BP1-mediated mobility involves cytoplasmic 
microtubules since it is diminished upon treatment with nocodazole, which 
depolymerizes microtubules. Furthermore, treatment of cells with the 
microtubule-stabilizing drug Taxol also reduced the mobility of dysfunctional 
telomeres. In addition, it was shown that the effect of 53BP1 on mobility involves 
the LINC complex (LInker of Nucleoskeleton and Cytoskeleton), which spans the 
inner and outer nuclear membranes (INM and ONM) (Starr and Fridolfsson, 
2010). The LINC complex is composed of Sun proteins (Sun1 and Sun2) in the 
INM that interact with nesprins spanning the ONM. The nesprins connect to the 
cytoskeleton, including microtubules, through interactions with kinesins amongst 
other proteins. How 53BP1 connects to the LINC complex is unknown. 
The function of the interaction between PTIP and 53BP1 remains 
controversial. Loss of PTIP has no effect on CSR in B cells but radial formation in 
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PARPi-treated BRCA-/- cells is diminished in absence of PTIP. This was 
attributed to increased resection after loss of PTIP (Callen et al., 2013). At 
telomeres, fusions were reduced in PTIP-/- MEFs treated with an shRNA against 
TRF2, which was speculated to be due to the increased resection. However, 
these experiments were done with a TRF2 shRNA and in PTIP-/- MEFs and it is 
unclear if these results represent a function of PTIP downstream of 53BP1. 
53BP1 uses its N-terminal S/TQ phosphorylation sites to interact with 
proteins that perform essential functions in DNA repair, such as Rif1 and PTIP. A 
proteomics screen in B cells identified hundreds of proteins that interact with the 
S/TQ sites in a damage inducible way, but the relevance of most of these factors 
remains unknown (Di Virgilio et al., 2013). 
The first part of my thesis is focused on understanding the role of 
phosphorylation dependent interaction partners of 53BP1 in regulating DNA 
repair. Telomeres depleted of TRF2 are used as a model system since 53BP1 
mediated NHEJ results in extensive telomere fusions that are easily visible in 
metaphase spreads. Furthermore, resection can be analyzed with telomere 
overhang assays using a telomere specific probe. 
2.2 Results 
2.2.1 Generation of 53BP1 mutants 
To study the role of 53BP1 interaction partners, a panel of mutant 53BP1 alleles 
was generated in which clusters of the 28 S/TQ sites are mutated to alanine. 
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Figure 2.1 Gibson cloning of 53BP1 mutant alleles 
Mutant 53BP1 alleles were created from 53BP1WT and 53BP1Δ28 via Gibson cloning. Primer pairs 
were designed containing short overlap with each other. One pair (black) was used to do a PCR 
around the plasmid copying the backbone and most of the 53BP1WT construct. A second PCR 
(red) on the 53BP1Δ28 vector copies part of the N-terminal region containing mutated S/TQ 
residues. The two PCR products are isolated and ligated together using Gibson cloning 
dependent on the overlap between the primer pairs. This strategy allows mixing parts of the 
53BP1WT and 53BP1Δ28 constructs 
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Figure 2.2 53BP1 mutant alleles 
(A) Schematic of 53BP1 and the mutant alleles. (B) Co-IP in 293T cells expressing MYC-tagged 
PTIP and FLAG-tagged 53BP1. Co-IP demonstrates that the interaction between 53BP1 and 
PTIP is lost with 53BP1Δ28 and 53BP1ΔPTIP but not with the other alleles. Left panel shows input 
DNA and the co-IP using FLAG antibody is shown on the right. Immunoblot was done with 
antibodies against 53BP1 and MYC. 
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These mutants were generated via Gibson cloning using WT and 53BP1Δ28 as 
template allowing the exchange of different parts of the plasmids (Fig. 2.1). This 
approach was taken since 53BP1 is a very large construct that hinders regular 
cloning protocols. Constructs were sequenced throughout to verify the correct 
change. All constructs contain a C-terminal FLAG-tag for IP and western blotting 
and lack the C-terminal BRCT domains, which were previously shown to be 
dispensable for NHEJ at telomeres (Lottersberger et al., 2013). These constructs 
will collectively be called S/TQ mutants or specifically named for their mutant 
domain. The different mutants are shown in Fig. 2.2a. 
For 53BP1ΔPTIP, the first 4 S/TQ sites were mutated to alanine based on 
previous studies that showed these to be required for the interaction with PTIP 
(Munoz et al., 2007; Callen et al., 2013). Co-IP experiments with FLAG tagged 
53BP1 and myc-tagged PTIP showed that the interaction with PTIP was indeed 
lost in the 53BP1ΔPTIP mutant but not the other alleles (Fig. 2.2c). The interaction 
between 53BP1 and Rif1 was previously mapped to 7 S/TQ sites in a central 
domain of 53BP1, in a mutant called 53BP1Δ3 (Callen et al., 2013) (Fig. 2.3a). 
However, this mutant still displayed residual Rif1 binding at telomeres after 
deletion of TRF2 (Fig 2.3a).  Therefore a different subset of mutant 53BP1 alleles 
was created in which additional domains of S/TQ sites were mutated (Fig. 2.3b). 
The interaction between 53BP1 and Rif1 was examined by analyzing Rif1 
recruitment to 53BP1 by IF-FISH at dysfunctional telomeres in TRF2F/F53BP1-/-
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Figure 2.3 Rif1 recruitment to 53BP1 
(A) Schematic of 53BP1 WT and 53BP1Δ3, which is supposedly deficient in Rif1 recruitment 
(Callen et al., 2013). Right panel shows Rif1 (white) recruitment to 53BP1 (red) by IF-FISH upon 
expression of the constructs in TRF2F/F53BP1-/- MEFs, 72 h after deletion of TRF2. Rif1 is still 
recruited to 53BP1Δ3. For clarity, panels with DAPI and telomere FISH signals are not shown in 
these images, but 53BP1 localizes to telomeres. (B) Generation of additional 53BP1 mutant 
constructs, shown on left. The domains of mutated S/TQ sites are depicted at the bottom. For 
example, 53BP1Δ1,2 has S/TQ sites in both domain 1 and 2 mutated to alanine. Right panel shows 
IF-FISH of Rif1 (white) recruitment to 53BP1 (red) upon expression of constructs in 
TRF2F/F53BP1-/- MEFs, 72 h after deletion of TRF2. The interaction between 53BP1 and Rif1 is 
only lost in mutants that have both domain 2 and 3 mutated or in the complete phosphorylation 
mutant 53BP1Δ28  (highlighted in red). 
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Figure 2.4 53BP1 mutant alleles localize to telomeres 
(A) Schematic of 53BP1 and the mutant alleles. (B) 53BP1 constructs were expressed in 
TRF2F/F53BP1-/- MEFs and localization analyzed via IF-FISH at 72 h after deletion of TRF2. IF-
fish shows 53BP1 (green) recruitment to telomeres (white). Rif1 (red) localizes to 53BP1 foci 
except in cells expressing the 53BP1Δ28 or 53BP1ΔRif1 alleles. Numbers on the right represent the 
quantification of the average percentage of cells with >5 53BP1 or 53BP1/Rif1 foci at telomeres 
from 3 independent experiments. 
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cells expressing the mutant 53BP1 alleles. Interestingly, only the 53BP1 alleles 
that have the S/TQ sites mutated in both domain 2 and 3 showed complete loss 
of Rif1 recruitment (Fig. 2.3b). The precise interaction between Rif1 and 53BP1 
was further mapped by mutating subsets of the S/TQ sites in this region. 
Especially S176 and S178 appeared to be required for Rif1 foci formation. The 
resulting 53BP1ΔRif1 allele contains 7 mutated S/TQ sites (different from 53BP1Δ3) 
and has lost all interaction with Rif1 (Fig. 2.4a and 2.4b). 
 The 53BP1ΔMOB allele was initially generated to examine whether S/TQ 
sites in this domain influence any of the known functions of 53BP1. As will be 
described in detail in chapter 2.2.4, this mutant affected the ability of 53BP1 to 
promote the mobility of dysfunctional telomeres and was thus called 53BP1ΔMOB. 
Importantly, all S/TQ mutants expressed equally well in TRF2F/F53BP1-/- MEFs 
and each localized to sites of damage (Fig. 2.2b and 2.4b). 
2.2.2 Rif1 is the only factor downstream of 53BP1 controlling resection 
53BP1 blocks CtIP-dependent end resection thereby promoting c-NHEJ in G1. At 
telomeres, 53BP1 also blocks CtIP-independent end-resection by Exo1/BLM in 
response to ATR activation upon loss of TPP1/POT1a/b (Kibe et al., 2016). In 
absence of 53BP1, hyper-resection occurs at DSBs and dysfunctional telomeres 
that inhibit c-NHEJ. The ability of 53BP1 to block resection is dependent on 
phosphorylation of the S/TQ sites and Rif1 was identified as the main 53BP1 
interacting factor responsible for this function (Di Virgilio et al., 2013; 
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Zimmermann et al., 2013). To analyze if any 53BP1-S/TQ binding factors other 
than Rif1 are required to block resection, the 53BP1 mutant alleles were 
expressed in TRF2F/FLig4-/-53BP1-/- MEFs and resection was analyzed by 
telomere overhang assays. These experiments are done in a Ligase 4 (Lig4) 
deficient setting since telomere fusions would mask a defect in protection from 
hyper-resection. 
Telomere overhang assays are native in-gel hybridization assays that 
enable quantification of the amount of ssDNA at telomeres (Fig. 2.5). Briefly, 
genomic DNA is isolated and digested with AluI and MboI, which frequently 
cleave anywhere in the genome except for the telomeric repeats. The generated 
telomeric fragments are then separated on a gel, which is hybridized with a 
telomere specific probe ([CCCTAA]4) under native conditions, resulting in a 
quantifiable signal for the amount of ssDNA at telomeres. The gel is then 
denatured and hybridized with the same telomeric probe to control for the total 
amount of DNA in the lane allowing normalization of the ssDNA signal, as 
explained in Figure 2.5. The measured ssDNA can be either internal or at the 3’ 
overhang. Treatment of the telomeric DNA with E. coli ExoI can distinguish 
between these two possibilities since ExoI removes 3’ overhangs but does not 
act on internal ssDNA. As it is already known that ssDNA formed after TRF2 
deletion is solely at the 3’ overhang, ExoI treatment was not included in these 
experiments (Celli and de Lange, 2005; Lottersberger et al., 2013). 
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Figure 2.5 Schematic of telomere overhang assay 
Genomic DNA is isolated and digested with AluI and MboI, which cannot cleave the telomeric 
sequence. Isolated telomeric DNA is separated on by PFGE and hybridized under native 
conditions with a telomere specific probe that binds to the ssDNA. The gel is then denatured and 
hybridized with the same probe to quantify the total telomeric DNA present to allow normalization 
of the amount of telomeric ssDNA to the total amount of telomeric DNA. To compare lanes, the 
normalized ssDNA signal in a control lane is set to 1.0 and the treated sample is quantified 
compared to this number. Figure provided by Titia de Lange. 
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Figure 2.6 53BP1ΔRif1 cannot protect telomeres from end resection 
(A) Telomere overhang assay of MboI/AluI digested DNA from TRF2F/FLig4-/-53BP1-/- MEFs 
expressing the mutant 53BP1 alleles. Telomeric DNA was analyzed 96 h after Cre-mediated 
deletion of TRF2 using the in-gel hybridization assay. Left panel shows native telomeric ssDNA 
signal, right panel displays the denatured total amount of telomeric DNA as explained in Fig. 2.5 
(B) Quantification of the overhang signal as in (A) from three independent experiments. Only the 
values from the Cre-treated samples are shown. Numbers were obtained by normalizing the 
native ssDNA signal to the total telomeric DNA signal in the denatured gel. The values of the Cre-
treated samples were obtained by comparison with the untreated control samples, which were set 
to 1.0. Means and SDs from three independent experiments are shown. P-values were 
determined compared to WT by a two-sided Students T-test (* p<0.05, ** p<0.01). (C) Western 
blot control showing the equal expression level of the 53BP1 alleles and the deletion of TRF2. 
Cells were harvested 72 h after deletion of TRF2 and antibodies against 53BP1 and TRF2 were 
used. 
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As expected, hyper-resection was observed in TRF2F/FLig4-/-53BP1-/-
MEFs upon deletion of TRF2 and expression of empty vector control and in cells 
expressing 53BP1Δ28 (Fig. 2.6a-c). The overhang signal increased 2 to 2.5 fold, 
similar to previous studies using TRF2F/FLig4-/-53BP1-/- MEFs (Dimitrova et al., 
2008; Lottersberger et al., 2013; Zimmermann et al., 2013). Cells expressing 
53BP1ΔRif1 showed a similar overhang increase as 53BP1Δ28 suggesting that Rif1 
is the only factor downstream of 53BP1 required to block end resection. 
Furthermore, 53BP1ΔPTIP behaved as WT 53BP1 with regards to end resection 
indicating that PTIP is not involved downstream of 53BP1 contrary to previous 
reports (Callen et al., 2013). It is possible that PTIP is recruited independent of 
53BP1 to inhibit end resection since these experiments were not done in a PTIP 
deficient setting.  However, other experiments from the lab using TRF2F/FLig4-/-
PTIP-/- MEFs indicate that PTIP does not affect resection at telomeres 
contradicting this explanation (Lottersberger et al., 2015). 
2.2.3  53BP1 mutant alleles promote varying levels of telomere fusions 
53BP1 promotes c-NHEJ of dysfunctional telomeres via at least two distinct 
mechanisms: blocking end-resection and stimulating chromatin mobility. To 
understand which domain of 53BP1 is required to induce chromatin mobility and 
whether other factors might be involved, the ability of the S/TQ mutants to induce 
c-NHEJ was analyzed. These experiments were done in TRF2F/F53BP1-/- cells 
expressing the S/TQ mutants and telomere fusion analyzed in metaphase 
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Figure 2.7 Analysis of telomere fusions in cells expressing mutant 53BP1 alleles. 
(A) Western blot control for the equal expression level of 53BP1 alleles and deletion of TRF2 from 
MEFs 72 h after Cre. (B) Metaphase spreads of TRF2F/F53BP1-/- MEFs expressing mutant 53BP1 
alleles. Cells were harvested 84 h after Cre-mediated deletion of TRF2. Metaphase spreads were 
stained with DAPI (red) and a telomeric TelG FISH probe (green). (C) Quantification of the 
percentage of telomere fusions. Results from 4 independent experiments are shown, each dot 
represents a metaphase spread. Bars represent the median % of telomere fusions. P-values 
determined by a two-sided Students T-test (* p<0.05, ** p<0.01, *** p<0.001).  
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Figure 2.8 Analysis of telomere fusions in cells deficient for the LINC complex 
(A) Immunoblot showing expression of 53BP1 alleles and Sun2 in TRF2F/F53BP1-/-Sun1-/-Sun2-/- 
and TRF2F/F53BP1-/-Sun1+/+Sun2+/+ MEFs expressing the indicated mutant alleles of 53BP1. (B) 
Telomere fusions of MEFs expressing 53BP1WT analyzed 84 h after deletion of TRF2. Bars 
represent the median % of telomeres fused in 4 independent experiments. (C and D) Telomere 
fusions of the mutant 53BP1 alleles in TRF2F/F53BP1-/-Sun1-/-Sun2-/- (C) and TRF2F/F53BP1-/-
Sun1+/+Sun2+/+ (D) MEFs. To allow comparison of telomere fusions in these two separate MEF 
cell lines, the median fusion frequency in cells expressing WT 53BP was set to 100% (this is the 
same data as in B). Telomere fusions of the mutant 53BP1 alleles were compared relative to the 
fusion frequency in the cells expressing WT 53BP1. This allows correction for variability between 
experiments. The frequency of telomere fusions was scored on metaphases harvested 84 h after 
TRF2 deletion. Bars represent the median % of telomeres fused in 4 independent experiments; 
each dot represents a metaphase spread. P-values determined by a two-sided Students T-test (* 




spreads 84 h after deletion of TRF2. As expected, telomeres of cells expressing 
wild type 53BP1 became extensively fused after deletion of TRF2 whereas 
expression of 53BP1Δ28 did not support c-NHEJ (Fig. 2.7a-c). Furthermore, 
53BP1ΔRif1 displayed reduced levels of c-NHEJ while 53BP1ΔPTIP showed only a 
mild fusion defect (Fig. 2.7b). Importantly, 53BP1ΔMOB showed a mild fusion 
defect as well, even though this mutant is fully capable of blocking end-resection 
(Figs. 2.7b and 2.6b). 
2.2.4 Identification of the 53BP1 mobility domain 
The mild fusion defect seen in 53BP1ΔMOB could be due to lack of the chromatin 
mobility promoted by 53BP1. To test whether this was the case, telomere fusions 
were analyzed in TRF2F/F53BP1-/-Sun1-/-Sun2-/- cells, which lack the LINC 
complex and are therefore defective for DNA damaged induced chromatin 
mobility (Lottersberger et al., 2015). If 53BP1ΔMOB is indeed responsible for 
inducing chromatin mobility, expression of this mutant should behave as wild type 
53BP1 with regards to c-NHEJ in cells lacking the LINC complex (Fig. 2.8e). This 
experiment was carried out in TRF2F/F53BP1-/-Sun1-/-Sun2-/- and TRF2F/F53BP1-/-
Sun1+/+Sun2+/+ littermate controls expressing the S/TQ alleles (Fig. 2.8a). As 
expected, the level of fused telomeres in cells expressing wild type 53BP1 was 
lower in cells deficient in the LINC complex (Fig. 2.8b). Next, all S/TQ alleles 
were analyzed in these two cell lines. To correct for variability between 
experiments, the median level of fusion in cells expressing wild type 53BP1 was 
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set to 100% in each set of parallel experiments and percent reduction was 
calculated for the S/TQ mutants tested (Fig. 2.8c and d). This comparison to the 
levels of fusions observed with wild type 53BP1 served as an internal control for 
the timing of each experiment. Such a control is needed because in different 
experiments, the timing of Cre mediated deletion can vary slightly. Since 
telomere fusions represent a cumulative phenotype that is affected by the 
duration of the TRF2 deficiency, variations in Cre timing can affect fusion 
frequencies. 
Interestingly, whereas telomere fusions were reduced in TRF2F/F53BP1-/-
Sun1+/+Sun2+/+ cells expressing 53BP1ΔMOB, this construct behaved similar to wild 
type 53BP1 in TRF2F/F53BP1-/-Sun1-/-Sun2-/- cells (Fig. 2.8c-d). This suggests 
that 53BP1ΔMOB harbors the S/TQ sites needed to induce chromatin mobility.  
To test the effect of the 53BP1ΔMOB mutations further, the ability of this 
mutant to induce chromatin mobility was studied via live cell imaging using the 
same experimental settings as used previously to describe 53BP1 induced 
chromatin mobility (Fig. 2.9a) (Dimitrova et al., 2008; Lottersberger et al., 2015). 
Briefly, a stable cell line was created by expressing the Tudor and UDR domains 
of 53BP1 fused to mCherry (mCherry-BP1-2) in TRF2F/F53BP1-/- cells. This 
construct localizes to sites of damage but has no effect on DNA damage repair 
since it lacks all other functional domains of 53BP1 (Dimitrova et al., 2008). Upon 
deletion of TRF2, mCherry-BP1-2 localizes to telomeres and the dynamic 
movement of telomeres can be tracked via live cell time-lapse imaging and the 
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Figure 2.9 53BP1ΔMOB is deficient in stimulating chromatin mobility 
(A) Experimental setup for analysis of telomere mobility. TRF2F/F53BP1-/- MEFs expressing a 
mCherry-BP1-2 construct are used in time-lapse imaging experiments. This protein localizes to 
damage sites upon deletion of TRF2. Z-stack images are acquired every 30 seconds during a 10 
minute timelapse experiment. Figure adapted from Lotterberger et al. 2015. (B) Examples of 
mCherry-53BP1 traces in TRF2F/F53BP1-/- cells expressing the indicated mutant 53BP1 alleles, as 
described in A. (C) The MSD calculated from the traces of mCherry-BP1-2 foci from 3 
independent experiments as described in A. (D) Percent of cells discarded from the analysis by 
the parameters described in 2.2.4. Values represent mean and SD from the 3 experiments from C 
and differences are not significant.  
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Mean Square Displacement (MSD) measured from the track lengths (Fig. 2.9b). 
Movies were 10 minutes long and the tracks were analyzed from 2D-maximum 
intensity projected images since MEF nuclei are flat (2-4 μm in z compared to 15-
20 μm in x and y). The resulting traces can be corrected for nuclear rotation and 
movement, but large-scale nuclear deformations, such as expansion, contraction 
or twisting can confound the results. Therefore, cells showing extensive distortion 
were discarded from the analysis according to parameters described in 
Lottersberger et al. 2015 (Lottersberger et al., 2015). Briefly, extensive distortion 
was measured by a shift in the geometrical center of the nucleus. Expansion and 
contraction of nucleus was measured by the maximal difference between the 
average distances of the foci from the geometrical center. For example, in an 
expanding nucleus all foci would increase their distance from the geometrical 
center. A folding or twisting nucleus was measured as groups of foci all moving in 
the same direction. Arbitrary parameters were set for all these conditions and 
cells were discarded based on whether their parameters were outside the set 
thresholds. In most experiments, approximately half the nuclei passed the 
selection criteria and where used for the mobility analysis. DNA damage 
induction and 53BP1 status did not affect the frequency of discarded cells (Fig. 
2.9d). 
As expected, cells expressing 53BP1WT displayed the expected DNA 
damage induced chromatin mobility with an MSD of 0.35 μm2 that is consistent 
with previous measurements (Fig. 2.9c). The 53BP1Δ28 allele was defective and 
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similar to an empty vector control showed an MSD of 0.25 μm2. Interestingly, the 
MSD of 53BP1ΔMOB was also 0.25 μm2, similar to 53BP1Δ28 and the empty vector 
control, indicating that this mutant has a complete defect in inducing chromatin 
mobility (Fig. 2.9c). Together with the c-NHEJ results from LINC complex 
deficient cells, the data argue that 53BP1ΔMOB indeed contains mutations in the 
residues needed to promote chromatin mobility. Furthermore, 53BP1ΔPTIP had no 
effect on stimulating chromatin mobility indicating that the mild fusion defect seen 
with this mutant is due to a different function of 53BP1 (Fig. 2.7c). 
2.2.5 No interaction detected between Sun1 and 53BP1 
Although the experiments described above argue that 53BP1ΔMOB harbors the 
S/TQ sites needed to promote mobility, it is unknown how 53BP1 connects to the 
LINC complex on a molecular level. Previous experiments in the lab have shown 
that Sun1 and Sun2 are redundant and therefore only the interaction with Sun1 
was tested. To investigate whether an interaction exists between Sun1 and 
53BP1, co-IP experiments were carried out in 293T cells overexpressing Sun1 
and FLAG-tagged 53BP1WT or 53BP1Δ28. Overexpressed myc-PTIP was used as 
positive control. Cells were irradiated or treated with zeocin to induce DNA 
damage signaling and phosphorylation of 53BP1. An IP was performed using 
antibodies against FLAG to pull down 53BP1 together with its interacting factors 
(Fig. 2.10a and b). The results were inconclusive. An interaction was seen 
between 53BP1 and Sun1 in some but not all experiments (compare Fig. 2.10a 
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Figure 2.10 Interaction between 53BP1 and Sun1 is not consistently detected 
(A) Co-IP of 53BP1, Sun1 and myc-PTIP in 293T cells using FLAG antibody. FLAG tagged 
53BP1, Sun1 and myc-PTIP were transiently expressed in 293t cells. After irradiation with 
10Gray, a co-IP was performed using FLAG antibodies and interacting factors visualized by 
western blot with myc and Sun1 antibodies. An antibody against phosphorylated S/TQ sites was 
used to demonstrate 53BP1 phosphorylation. (B) Co-IP of 53BP1, Sun1 and myc-PTIP in 293T 
cells using FLAG antibody. FLAG tagged 53BP1, Sun1 and myc-PTIP were transiently expressed 
in 293T cells. After treatment with/without zeocin, a co-IP was performed using FLAG beads and 
interacting factors detected by western blot with myc and Sun1 antibodies. (C) Co-IP of 53BP1, 
myc-Sun1 and myc-PTIP in 293T cells using myc antibody. FLAG tagged 53BP1, Myc-tagged 
truncated Sun1 constructs and myc-PTIP were transiently expressed in 293T cells. After IP with 
myc reactive antibody, interacting factors were visualized by immunoblot with 53BP1 and myc 
specific antibodies. Schematics of the Sun1 constructs are drawn on the right. The full length 
Sun1 construct is indicated at the top with LMNA interaction domain (blue), transmembrane 
domain (green) and KASH domain (red) shown.  
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and b). There was a correlation between the overexpression levels of Sun1 and 
the amount recovered in co-IP suggesting that this might be non-specific binding 
of Sun1 to the beads. The positive control, myc-PTIP, was pulled down 
specifically by 53BP1WT but not 53BP1Δ28 in a zeocin inducible manner indicating 
that the experimental setup was correct (Fig. 2.10a and b). To try to minimize 
non-specific binding of Sun1, different wash buffers and magnetic beads were 
used but the results remained inconclusive (see materials and methods for 
details). 
The reverse IP reaction was also attempted, using antibodies against the 
myc-tag and western blotting for FLAG-53BP1 (Fig. 2.10c). The positive control, 
myc-PTIP, was pulled down with 53BP1, but an interaction was not observed 
with myc-Sun1. In these experiments, truncated versions of Sun1 were used in 
addition to the full-length protein. Both a nuclear and luminal Sun1 mutant were 
used, both lacking the transmembrane domain and thus soluble (Fig. 2.10c). 
Possibly, the soluble nuclear truncation mutant of Sun1 interacts more strongly 
with 53BP1 due to its localization throughout the nucleus. A luminal version of 
Sun1 was used as a negative control since the interaction between 53BP1 and 
Sun1 is not expected in the perinuclear space between INM and ONM. A 
potential caveat to this experiment is that the nuclear or luminal localization of 
these constructs was not verified. However, an interaction was not observed 
between these constructs and 53BP1. 
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Figure 2.11 Interaction between 53BP1 and endogenous Sun1 in MEFs 
(A) Levels of endogenous Sun1 in MEFs lysed in 2x sample buffer. The MEFs are either 
TRF1F/F53BP1-/-Sun1+/+Sun2+/+ or TRF1F/F53BP1-/-Sun1+/+Sun2+/+ as indicated. Two sampes of 
each MEF line were analyzed on western blot stained with a Sun1 reactive antibody.  (B) 
Immunoblot of TRF1F/F MEFs lysed in 0.5% NP40 and high salt concentrations (see materials and 
methods for further details). Sun1 presence in soluble (S) and Pellet (P) fraction was visualized 
by immunoblot with a Sun1 specific antibody. (C) Immunoblot of TRF1F/F MEFs lysed in high salt 
lysis buffer with/without prior isolation of nuclei as indicated. Lysate was sonicated for 5 or 10 
minutes. Sun1 extraction in the indicated fractions was visualized by western blot with Sun1 
specific antibody. Immunoblot for tubulin suggests correct separation of fractions. (D) Co-IP of 
53BP1 and Sun1 using FLAG-beads from TRF2F/F53BP1-/- MEFs expressing the indicated 53BP1 
allele with a 3xFLAG tag at its C-terminus. Cells were harvested 72 h after Cre mediated deletion 
of TRF2 or untreated control cells. MEFs were treated with/without DSP crosslinker prior to lysis 
and sonication for 5 minutes as in C. A co-IP was performed using magnetic FLAG beads and 
interacting factors detected by western blot with Sun1 and 53BP1 specific antibodies. (E) Same 
experiment as in D, only now minimal interaction is seen between Sun1 and 53BP1.  
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Since co-IP experiments with overexpressed Sun1 were unconvincing, the 
experiments were carried out with endogenous Sun1 in MEFs. The rationale for 
these experiments was that overexpressed nuclear envelope proteins often 
accumulate in other cellular compartments where an interaction with 53BP1 
might not be found. However, extraction of endogenous Sun1 is difficult since it is 
not released in most common lysis buffers, unless 2xSample buffer is used (Fig. 
2.11a and b). Different approaches were tested and the most consistent release 
of Sun1 was found when nuclei were isolated and subsequently lysed in a high 
salt lysis buffer followed by brief sonication (Fig. 2.11c). Cells were briefly treated 
with dithiobis(succinimidylpropionate) (DSP) prior to IP, a reversible crosslinker 
that reacts with primary amines in lysine residues to form stable amide bonds 
(Lomant and Fairbanks, 1976). The DSP crosslinker was used to increase the IP 
strength in case the interaction is transient. The addition of the reducing agent 
dithiothreitol (DTT) to the sample buffer prior to western blot removes the 
crosslinks to allow separation of proteins by SDS page. Furthermore, for these 
experiments 3xFLAG tagged 53BP1 constructs were used to increase the 
efficiency of the co-IP. The indicated 53BP1 constructs were overexpressed in 
TRF2F/F53BP1-/- cells, which were treated with Cre 72 h prior to harvest. To 
reduce potential background binding due to pelleting of large complexes, 
magnetic anti-FLAG beads were used. However, an interaction between 53BP1 
and Sun1 was still not consistently observed (Fig. 2.11d and e). 
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2.2.6 Exploring a role for known 53BP1 interacting partners in chromatin mobility 
It is possible that the interaction between 53BP1 and the LINC complex is either 
transient or indirect, explaining why co-IP experiments failed to show an 
interaction. To test whether known interaction partners of 53BP1 are involved in 
chromatin mobility, a candidate list of proteins from a proteomics screen in B-
cells was examined (Di Virgilio et al., 2013). Several Coiled-Coil Domain-
Containing (CCDC) proteins are found on this list, including CCDC124, CCDC9 
and CCDC79. This is of interest given that during meiosis, CCDC proteins 
connect telomeres to Sun1 (Shibuya et al., 2014). To test whether any of these 
proteins are involved in 53BP1 mediated chromatin mobility, shRNAs were used 
to knockdown CCDC124, CCDC9 or CCDC79 in TRF2F/F cells and telomere 
fusions assessed 96 h after deletion of TRF2. Although the level of knockdown 
was not assessed, none of the shRNA yielded a significant reduction in c-NHEJ 
upon deletion of TRF2 (Fig. 2.12a and b). For CCDC9, a small reduction was 
seen but knockdown of this protein significantly affected cell growth. Since 
telomere fusions are a cumulative phenotype, the reduced cell growth is 
expected to decrease telomere fusions and the results with the shCCDC9 are 
therefore inconclusive. The shRNA against CCDC79 was also toxic to cells and 
resulted in endoreduplication. Telomere fusions were therefore not assessed. 
Another protein that surfaced in the proteomics screen for 53BP1 is 
TopBP1. Despite the potentially confounding roles of TopBP1 in the ATR 
mediated DNA damage response pathway and DNA replication, the effect of 
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Figure 2.12 Telomere fusions upon depletion of potential 53BP1 and Sun1 interaction 
partners 
(A) Frequency of telomere fusions in TRF2F/F MEFs after shRNA mediated depletion of 
CCDC124. Five independent shRNAs were used. Metaphase spreads were analyzed 96 h after 
deletion of TRF2. Each dot represents a metaphase spread and bars represent the median % of 
telomeres fused in one experiment. (B) Frequency of telomere fusions in TRF2F/F MEFs after 
shRNA mediated depletion of CCDC9. Metaphase spreads were analyzed 96 h after deletion of 
TRF2. Bars represent the median % of telomeres fused in one experiment. (C) Frequency of 
telomere fusions in TRF2F/F MEFs after shRNA mediated depletion of TopBP1. Metaphases were 
analyzed 96 h after deletion of TRF2. Bars represent the median % of telomeres fused in one 
experiment. (D) Western blot from TRF2F/F MEFs after depletion of TOPBP1. Cells were 
harvested 72 h after deletion of TRF2 and shRNA effectiveness analyzed with a TOPBP1 specific 
antibody.  
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Figure 2.13 Telomere CHIP 
(A) Telomere ChIP performed in the indicated MEFs (top) 72 h after deletion of TRF2. ChIP was 
done with the antibodies indicated on either sides and recovered telomeric DNA visualized by dot-
blot using a telomere specific probe (Sty11, TTAGGG). (B) ChIP samples from A were hybridized 
on dot-blot with a BAMH1 probe to control for unspecific binding. (C) Quantification of the 
recovered telomeric DNA in ChIP from A. Signals of telomeric DNA recovered with indicated 
antibodies were normalized to the input and are given relative to the signal in no-Cre TRF2F/F 
cells. The Sun1 antibodies did not result in a ChIP signal and was therefore not quantified. 
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shRNA-mediated knockdown of TopBP1 was analyzed (Kumagai et al., 
2006)}(Delacroix et al., 2007),. Whereas the knockdown of TopBP1 was efficient, 
no reduction in telomere fusions was observed indicating that TopBP1 is not 
required for NHEJ of telomeres depleted of TRF2 and thus is unlikely to 
constitute the link between 53BP1 and the LINC complex (Fig. 2.12c and d). 
In a final attempt to show an interaction between 53BP1 and the LINC 
complex, a telomeric chromatin immunoprecipitation (CHIP) experiment was 
done using Sun1 or Sun2 specific antibodies.  As a positive control, antibodies 
against TRF1 and 53BP1 were used. Whereas a DNA damage inducible 
accumulation of 53BP1 was seen at telomeres, there was no increase in 
telomeric DNA seen with Sun2 specific antibodies (Fig. 2.13a-c) and the Sun1 
ChIP failed altogether. It thus remains unclear how 53BP1 connects to the LINC 
complex. 
2.2.7 Oligomerization domain of 53BP1 
The C-terminus of 53BP1 contains an oligomerization domain that is required for 
efficient IR-induced focus formation, although chromatin binding itself is partially 
retained (Zgheib et al., 2009; Bothmer et al., 2011). The oligomerization domain 
is also crucial for CSR in B cells but at dysfunctional telomeres, NHEJ is only 
partially affected when this domain is deleted (Lottersberger et al., 2013). It was 
previously shown that the oligomerization domain does not affect the ability of 
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53BP1 to protect against resection and does not affect the mobility of 
dysfunctional telomeres (Lottersberger et al., 2013). 
To further understand the role of the oligomerization domain at 
dysfunctional telomeres, a mutant 53BP1 allele was made in which the 
oligomerization domain was deleted and the N-terminal S/TQ sites mutated to 
alanine (53BP1ΔOligoΔ28) (Fig. 2.14a). This mutant and the control 53BP1 alleles 
were expressed in TRF2F/F53BP1-/- cells and resection and telomere fusions 
analyzed after Cre mediated deletion of TRF2 (Fig. 2.14b). As expected, 
53BP1ΔOligoΔ28 behaved similar to 53BP1Δ28 with regards to blocking resection 
since the interaction with Rif1 is lost in both mutants (Fig. 2.14c and d). The 
overhang signal increased 2.5 fold upon expression of either 53BP1ΔOligoΔ28 or 
53BP1Δ28 similar to the empty vector control. Next, telomere fusions were 
analyzed on metaphase spreads. Interestingly, NHEJ was more strongly affected 
in cells expressing the 53BP1ΔOligoΔ28 mutant compared to 53BP1ΔOligo or
53BP1Δ28 as telomere fusions in the 53BP1ΔOligoΔ28 expressing cells were reduced 
to levels similar to empty vector control (Fig. 2.15). In contrast, cells expressing 
the 53BP1Δ28 allele show residual telomere fusions with a small percentage of 
metaphases containing significant telomere fusions (20-60% telomeres fused) 
even though the median remains below 10% when analyzed 96 h after deletion 
of TRF2. These cells with higher levels of telomere fusions are never observed in 
empty vector control cells and are also not observed in cells expressing 
53BP1ΔOligoΔ28.  
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Figure 2.14 53BP1 oligo mutants 
(A) Schematic of 53BP1 oligo mutants. (B) Western blot control for the equal expression level of 
the 53BP1 oligo alleles and the deletion of TRF2. Cells were harvested 72 h after deletion of 
TRF2 and antibodies against 53BP1 and TRF2 were used. C. Telomere overhang assay of 
MboI/AluI digested DNA from TRF2F/FLig4-/-53BP1-/- MEFs expressing the indicated 53BP1 
alleles. Telomeric DNA was analyzed 96 h after Cre-mediated deletion of TRF2 using the in-gel 
hybridization assay (Fig. 2.5). Left panel shows native telomeric ssDNA signal, right panel 
displays the denatured total amount of telomeric DNA. (D) Quantification of the overhang signal 
from three independent experiments. Only the values from the Cre-treated samples are shown. 
Numbers were obtained by normalizing the native ssDNA signal to the total telomeric DNA signal 
in the same lane in the denatured gel. The values of the Cre-treated samples were obtained by 
comparison with the untreated control samples, which were set to 1.0. Means with SD from three 
independent experiments are shown. P-values were determined compared to WT by a two-sided 






Figure 2.15 Telomere fusions in MEFs expressing oligo mutants 
Example of metaphase spreads from TRF2F/F53BP1-/- MEFs, expressing the indicated 53BP1 
allele. Cells were harvested 96 h after Cre-mediated deletion of TRF2. Metaphase spreads were 
stained with DAPI (red) and a telomeric TelG FISH probe (green).  Quantification of the level of 
telomere fusions is shown on the right. Bars represent median % of telomere fusions from 4 
independent experiments, each dot represents a metaphase spread. P-values were determined 
compared to WT with a two-sided Student’s t-test (* p<0.05, ** p<0.01, *** p<0.001). 
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Interestingly, this reduction in NHEJ appeared to be due to an inability of 
53BP1ΔOligoΔ28 to form foci at telomeres as shown in Fig. 2.16a (left panel). 
Whereas the localization of 53BP1ΔOligo to telomeres was somewhat reduced 
compared to wild type 53BP1, the 53BP1ΔOligoΔ28 mutant failed to localize 
effectively explaining the behavior similar to the empty vector control. Of interest, 
whereas 53BP1ΔOligo recruitment to dysfunctional telomeres was only mildly 
disrupted, it could not localize to IR induced foci suggesting an alternative mode 
of localization to telomeres (Zgheib et al., 2009; Lottersberger et al., 2013). 
To further validate these results, TRF2F/F53BP1-/- cells expressing the 
mutant 53BP1 alleles were irradiated and recruitment to γH2AX-marked sites 
was analyzed 30 min later by IF (Fig. 2.16a, right panel). Upon irradiation, neither 
53BP1ΔOligo nor 53BP1ΔOligoΔ28 was efficiently recruited to DSBs in agreement with 
published experiments (Zgheib et al., 2009). Thus, whereas the oligomerization 
domain is necessary for foci formation at IR-induced DSBs, 53BP1 can use an 
alternative method to localize to telomeres in absence of the oligomerization 
domain, and this recruitment requires a phosphorylation dependent interaction 
partner of 53BP1. 
To analyze which S/TQ sites might be required for localization of 53BP1 to 
telomeres in absence of the oligomerization domain, a second subset of mutant 
alleles was made with clusters of the S/TQ sites mutated to alanine (Fig. 2.16b). 
These mutants were made prior to identification of the proper Rif1 binding site 
but domain 2 and 3 contain the required sites for Rif1 binding, as explained in 
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Figure 2.16 Localization of 53BP1 oligo mutants to telomeres is affected 
(A) IF-FISH images of TRF2F/F53BP1-/- MEFs expressing the indicated 53BP1 construct. Left 
panel shows recruitment of 53BP1 (FLAG tag, green) to telomeres (red) 72 h after deletion of 
TRF2, recruitment of Rif1 is shown in yellow. The right panel shows the foci formation of the 
53BP1 alleles (FLAG tag-red) 30 minutes after treatment with IR (10Gray). Staining for γH2AX 
(green) indicates IR induced DSB formation. (B) Schematic of additional 53BP1 oligo mutants 
created with subsets of the S/TQ sites mutated to alanine, similar to Fig. 2.3.  (C) IF-FISH images 
of TRF2F/F53BP1-/- MEFs expressing the additional 53BP1 constructs after deletion of TRF2 (left) 
or IR (right), with the same experimental conditions as in A. (D) Quantification of 53BP1 
recruitment to telomeres 72 h after deletion of TRF2. The percentage of cells with >5 53BP1 foci 




Figures 2.2.1 and 2.3. Localization of these constructs to telomeres after deletion 
of TRF2 was analyzed via IF-FISH (Fig. 2.16c and d). Preliminary data indicates 
that the S/TQ sites needed for Rif1 binding are also required for localization of 
53BP1 to dysfunctional telomeres in absence of the oligomerization domain since 
the mutant lacking S/TQ sites in both domain 2 and 3 showed deficient 53BP1 
recruitment (Fig. 2.16c and d). However, these are very preliminary results, which 
need to be repeated before any conclusion can be made. Repeating this 
experiment in a Rif1 deficient and proficient setting would ascertain that this 
phenotype is dependent on Rif1 and not another interacting factor of 53BP1.  
 
2.3 Summary of findings 
The creation of a panel of mutant 53BP1 alleles enabled analysis of the function 
of 53BP1 interaction partners in DNA repair at telomeres lacking TRF2. The 
results indicate that the S/TQ domain needed for the Rif1 interaction is the only 
domain required for inhibiting end resection downstream of 53BP1 (Fig. 2.6). 
However, the 53BP1ΔRIF1 allele was not tested in TRF2F/F53BP1-/-Rif1-/- cells. 
Thus even though the results suggest that Rif1 is the only factor downstream of 
53BP1 required for blocking end resection, this cannot be fully confirmed based 
on these experiments. Furthermore, the results suggest that PTIP is not required 
to control end resection at telomeres since 53BP1ΔPTIP behaved as a wild type 
allele in telomere overhang assays. Even though PTIP does not have a role in 
preventing hyper resection, the telomere fusions are slightly delayed in cells 
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expressing 53BP1ΔPTIP (Fig. 2.7). It is possible that this reduction is due to the 
role of PTIP in recruiting the Artemis nuclease that is required for end-trimming of 
obstructed ends (Wang et al., 2014). Possibly, a subset of telomeres requires 
Artemis mediated processing before NHEJ can occur explaining the lower levels 
of telomere fusions in absence of PTIP. 
The results also describe a separation of function mutant of 53BP1 that is 
deficient in inducing chromatin mobility. Cells expressing the 53BP1ΔMOB allele 
failed to induce chromatin mobility in live cell imaging experiments and had lower 
levels of telomere fusions (Fig. 2.7 and 2.9). Furthermore, the reduction in 
telomere fusions was absent in cells lacking SUN1/SUN2 indicating that 
53BP1ΔMOB lacks activity in the same pathway as the LINC complex, confirming 
that this domain contains the S/TQ sites that are required for mobility (Fig. 2.8). 
Importantly, 53BP1ΔMOB had no effect on resection, firmly placing chromatin 
mobility in a NHEJ-promoting pathway separate from resection (Fig. 2.6). 
Unfortunately, attempts to show an interaction between the LINC complex 
and 53BP1 were unsuccessful. Possibly, the interaction is transient and therefore 
difficult to detect. Furthermore, antibodies against endogenous LINC complex 
components are not very effective, hindering co-IP experiments. 
Lastly, experiments using the 53BP1ΔOligoΔ28 mutant suggest that 53BP1 
has a unique mechanism to efficiently accumulate at dysfunctional telomeres. 
Whereas the oligomerization domain is required for optimal recruitment to IR-
induced DSBs, this domain is dispensable at telomeres. However, a mutant 
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lacking the oligomerization domain in combination with mutated S/TQ sites no 
longer binds to dysfunctional telomeres (Fig. 2.16). These experiments suggest 
that a 53BP1 interaction partner can replace the function of the 53BP1 
oligomerization domain for accumulation at dysfunctional telomeres but not at 
other sites of DNA damage. Preliminary data indicate that it might be Rif1 that is 
required for this function, but further studies are needed to confirm this.
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Chapter 3: The nature of telomere sister associations formed 
upon loss of TRF1 
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3.1 Introduction 
The main role for TRF1 at telomeres is to aid progression of the replication fork. 
The telomeric TTAGGG repeat sequence represents a problem for the replication 
machinery since the G-rich strand has the tendency to form G-quadruplexes 
(G4), a secondary structure held together by Hoogsteen hydrogen bonds 
(Henderson et al., 1987). In absence of TRF1, replication forks often stall in the 
telomeric repeat array resulting in activation of the ATR signaling cascade 
(Martinez et al., 2009; Sfeir et al., 2009). Fork stalling also occurs when the 
telomeric sequence is located internally in chromosomes, further indicating that 
the DNA sequence itself forms a problem for the replication machinery (Miller et 
al., 2006; Bosco and de Lange, 2012). One consequence of TRF1 deletion is the 
appearance of fragile telomeres, which appear as multiple telomeric signals on 
chromosome ends in staining on metaphase spreads (Sfeir et al., 2009). Fragile 
telomeres are thought to be similar to the breaks and gaps seen on metaphase 
spreads at Common Fragile Sites (CFSs), which are regions of the genome that 
are difficult to replicate and show ‘broken’ chromatin in metaphase cells after 
treatment with aphidicolin (Hecht and Glover, 1984). Low dose aphidicolin 
treatment induces the appearance of fragile telomeres similar to the expression 
CFSs. TRF1 was shown to recruit BLM and possibly the RTEL1 helicase to 
prevent G4-formation and fork stalling and aid the replication machinery (Sfeir et 
al., 2009). A TRF1 mutant lacking the BLM interaction site displays increased 
levels of fragile telomeres (Zimmermann et al., 2014). This fragility was observed 
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primarily on telomeres formed by lagging strand DNA synthesis (lagging end 
telomeres) indicating that BLM specifically functions to remove secondary 
structures formed by the TTAGGG repeat array which is the template for lagging 
strand DNA synthesis. However, loss of TRF1 results in both leading and lagging 
strand fragility and how leading strand telomere fragility is prevented by TRF1 is 
still unknown. Possibly, the RTEL1 helicase is involved in preventing telomere 
fragility in the leading strand since BLM and RTEL1 prevent telomere fragility in 
an additive manner (Vannier et al., 2012). RTEL1 contains a PCNA interacting 
domain that is required for its ability to suppress telomere fragility but the 
molecular details and function of this interaction are not yet understood (Ding et 
al., 2004; Vannier et al., 2013). 
A second phenotype observed after deletion of TRF1 is the formation of 
telomeric sister associations (SAs) (Martinez et al., 2009; Sfeir et al., 2009). 
These structures are visible on metaphase spreads as fused sister telomeres but 
their molecular nature remains unclear (Fig. 3.1). They are not dependent on c-
NHEJ since an shRNA against Lig4 has no effect on their prevalence (Sfeir et al., 
2009). It is possible that SAs are formed via a-NHEJ, a relatively recently 
described pathway that operates when core components of the c-NHEJ 
machinery are missing, such as Ku or Lig4 (Kabotyanski et al., 1998; Verkaik et 
al., 2002; Wang et al., 2003; Weinstock et al., 2007). In a-NHEJ, a DSB is 
recognized by PARP1, a step normally inhibited by Ku (Wang et al., 2006). A-
NHEJ is furthermore thought to be dependent on microhomology at the junction 
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Figure 3.1 TRF1 deletion phenotype 
Metaphase spreads of TRF1F/F cells before (left) and 96 h after (right) Cre mediated deletion of 
TRF1. Telomeres are in green (TelC FISH) and chromosomes in red (DAPI). Fragile telomeres 
and sister associations are marked with an asterix and arrow respectively. Enlargements are 
shown in the bottom right. 
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that is exposed upon limited resection by the MRN complex and CtIP (Truong et 
al., 2013). After annealing of the microhomology regions, fill-in synthesis occurs 
by Polθ, which lacks proofreading capacity and is therefore prone to produce 
mutagenic insertions (Mateos-Gomez et al., 2015). Ligation of the DSB is 
independent of the c-NHEJ Lig4, but requires Lig3 or Lig1 instead (Frit et al., 
2014). Deletions are frequently observed in a-NHEJ and the pathway is 
considered pathogenic and has been linked to chromosomal translocations in 
cancer cells (Simsek and Jasin, 2010). 
The telomeric 3’ overhangs of the TTAGGG repeat strand have 
microhomology (2 bp/repeat) so that a-NHEJ could take place (Fig. 3.2a). 
Interestingly, analysis of telomere fusion junctions in human tumors revealed the 
presence of microhomology and fusions of critically short telomeres are 
dependent on Lig3 and the a-NHEJ (Letsolo et al., 2010; Lin et al., 2010; Jones 
et al., 2014). The molecular mechanism underlying these fusions is unknown and 
why they occur by a-NHEJ instead of c-NHEJ remains unclear. Under normal 
circumstances, a-NHEJ is strictly suppressed at telomeres by shelterin and Ku. 
However, in the absence of the entire shelterin complex and Ku, a-NHEJ takes 
place at telomeres as evidenced by chromosome type fusions dependent on Lig3 
and Parp1 (Sfeir and de Lange, 2012; Mateos-Gomez et al., 2015). The a-NHEJ 
pathway can thus be activated at telomeres that lack shelterin protection. 
However, if SAs were telomeres fused via a-NHEJ, a covalent linkage 
would be formed. Around 15-20% of chromosomes contain SAs after loss of 
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TRF1 and as a result, isochromosomes should appear in the next metaphase if a 
chromosome with sister fusions missegregates into one daughter cell and is 
replicated (Fig. 3.2b). However, isochromosomes are not readily detected upon 
deletion of TRF1 (Sfeir et al., 2009). It is therefore also possible that SAs 
represent a different structure. Possibly, they are non-covalent interactions 
resulting from replication intermediates formed upon fork stalling in the telomeric 
sequence.  
SAs are not simply a consequence of telomere fragility since loss of BLM 
or expression of a TRF1 mutant lacking the BLM interaction domain does not 
induce SAs although telomere fragility is observed (Zimmermann et al., 2014). 
Instead, the prevalence of SAs appears to correlate with the level of ATR 
activation. TRF1 inhibits ATR activation through its association with TIN2, 
allowing TPP1/POT1 binding to the ssDNA that can arise at the replication fork 
(Zimmermann et al., 2014). When TRF1 is removed from telomeres, TIN2 is no 
longer effectively recruited to telomeres (Frescas and de Lange, 2014). However, 
some residual TIN2 remains at telomeres through its interaction with TRF2, and 
the associated TPP1 and POT1 are capable of protecting the 3’ overhang since 
there is no evidence for a POT1 null phenotype when TRF1 is missing. But 
apparently, the residual TRF2 bound TIN2 is not enough to block replication 
associated ATR activation in cells lacking TRF1 since replication dependent ATR 
activation is observed at telomeres (Sfeir et al., 2009). By enforcing the 
interaction between TRF2 and TIN2, using a TIN2 fusion to the TRF2 binding  
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Figure 3.2 Sister telomere fusions 
(A) Microhomology within telomeres. Two telomere ends are shown with potential microhomology 
shown in red. Upon 5’ resection of the ends, the TA-AT nucleotides can anneal explaining how 
telomeres provide a substrate for a-NHEJ. (B) Model for the generation of an isochromosome 
from a sister telomere fusion. When an entire chromosome with sister fusion (red) is 
missegregated into one daughter cell, replication through the sister fusion in the next S-phase 
would result in the formation of an isochromosome. Examples of potential isochromosomes from 
MEF metaphases are shown on the right (DAPI in blue and telomeres in red (TelG). Note, mouse 
chromosomes are acrocentric and the short arm thus appears to be absent.  
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domain of RAP1, the localization of TIN2 to telomeres after deletion of TRF1 is 
rescued. Expression of this TIN2 mutant completely represses the ATR activation 
upon loss of TRF1 indicating that replication associated ATR activation is blocked 
by TRF1 using TIN2 (and TTP1/POT1) (Zimmermann et al., 2014). Interestingly, 
expression of this TIN2 mutant in TRF1 null cells does not rescue telomere 
fragility whereas SAs are repressed (Zimmermann et al., 2014). This strongly 
suggests that SAs require ATR activation. In agreement with this, shRNA 
mediated knockdown of ATR represses SAs (Sfeir et al., 2009). However, ATR 
activation at telomeres by itself is not enough to induce SAs as only low levels of 
SAs are detected in a POT1 null setting (~3%), where ATR signaling occurs at 
most telomeres (Hockemeyer et al., 2006; Denchi and de Lange, 2007). Low 
levels of SAs are also observed after deletion of TPP1 (~3%) or TIN2 (~7%), 
presumably due to the loss of POT1a/b (Kibe et al., 2010; Takai et al., 2011; 
Frescas and de Lange, 2014). Thus, SAs require ATR activation but also a 
replication associated event that is normally repressed by TRF1 since much 
higher levels are seen after TRF1 loss (15%) compared to TIN2/TPP1/POT1 (3-
7%). Possibly, the low levels of SAs observed upon loss of TIN2/TPP1/POT1 are 
due to residual replication stress at telomeres that occurs even when TRF1 is 
present. 
In this chapter, I use a genetic approach to illuminate the nature of the 
telomere associations formed upon loss of TRF1. 
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3.2 Results 
3.2.1 PARP1 is required for Sister Associations 
To examine whether the a-NHEJ pathway might create SAs, the role of PARP1 
was tested. First, the PARP1 inhibitor (PARPi) olaparib was used to prevent 
PARP1 function. For this experiment, TRF1F/F MEFs were first treated with Cre 
and olaparib was added for the final 24 or 48 h prior to harvest, and 96 h after 
deletion of TRF1. To test the efficacy of olaparib treatment, cells were briefly 
treated with H202, which produces robust PARsylation. Samples were analyzed 
by western blot and indeed, both 24 and 48 h of olaparib treatment completely 
abolished the H202 induced PARsylation indicating that the PARPi treatment 
worked (Fig. 3.3a). Metaphase spreads of cells treated with PARPi were 
analyzed and SAs and fragile telomeres scored 96 h after Cre mediated deletion 
of TRF1. Because the short arm of mouse chromosomes is too short to detect a 
separation of the arms, both SAs and fragility were scored on long arm 
chromosomes only for all experiments. Interestingly, PARPi treatment for 24 or 
48 h significantly reduced the levels of SAs compared to untreated control cells 
from around 15% to 8% (Fig. 3.3b). Telomere fragility was not affected by PARPi 
and remained around 20% (Fig. 3.3c). To confirm that the reduction in SAs was 
due to PARP inhibition and not a side effect of the olaparib treatment, PARP1 
was depleted using shRNA. Two different shRNAs were used and western blot 
analysis indicated knockdown of PARP1 (Fig. 3.3d). When metaphase spreads 
were analyzed 96 h after deletion of TRF1, a similar reduction in SAs was 
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Figure 3.3 PARP1 is required for the formation of SAs 
(A) Western blot of TRF1F/F MEFs treated with olaparib. Cells were harvested at 72 h after 
deletion of TRF1 with the indicated duration of olaparib (2 μM) treatment. MEFs were treated with 
H2O2 prior to harvest when indicated and parsylation and TRF1 deletion visualized on western 
blot with TRF1 and PAR reactive antibodies. (B) Frequency of SAs on metaphase spreads from 
olaparib treated TRF1F/F MEFs 96 h after deletion of TRF1. Duration of olaparib treatment (2 μM) 
is shown below. Bars represent median % of SAs from 5 independent experiments, each dot 
represents a metaphase spread. (C) Frequency of telomere fragility on the metaphase spreads 
from (B). Means and SD from 5 independent experiments is shown. (D) Western blot of shPARP1 
treated TRF1F/F MEFs. Cells were harvested 72hrs after deletion of TRF1 and deletion of PARP1 
and TRF1 visualized on western blot with indicated antibodies. (D) Frequency of SAs on 
metaphase spreads from shRNA treated cells, 96 h after Cre. Bars represent the median % of 
SAs from 3 independent experiments. (F) Frequency of telomere fragility on the metaphase 
spreads from (E). Means and SD from 3 independent experiments is shown. P-values determined 
by a two-sided Students T-test (* p<0.05, ** p<0.01, *** p<0.001, ns: not significant). 
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observed as after the olaparib treatment (Fig. 3.3e and 3.3b). The frequency of 
SAs was reduced to around 8% with both shRNAs against PARP1. Again, 
telomere fragility was not affected upon depletion of PARP1 (Fig. 3.3f). The data 
thus suggest that PARP1 activity is needed for the formation of SAs, implicating 
the a-NHEJ pathway. 
However, the activity of PARP1 in DNA repair is extensive and there are 
additional explanations why PARP1 could be required for SAs. First of all, PARP1 
is known for its role in BER where it detects ssDNA breaks and attracts repair 
proteins (Dantzer et al., 2000). Furthermore, PARP1 has been implicated in HR 
mediated restart of replication forks (Bryant et al., 2009). Thus, additional 
experiments are needed to firmly establish the a-NHEJ pathway in the formation 
of SAs. 
3.2.2. Ligase 3 is involved in the formation of Sister Associations 
To further examine whether a-NHEJ is involved in the formation of SAs, Lig3 was 
deleted using shRNA because this ligase is an important component of the a-
NHEJ pathway (Simsek et al., 2011). Unfortunately, whereas the function of Lig3 
in the nucleus is not essential, it has a vital role in mitochondria and cells without 
Lig3 are not viable. Long-term shRNA-mediated depletion of Lig3 is therefore 
toxic to cells and not achievable. To circumvent this problem, TRF1F/F cells were 
first treated with Cre immediately followed by lentiviral infection with two different 
shRNA. This allowed analysis of the effect of Lig3 depletion before cells are too 
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Figure 3.4 Depletion of Lig3 reduces SAs 
(A) Western blots of TRF1F/F MEFs treated with two different shRNA against Ligase 3. Cells were 
harvested 72 h after deletion of TRF1 and analyzed on western blot with Lig3 and TRF1 reactive 
antibodies. (B) Frequency of SAs on metaphase spreads from shRNA treated TRF1F/F MEFs 96 h 
after deletion of TRF1. Bars represent median % of SAs from 3 independent experiments, each 
dot represents a metaphase spread. (C) Analysis of telomere fragility on the metaphase spreads 
from (B). Means and SD from 3 independent experiments is shown. P-values determined by a 
two-sided Students T-test (*** p<0.001, **** p<0.0001, ns: not significant). 
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Figure 3.5 Lig1 and Lig4 do not affect the frequency of SAs 
(A) Western blots of TRF1F/F MEFs treated with three different shRNA against Ligase 1. Cells 
were harvested 72 h after deletion of TRF1 and analyzed on western blot with Lig1 and TRF1 
reactive antibodies. (B) Frequency of SAs on metaphase spreads from shRNA treated TRF1F/F 
MEFs 96 h after deletion of TRF1. Bars represent median % of SAs from 3 independent 
experiments, each dot represents a metaphase spread. (C). Frequency of SAs on metaphase 
spreads from TRF1F/FLig4+/+ and TRFF/FLig4-/- MEFs 96 h after Cre. Bars represent median % of 
SAs from one experiment. P-values determined by a two-sided Students T-test (ns: not 
significant). 
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sick for analysis. The proliferation rate of cells after shRNA against Lig3 is still 
somewhat lower compared to control cells (~40% or ~20% fewer cells with 
shRNA1 and 2 respectively, at time of harvest 2 days after plating). However, this 
is not expected to affect the level of SAs as they are formed in the last S/G2 
phase before analysis. SAs therefore do not represent a cumulative phenotype, 
unlike the chromosome type fusions seen after TRF2 loss. A lower proliferation 
rate is thus not expected to reduce the prevalence of SAs. 
Western blot analysis indicates that both shRNA are effective in knocking 
down Lig3 expression (Fig. 3.4a). Metaphase spreads were analyzed 96 h after 
deletion of TRF1 and SAs and fragile telomeres were scored. Interestingly, both 
shRNA against Lig3 significantly reduced the level of SAs to around 8% (Fig. 
3.4b). No effect on the frequency of fragile telomeres was observed after 
depletion of Lig3 (Fig. 3.4c). The reduction in SAs with the shRNA against Lig3 is 
similar to the reduction seen with olaparib and the shRNA against PARP1 (Fig. 
3.3b,e and Fig 3.4b). 
Another ligase implicated in a-NHEJ is Ligase 1 (Lig1). This ligase has 
been shown to mediate a-NHEJ in absence of Lig3 (and Lig4) and could thus be 
involved in the formation of SAs (Liddiard et al., 2016; Lu et al., 2016). To 
examine the role of Lig1, three different shRNA against Lig1 were tested in 
TRF1F/F MEFs and SAs analyzed 96 h after deletion of TRF1. Western blot 
analysis indicates good knockdown of Lig1 with all shRNA (Fig. 3.5a). However, 
the levels of SAs were not affected by the absence of Lig1 (Fig. 3.5b). It is 
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possible that Lig1 functions as a backup enzyme for Lig3. This was suggested in 
earlier experiments where an effect for Lig1 in a-NHEJ was only seen in absence 
of Lig3 (Liddiard et al., 2016). However, given that knockdown of Lig3 is toxic for 
cells, the combined knockdown of Lig3 and Lig1 was not attempted. 
Nevertheless, the results clearly establish that Lig1 is not involved in the 
formation of SAs when Lig3 is present. Furthermore, as previously shown, SAs 
were still present in TRF1F/FLig4-/- MEFs establishing that the fusions are not 
formed via c-NHEJ (Fig. 3.5c) (Sfeir et al., 2009). The combined results of the 
effect of PARP1 and Lig3 strongly suggest that SAs are formed via a-NHEJ. 
3.2.3 Ku does not affect Sister Associations 
The fact that telomeric sequences contain microhomology (Fig. 3.2a) and that a-
NHEJ can take place under certain circumstances supports the hypothesis that 
SAs may represent a-NHEJ mediated fused telomeres. It was previously shown 
that a-NHEJ takes places at telomeres when the entire shelterin complex is 
missing (Sfeir and de Lange, 2012). However, the pathway was only fully 
unleashed when Ku was absent. Ku prevents a-NHEJ by at least two 
mechanisms. It prevents DNA resection and competes with PARP1 for DNA 
binding thus inhibiting its activation (Wang et al., 2006). To test whether Ku has a 
similar role in preventing a-NHEJ after TRF1 deletion, SAs were analyzed in 
TRF1F/FKu70-/- MEFs. If Ku prevents a-NHEJ, SAs are expected to increase in 
absence of Ku. Metaphase spreads of TRF1F/FKu70-/- cells were analyzed  
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Figure 3.6 Ku does not affect SAs 
(A) Western blot of TRF1F/FTin2+/+Ku70+/+ and TRF1F/FTin2+/+Ku70-/- littermate MEFs. Cells were 
harvested 72 h after deletion of TRF1 and analyzed with TRF1 and Ku70 reactive antibodies. (B) 
Frequency of SAs on metaphase spreads from TRF1F/FTin2+/+Ku70+/+ and TRF1F/FTin2+/+Ku70-/- 
MEFs 96 h after deletion of TRF1. Bars represent median % of SAs from 3 independent 
experiments, each dot represents a metaphase spread. (C) Frequency of SAs on metaphase 
spreads from TRF1F/FmTR+/- and TRF1F/FmTR-/- littermate MEFs 96 h after Cre. Bars represent 
the median % SAs from one experiment. P-values determined by a two-sided Students T-test (ns: 
not significant). 
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together with Ku positive littermate controls (Fig. 3.6a and b). Unexpectedly, lack 
of Ku did not significantly increase the level of SAs upon deletion of TRF1 
indicating that Ku does not prevent a-NHEJ in this setting. Possibly, the presence 
of TRF2 prevents Ku from acting at telomeres lacking TRF1 (Ribes-Zamora et 
al., 2013). In vitro experiments suggested that TRF2 directly interacts with Ku to 
prevent it from stimulating NHEJ. Thus, upon deletion of TRF1, Ku may continue 
to be inhibited by TRF2 explaining why loss of Ku does not result in higher levels 
of SAs. 
Recently, unpublished experiments from the Boulton lab suggested a role 
for the telomerase enzyme in the formation of fragile telomeres. In absence of 
telomerase, the prevalence of telomere fragility upon RTEL1 deletion was 
drastically reduced. To ascertain that SAs are not affected by telomerase, 
metaphase spreads from cells deficient for mTR, the RNA component of 
telomerase complex, were analyzed. Yet, SAs were unchanged in TRF1F/FmTR-/-
cells compared to littermate controls, suggesting that telomerase does not affect 
their formation (Fig. 3.6c). 
3.2.4 Anaphase bridges are seen upon deletion of TRF1 
If SAs are truly fused telomeres, abnormalities should be visible during mitosis as 
dicentric chromosomes form anaphase bridges, which can result in Breakage-
Fusion-Bridge cycles (BFB) and genome instability (Maciejowski et al., 2015). To 
analyze whether cells lacking TRF1 display abnormalities, the behavior of 
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chromosomes in mitosis was examined using spinning-disk confocal imaging. 
For these experiments, a TRF1F/F cell line was created that stably expresses 
H2B-venus to allow visualization of chromosome dynamics in live cell imaging 
experiments.  Cells were imaged before and 72 h after deletion of TRF1 using a 
Yokogawa spinning-disk confocal system and a Z-stack set of images was 
acquired every 5 minutes. This experimental setup permits imaging adjacent 
fields that are computationally stitched together to follow the fate of mitotic cells 
(Stephens et al., 2011). Interestingly, more than 80% of mitotic cells displayed 
anaphase bridges upon deletion of TRF1 versus only 20% of untreated control 
cells (Fig. 3.7a and b). The high background of chromatin bridges in the no-Cre 
control cells might be due to the repression of p53/Rb in these SV-40 
immortalized MEFs, since these MEFs bypass cell cycle arrest upon DNA 
damage. 
TRF1 loss has previously been linked to mitotic abnormalities in a mouse 
model of tissue specific TRF1 deletion (Martinez et al., 2009). When TRF1 was 
conditionally deleted from epithelial cells, mice deficient for p53-/- spontaneously 
developed squamous cell carcinomas in the tail and ear skin. These lesions 
contained many multinucleated giant cells and anaphase bridges consistent with 
chromosome segregation problems in TRF1 deficient cells. However, the reason 
for the appearance of these anaphase bridges was not further analyzed. 
The presence of anaphase bridges further suggests that SAs are fused 
telomeres (Fig. 3.7a). However, one caveat of these experiments is that TRF1F/F  
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Figure 3.7 Mitotic abnormalities after TRF1 loss 
(A) Images of H2B-Venus marked chromatin of a mitotic cell from TRF1F/F MEFs left untreated 
(top) or 72hrs after Cre. Image stills were taken from movies made on a confocal spinning disk 
microscope with Z-stacks taken 5 minutes apart. (B) Analysis of the frequency of mitotic bridges 
in movies from A. At least 60 mitotic cells were analyzed per condition. Numbers represent mean 
and SDs from 3 movies per condition from 2 independent experiments. 
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MEFs also display low levels of chromosome type fusions after deletion of TRF1 
that could explain the appearance of the mitotic abnormalities. Unfortunately, 
these chromosome type fusions are still present in TRF1F/FLig4-/- and in TRF1F/F 
MEFs depleted of Lig3. Therefore it is not possible to strictly ascertain that the 
anaphase bridges upon deletion of TRF1 are the result of SAs or due to the low 
level of chromosome type fusions present in these cells. Most metaphases 
contain at least one chromosome type fusion 96 h after deletion of TRF1 but the 
percentage of SAs is much higher (5-10 per metaphase). Analysis of the mitotic 
cells in the movies of TRF1F/F cells after Cre suggests that multiple anaphase 
bridges are present, arguing that they represent the SAs. However, it is difficult to 
quantify the exact numbers with this imaging setup, hindering a direct correlation 
with the numbers of SAs or chromosome type fusions. Possibly, imaging 
experiments at very early time points after deletion of TRF1 would offer a solution 
as chromosome type fusions will not have accumulated to such an extent. 
3.2.5 PICH localizes to DNA bridges upon deletion of TRF1 
Plk1-interacting checkpoint helicase (PICH) is a DNA translocase that is 
activated by Plk1 during mitosis and is recruited to a special class of anaphase 
bridges, ultrafine bridges (UFBs) (Baumann et al., 2007; Chan et al., 2007). 
These bridges are not detectable with conventional DNA dyes but can be 
visualized with antibodies to BLM and PICH. UFBs appear in every anaphase 
between centromeres but are resolved as mitosis proceeds. These centromeric 
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UFBs represent intertwined DNA structures that require decatenation by 
Topoisomerase IIa  (TopoIIa) and BLM, a process stimulated by PICH (Nielsen et 
al., 2015). UFBs not only originate from centromeres but can also arise at fragile 
sites and telomeres (Chan et al., 2009; Barefield and Karlseder, 2012). These 
UFBs are increased in cells lacking BLM and are thought to represent replication 
intermediates. 
Since TRF1 loss induces anaphase bridging and replication stress, it is 
possible that telomeric UFBs appear as a results of TRF1 deletion. In human 
cells, a small increase in UFBs was detected when TRF1 was depleted by 
shRNA from IMR90 cells but these results were difficult to interpret due to 
concomitant telomere loss hindering the classification of telomeric UFBs versus 
those at CFSs or centromeres (Barefield and Karlseder, 2012). Since mouse 
telomeres are much longer then human telomeres, deletion of TRF1 in MEFs 
might be a better experimental setup to examine the appearance of telomeric 
UFBs. 
Unfortunately, antibodies against mouse BLM or PICH are not available 
for IF analysis since most of the prior work was done in human cells. To enable 
visualization of UFBs, a GFP or RFP tagged PICH construct was therefore 
generated (Fig. 3.8a). These constructs were stably expressed in TRF1F/F cells 
and high expressing cells were isolated by FACS sorting (Fig. 3.8a). To show 
that the N-terminal tag had no effect on PICH localization, cells were treated with 
ICRF-193, a topoisomerase inhibitor that is known to induce centromeric UFBs. 
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Figure 3.8 PICH localizes to anaphase bridges 
(A) Schematic of PICH-RFP and PICH-GFP constructs (top) and FACS plots of the isolation of 
TRF1F/F MEFs expressing these constructs by FACS sorting (bottom). The fraction of GFP high 
and RFP high expressing MEFs were sorted. (B) Examples of PICH localization to anaphase 
bridges in PFA fixed cells. Sorted PICH expressing TRF1F/F MEFs from A were treated with 
ICRF93 (top) or analyzed 72 h after TRF1 deletion (bottom) by microscopy. DNA is stained with 
DAPI and PICH is either RFP or GFP positive. (C) Example of a mitotic cell from live cell imaging 
experiments of TRF1F/FPICHRFPH2Bvenus MEFs 72 h after deletion of TRF1. Z-stacks were taken 4 
minutes apart on a confocal spinning disk microscope.  (D) Quantification of the percentage of 
cells with H2B-venus and PICH positive mitotic bridges before and 72 h after deletion of TRF1. 
Values represent the mean from one experiment with at least 60 mitotic cells analyzed per 
condition. All H2B-venus bridges have PICH staining and only few PICH only bridges are seen. 
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Indeed, PICH positive bridges were readily detected in anaphase cells upon 
ICRF-193 treatment of TRF1F/F RFP-PICH expressing cells (Fig. 3.8b, top). To 
examine the effect of TRF1 deletion, TRF1F/F GFP-PICH cells were treated with 
Cre and mitotic cells analyzed IF 72 h later. Interestingly, PICH positive treads 
were seen upon TRF1 loss, although their abundance was not as high compared 
to treatment with ICRF-193 (Fig. 3.8b, bottom). To better understand the 
dynamics of PICH positive anaphase bridges upon deletion of TRF1, H2B-venus 
was expressed in TRF1F/F PICH-RFP cells to enable live cell imaging. Cells were 
imaged 72 h after deletion of TRF1 on the Yokogawa spinning-disk confocal 
system and images (Z-stack) were acquired every 4 minutes. Again, PICH 
positive threads were detected in anaphase similar to live cell imaging or fixed 
samples (Fig. 3.8c). Around 70% of anaphases analyzed displayed PICH 
localization. However, most PICH positive threads contained histones as 
indicated by the overlap with H2B-venus (Fig. 3.8d). Therefore, it is unclear 
whether these bridges represent genuine UFBs or regular anaphase bridges. 
Possibly, the resolution of the microscope is not sufficient to visualize UFBs using 
this method. The PICH positive threads seen in fixed cells using regular imaging 
suggests that more bridges might be present then detected in live cell imaging 
experiments (compare Fig. 3.8b and 3.8c). The PICH structures seen in live cell 
imaging show a speckled pattern compared to the full threads seen in fixed cells 
indicating that microscope resolution might be an issue. However, even in fixed 
cells, the PICH positive threads appear to overlap with DAPI signals suggesting 
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Figure 3.9 PICH localizes to bridges after deletion of TRF2 
(A) Example of a mitotic cell from a live cell imaging experiment of TRF2F/FPICHGFPH2Bvenus
expressing MEFs 72 h after deletion of TRF2. Z-stacks were taken 4 minutes apart on a confocal 
spinning disk microscope. (B) PICH recruitment to a chromatin bridge remaining after mitosis 
from the same movie as in A. 
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that they represent regular anaphase bridges instead of genuine UFBs (Fig. 
3.8b). 
To better understand the distinction between UFBs and regular anaphase 
bridges, the effect of TRF2 loss was analyzed. Deletion of TRF2 results in 
massive chromosome type fusion and the appearance of anaphase bridges but 
there is no replication stress and telomeric UFBs are therefore not expected. A 
TRF2F/F cell line was created expressing H2B-venus and PICH-RFP and high 
expressing cells isolated by FACS sorting. Live cell imaging experiments were 
done using the same conditions as for TRF1F/F cells using the Yokogawa 
spinning-disk confocal system. Remarkably, deletion of TRF2 resulted in the 
appearance of PICH positive threads similar to those seen upon TRF1 deletion 
(Fig. 3.9a). In some cases, a PICH positive thread remained long after cell 
division (Fig. 3.9b). Thus, it appears as though PICH is not just recruited to UFBs 
but also to regular DAPI positive chromatin bridges formed upon telomere 
dysfunction. 
Because PICH recruitment was not specific to TRF1 deletion and 
microscope resolution prohibits definitive analysis of telomeric UFBs by live cell 
imaging, this line of experimentation was not continued. Therefore, it cannot be 
concluded whether TRF1 loss leads to the appearance of UFBs at telomeres. It 
would be interesting to repeat the experiment in fixed cells since the resolution of 
PICH-GFP imaging appears to be higher. 
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3.2.6 The role of 53BP1 at sites of replication stress 
53BP1 is mostly known for its role in DSB repair. However, 53BP1 is also 
recruited to sites of replication stress (Jowsey et al., 2007), including replication 
stress at telomeres (Sfeir et al., 2009). While ATM is the main kinase that acts on 
53BP1 in response to DSBs, phosphorylation by ATR occurs in response to UV 
damage or loss of TRF1. Whether similar or different S/TQ sites are 
phosphorylated in response to DSBs or replication stress remains unclear. At 
DBSs, the main role for 53BP1 is to promote NHEJ by blocking extensive end 
resection. However, stalled replication forks are not repaired by NHEJ and it is 
therefore unclear what the role (if any) of 53BP1 is at these sites. It is possible 
that 53BP1 only localizes to collapsed replication forks that have turned into 
DSBs and have activated ATM kinase. However, 53BP1 is recruited to telomeres 
in TRF1F/FATM-/- cells, arguing against this hypothesis (Sfeir et al., 2009). 
Furthermore, phosphorylation of 53BP1 by ATR occurs independently of ATM 
(Jowsey et al., 2007). A recent study from this lab provided evidence that 53BP1 
is capable of blocking resection at telomeres in an ATR dependent manner (Kibe 
et al., 2016). This was shown at cells lacking TPP1/POT1a/b, which are 
incapable of protecting the 3’ overhang at telomeres. Deletion of 53BP1 from 
these cells resulted in a hyper resection phenotype at telomeres. Interestingly, 
this resection pathway was dependent on BLM and Exo1, instead of the ATM 
mediated CtIP resection pathway. Furthermore, the results showed that 53BP1 
recruits Rif1 to inhibit the ATR mediated resection pathway, similar to the  
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Figure 3.10 Phosphorylation of 53BP1 upon TRF1 or TRF2 deletion 
Western blot of 53BP1 isolated from TRF1F/F53BP1-/- and TRF2F/F53BP1-/- MEFs expressing 
FLAG-53BP1. Cells were harvested 72 h after deletion of either TRF1 or TRF2 and 53BP1 was 
isolated using FLAG-beads. Isolated 53BP1 was analyzed by western blot for phosphorylation 
using an antibody specific for phosphorylated S/TQ sites. Total levels of 53BP1 were visualized 
with a 53BP1 reactive antibody. 
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situation at DSBs (Kibe et al., 2016). Whether there is a similar role for 
53BP1/Rif1 in response to ATR activation at the replication fork remain unknown. 
To analyze whether 53BP1 is phosphorylated in a different manner in 
response to ATR activation versus ATM, a phosphorylation status of 53BP1 was 
compared after TRF1 and TRF2 deletion. A FLAG-tagged 53BP1 wild type allele 
was expressed in TRF1F/F53BP1-/- and TRF2F/F53BP1-/- cells. Upon deletion of 
either TRF1 or TRF2, 53BP1 was isolated using FLAG antibodies to recover 
53BP1. An immunoblot against 53BP1 or with an antibody specifically reactive 
with phosphorylated S/TQ residues revealed the phosphorylation status of 53BP1 
(Fig. 3.10). In absence of Cre, some background phosphorylation of 53BP1 is 
detected in both TRF1F/F and TRF2F/F cells. Interestingly, whereas deletion of 
TRF2 results in considerable S/TQ phosphorylation of 53BP1, this effect is much 
less when TRF1 is deleted (Fig. 3.10). This could indicate that fewer sites are 
phosphorylated in response to ATR activation but it is also possible that a smaller 
fraction of the 53BP1 pool is affected after TRF1 deletion versus TRF2. This 
experimental approach does not allow distinction between these two possibilities. 
However, the results suggest that ATR does not affect 53BP1 phosphorylation as 
strongly as ATM activation at telomeres. 
To evaluate the role of 53BP1 at telomeres upon ATR activation, 
TRF1F/F53BP1-/- MEFs were examined. The mutant 53BP1 alleles described in 
Chapter 2 were expressed in these cells to enable analysis of 53BP1 function 




Figure 3.11 53BP1 mutants in TRF1F/F53BP1-/- MEFs 
(A) Schematic of the 53BP1 mutant alleles with the S/TQ sites illustrated in red (B) Immunoblot 
showing the expression level of the 53BP1 mutant alleles in TRF1F/F53BP1-/- MEFs. Cells were 
harvested 72 h after deletion of TRF1 and visualized on western blot with 53BP1 or TRF1 specific 
antibodies. (C) Recruitment of 53BP1 and Rif1 to telomeres. Example of IF-FISH images from 
TRF1F/F53BP1-/- MEFs expressing the indicated mutant 53BP1 allele. Cells were imaged 72 h 





Figure 3.12 Telomere overhang gel in TRF1F/F53BP1-/- cells 
(A) Telomere overhang assay of MboI/AluI digested DNA from TRF1F/F53BP1-/- MEFs expressing 
the indicated mutant 53BP1 alleles. Telomeric DNA was analyzed 96 h after Cre-mediated 
deletion of TRF1 using the in-gel hybridization assay. Left panel shows native telomeric ssDNA 
signal, right panel displays the denatured total amount of telomeric DNA. Where indicated, 
telomeric DNA was treated with Exo1 to remove ssDNA at the 3’ overhang. (B) Quantification of 
the overhang signal as in (A) from two independent experiments. Numbers were obtained by 
normalizing the native ssDNA signal to the total telomeric DNA signal in the same lane in the 
denatured gel. The values of the Cre-treated samples were obtained by comparison with the no-
Cre empty vector control lane, which was set to 1.0. Means and SDs from two independent 
experiments are shown. (C) Western blot with 53BP1 and TRF1 reactive antibodies from 
TRF1F/F53BP1-/- MEFs expressing the indicated 53BP1 allele. Cells were harvested 72 h after 
deletion of TRF1. 
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blot (Fig. 3.11b). Similar to the setting of TRF2 deletion, IF-FISH showed that 
localization of 53BP1S/TQ to telomeres lacking TRF1 was not affected by mutating 
the S/TQ sites (Fig. 3.11c). Furthermore, Rif1 was recruited to 53BP1 in cells 
expressing 53BP1WT, 53BP1ΔPTIP, and 53BP1ΔMOB but not to 53BP1Δ28 or 
53BP1ΔRif1, similar to the situation upon deletion of TRF2 (Fig. 3.11c).  
TRF1 deletion itself does not unleash resection at the telomere end but 
co-deletion of 53BP1 results in a mild hyper-resection phenotype (Sfeir et al., 
2009; Sfeir and de Lange, 2012). To confirm that resection is increased in 
absence of 53BP1, a telomere overhang analysis was done in TRF1F/F53BP1-/- 
cells expressing empty vector, 53BP1WT or 53BP1Δ28 (Fig. 3.12a-c). Samples 
were analyzed with our without treatment with the E. coli ExoI 3’ exonuclease to 
verify that the observed ssDNA is at the overhang and not telomere internal. 
Indeed, all telomeric signals disappeared from the native gel upon treatment with 
ExoI confirming that the ssDNA is at the telomere end (Fig. 3.12a and b). As 
expected from experiments in TRF2F/F MEFs, expression of 53BP1WT allele was 
able to rescue the mild hyper-resection phenotype seen in cells expressing 
empty vector (Sfeir and de Lange, 2012). Moreover, 53BP1Δ28 was unable to 
rescue the resection phenotype suggesting a similar role for 53BP1 (and Rif1) in 
blocking resection at telomeres upon TRF1 deletion as at DSBs. 
Next, metaphase spreads from TRF1F/F53BP1-/- MEFs were analyzed and 
SAs and fragile telomeres scored (Fig. 3.13a). Interestingly, SAs were 
significantly reduced when 53BP1 was absent (Fig. 3.13b). This is in agreement  
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Figure 3.13 53BP1 S/TQ sites affect the frequency of SAs 
(A) Examples of metaphase spreads of TRF1F/F53BP1-/- MEFs expressing indicated 53BP1 allele, 
harvested 96 h after deletion of TRF1. (B) Frequency of SAs in TRF1F/F53BP1-/- MEFs expressing 
the indicated 53BP1 allele, 96 h after the deletion of TRF1. Bars represent median % of SAs from 
three independent experiments. Each dot represents a metaphase spread. (C) Analysis of 
telomere fragility in the same metaphase spreads as in (B). Values represent means and SDs 
from three independent experiments. P-values determined by a two-sided Students T-test (*** 
p<0.001, ns: not significant). (D) Western blot visualizing the equal expression of the indicated 
53BP1 alleles in TRF1F/F53BP1-/- MEFs. Cells were harvested 72 h after deletion of TRF1. 
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Figure 3.14 53BP1 S/TQ sites affect SAs in two additional cell lines 
(A) Western blot visualizing the equal expression of the indicated 53BP1 alleles in two additional 
TRF1F/F53BP1-/- MEF cell lines. Cells were harvested 72 h after deletion of TRF1. (B and C) 
Frequency of SAs in TRF1F/F53BP1-/- cell line 2.5 (B) and 2.3 (C). Cells express the indicated 
53BP1 allele and were harvested 96 h after the deletion of TRF1. Bars represent median % of 
SAs from three independent experiments. Each dot represents a metaphase spread. (D) Analysis 
of telomere fragility in cell line 2.3 on the metaphase spreads from (C). Values represent means 
and SDs from three independent exepriments. P-values determined by a two-sided Students T-
test (* p<0.05, ** p<0.01, *** p<0.001, ns: not significant). 
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with a previous report that noted reduced levels of sister chromatid fusion in 
absence of 53BP1 (Martinez et al., 2012). The reduction in SAs appeared to be 
dependent on phosphorylation of 53BP1 as 53BP1Δ28 displayed a similar 
decrease in SAs as the empty vector control (Fig. 3.13b). There was no 
difference between 53BP1ΔMOB and 53BP1ΔPTIP compared to 53BP1WT, indicating 
that these domains play no role in the formation of SAs. However, cells 
expressing 53BP1ΔRif1 displayed reduced levels of SAs similar to empty vector 
control, suggesting that 53BP1 recruits Rif1 to help the formation of SAs. 
Telomere fragility was also analyzed but no difference was observed with any of 
the 53BP1 alleles (Fig. 3.13c). 
To confirm these results, additional TRF1F/F53BP1-/- MEFs were made to 
ascertain that this phenotype was not cell line specific. To generate MEFs, 
TRF1F/F53BP1+/- mice were intercrossed to obtain TRF1F/F53BP1-/- genotypes. 
MEFs were isolated from E12.5 embryos and immortalized through introduction 
of the SV40 large T antigen. Two different TRF1F/F53BP1-/- cell lines were 
analyzed (2.3 and 2.5) upon expression of the different 53BP1 alleles using the 
same experimental conditions as used in Figure 3.13. Again, SAs were lowered 
in absence of 53BP1 or when 53BP1Δ28 or 53BP1ΔRif1 was expressed (Fig. 3.14b 
and c). Telomere fragility was not affected by any of the mutant 5BP1 alleles 
indicating that 53BP1 has no role in their formation (Fig. 3.14d). Together, these 
results suggest that 53BP1 promotes formation of SAs through the recruitment of 
Rif1. 
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3.2.7 Rif1 acts downstream of 53BP1 to promote Sister Associations 
To further assess the function of Rif1 in the formation of SAs, 
TRF1F/FRif1F/F53BP1-/- triple knockout cells were analyzed. If Rif1 is required 
downstream of 53BP1, there should be no difference in the level of SAs between 
any of the mutant 53BP1 alleles when Rif1 is absent. To create the 
TRF1F/FRif1F/F53BP1-/- cell line, the 53BP1 locus was edited in TRF1F/FRif1F/F 
MEFs using CRISPR/Cas9. Since 53BP1 is a large protein (encoded by 5760 bp 
in 27 exons), early exons in the gene were targeted to maximize the chance of 
deleting the entire protein instead of generating a possibly functional truncation 
mutant (Fig. 3.15a). Three different guide RNAs (gRNAs) were designed 
targeting exon 2 and exon 3 and TRF1F/FRif1F/F MEFs transiently transfected with 
one of the gRNA vector together with Cas9. MEFs were subcloned and 
subsequently screened via western blot for deletion of 53BP1. Several clones 
were identified that lost expression of 53BP1 and two clones were picked for 
further analysis (Fig. 3.15b). Sequencing confirmed a frame shift mutation in 
clone g3#3 and g5#7, although for both clones only one allele variant was 
detected (Fig. 3.15c). Possibly, the mutation in the second alleles is so 
substantial that the PCR amplification required for sequencing failed or the 
clones became hemizygous.  
To address the role of Rif1 in the formation of SAs, selected 53BP1S/TQ 
alleles were expressed in the TRF1F/FRif1F/F53BP1-/- MEF clones g3#3 and clone 
g5#7. The mutant 53BP1 alleles were expressed equally as gleaned from 
121 
Figure 3.15 CRISPR/Cas9 editing of 53BP1 in TRF1F/FRif1F/F MEFs 
(A) Schematic of the mouse 53BP1 locus on chromosome 2, only the first 5 exons (of 27) are 
shown. The gRNAs target either exon2 or exon3 as indicated. (B) Immunoblot for 53BP1 in MEF 
clones picked after targeting with the indicated gRNAs, showing several clones with deletion of 
53BP1. Clone g3#3 and g5#7 (in red) were picked for further analysis. Immunoblot for TRF1 is 
used as loading control. (C) DNA sequencing of clones g3#3 and g5#7. The reference sequence 
shows the untargeted DNA with the gRNA sequence (red) and PAM (green). For both clones, 
only one allele was found with sequencing (out of 11 or 12 sequences analyzed) suggesting the 
other allele has a larger deletion that was not PCR amplified. 
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Figure 3.16 Analysis of SAs and fragility in TRF1F/FRif1F/F53BP1-/- MEFs 
(A) Immunoblot of TRF1F/FRif1F/F53BP1-/- MEFs clone g3#3 and g5#7. Cells were harvested 72 h 
after Cre and analyzed with TRF1, Rif1 and 53BP1 reactive antibodies. (B) Frequency of SAs in 
metaphase spreads from clone g3#3 (left) and clone g5#7 (right) expressing the indicated 53BP1 
allele 96 h after Cre. Bars represent median % of SAs from three independent experiments. Each 
dot represents a metaphase spread.  (C) Analysis of telomere fragility on the metaphase spreads 
from (B). Values represent means and SDs from three independent experiments. P-values 
determined by a two-sided Students T-test (*** p>0.001, ns: not significant). 
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western blot analysis (Fig. 3.16a). SAs and telomere fragility were analyzed in 
metaphase spreads harvested 96 h after deletion of TRF1 and Rif1. Interestingly, 
there was no longer a difference in the level of SAs in absence of 53BP1 (Fig. 
3.16b). All mutant 53BP1 alleles displayed a similar frequency of SAs compared 
to empty vector control. The results were comparable in the two CRISPR clones 
analyzed substantiating this finding. Telomere fragility was also unaltered upon 
expression of any 53BP1 allele (Fig. 3.16c). 
These results strongly suggest that 53BP1 recruits Rif1 to aid the 
formation of SAs. Of note, the overall levels of SAs are much lower in these 
TRF1F/FRif1F/F53BP1-/- clones compared to other cell lines analyzed (median ~8% 
versus ~15-20%) (Compare Figs 3.13/3.14 and 3.16b). It is interesting to 
speculate that this lower level of SAs in TRF1F/FRif1F/F53BP1-/- MEFs is due to 
the absence of Rif1 but it is also possible that this is a clonal effect. The 
frequency of SAs changes slightly between the different cell types analyzed, with 
wild type levels ranging from ~15-20%. It would be interesting to overexpress 
Rif1 in TRF1F/FRif1F/F53BP1-/- MEFs cells to examine if this increases the 
frequency of SAs. However, Rif1 is a large protein and difficult to express and 
this experiment was therefore not attempted. 
The main known function of Rif1 downstream of 53BP1 is to control end 
resection via Rev7 (Callen et al., 2013; Di Virgilio et al., 2013; Zimmermann et 
al., 2013; Boersma et al., 2015; Xu et al., 2015). If SAs are formed by a-NHEJ, 
limited resection is required to expose the microhomology needed for the 
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reaction to occur. It is therefore unclear why loss of Rif1 and 53BP1 reduces the 
levels of SAs. Absence of these proteins increases the amount of end resection, 
which should increase the prevalence of SAs instead of reducing them. Possibly, 
the extensive end resection that occurs in absence of 53BP1/Rif1 instead 
channels repair to HR. 
3.2.8 A enigmatic role for Exo1 in the formation of Sister Associations 
To better understand the role for end resection in the formation of SAs, the effect 
of shRNAs against BLM and Exo1 was examined. At DSBs, end resection is 
initiated by the MRN complex and CtIP, followed by more extensive resection by 
Exo1, BLM, DNA2 and WRN (Sartori et al., 2007; Mimitou and Symington, 2008; 
Nimonkar et al., 2008). Whether this process is similar at stalled replication forks 
is not well understood. 
To examine whether BLM and Exo1 are involved in the development of 
SAs, TRF1F/F cells were treated with shRNAs against these proteins. Since cells 
do not divide well after knockdown of either BLM or Exo1, MEFs were treated 
with Cre prior to the shRNA infection to minimize effects on cell growth. 
Metaphase spreads were analyzed 96 h after Cre infection, which corresponds to 
72 h after the first shRNA infection. Two independent shRNA against BLM were 
tested and both display reduced BLM expression by western blot (Fig 3.17a). 
However, the frequency of SAs was not affected by BLM depletion (Fig. 3.17b). 
This is not surprising since a previous paper already described that BLM has no 
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Figure 3.17 Analysis of SAs and fragility upon deletion of Exo1 or BLM 
(A) Immunoblot of TRF1F/F MEFs treated with shRNA against BLM. Cells were harvested 72 h 
after Cre and analyzed with TRF1 and BLM reactive antibodies. (B) Frequency of SAs in 
metaphase spreads from TRF1F/F MEFs after depletion of BLM, 96 h after Cre. Bars represent 
median % SAs from three independent experiments. Each dot represents a metaphase spread. 
For MEFs treated with shBLM2, few metaphases were analyzed because cells were sick and not 
many spreads were obtained. (C) Analysis of telomere fragility on the metaphase spreads from B. 
Bars represent the median % of fragility from three independent experiments. (D) Immunoblot of 
TRF1F/F MEFs treated with shRNA against Exo1. Cells were harvested 72 h after Cre and 
analyzed with TRF1 and Exo1 specific antibodies. (E) Frequency of SAs in metaphase spreads 
from TRF1F/F cells after depletion of Exo1, 96 h after Cre. Bars represent median % SAs from 4 
independent experiments. (D) Analysis of telomere fragility on the metaphase spreads from E. 
Bars represent the median % of fragile telomeres from 4 experiments. P-values determined by a 
two-sided Students T-test (* p>0.05, *** p>0.001, ns: not significant). 
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effect on SAs (Zimmermann et al., 2014). As expected, telomere fragility was 
slightly increased in absence of BLM consistent with its role in removing G4 
structure in the lagging strand template (Fig. 3.17c). 
Next, shRNA against Exo1 were examined. Knockdown of Exo1 by 
shRNA was efficient as indicated by western blot and loss of Exo1 did not affect 
telomere fragility (Fig. 3.17d and f). Surprisingly, the level of SAs was significantly 
decreased upon knockdown of Exo1 (Fig. 3.17e). This is unexpected given the 
finding the Rif1, an inhibitor of end resection, also reduces SAs (Fig. 3.13 and 
3.14). 
3.3 Summary of findings 
The results in this chapter elucidate the molecular nature of SAs that arise when 
replication stress occurs at telomeres upon loss of TRF1. The results indicate 
that telomeres lacking TRF1 are subject to the a-NHEJ pathway and fusion of 
sister chromatids, which are visible as SAs on metaphase spreads. The results 
show that SAs are dependent on PARP1 as both shRNA and PARP1 inhibition 
by olaparib reduced their appearance (Fig. 3.3b and e). Furthermore, depletion of 
Lig3 also reduced the prevalence of SAs, further implicating that the a-NHEJ 
pathway is involved (Fig. 3.4b). However, deletion of Ku70, a known inhibitor of 
a-NHEJ, did not increase the level of SAs (Fig. 3.6b). Possibly, the interaction 
between TRF2 and Ku prevents the latter from affecting a-NHEJ upon TRF1 
deletion (Ribes-Zamora et al., 2013). Ku is strictly suppressed at telomeres by 
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TRF2 to prevent c-NHEJ and telomere fusions. Thus, upon deletion of TRF1, Ku 
is still bound by TRF2 and kept away from telomere ends. Therefore it is unable 
to influence a-NHEJ, explaining why loss of Ku loss has no effect on SAs. 
 Consistent with SAs being formed by a-NHEJ, live cell imaging 
experiments indicates mitotic abnormalities upon deletion of TRF1 (Fig. 3.7). The 
fusion of sister chromatids creates dicentric chromosomes that form anaphase 
bridges in mitotic cells. Indeed, around 70-80% of cells display this phenotype 
upon deletion of TRF1 consistent with SAs representing fused telomeres.  
Interestingly, PICH was also recruited to anaphase bridges (Fig. 3.8b). PICH is a 
marker for UFBs that arise from centromeric regions and fragile sites, and are 
thought to represent underreplicated regions or replication intermediates that 
require additional processing for resolution during anaphase (Chan et al., 2007; 
Chan et al., 2009). However, the anaphase bridges detected upon loss of TRF1 
were mostly DAPI or H2B-venus positive indicating that they might not be true 
UFBs. It is possible that the resolution of the live cell-imaging microscope was 
not high enough to detect true UFBs in these cells. But, even though the 
appearance of UFBs awaits further investigation, the results clearly show the 
appearance of mitotic defects upon TRF1 loss.  
The function of 53BP1 and Rif1 in the formation of SAs is more 
complicated. The results indicate that 53BP1 recruits Rif1 to promote the 
formation of SAs as loss of either protein reduces the frequency of SAs (Fig. 
3.13b and 3.16b). However, if SAs are formed by a-NHEJ, there is a requirement 
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for end-resection to expose the microhomology domains, a process inhibited by 
53BP1 and Rif1. Therefore, the results are counterintuitive, as loss of 53BP1 and 
Rif1 would be expected to promote resection and increase the levels of SAs. 
Possibly, the resection occurring in absence of 53BP1/Rif1 is too extensive for a-
NHEJ and promotes HR-mediated repair instead. Alternatively, it could mean that 
Rif1 has another function at the replication fork that is independent from 
resection. On the other hand, the effect of Exo1 inhibition could be easily 
explained if Exo1 is the main nuclease involved in the end-resection at telomeres 
lacking TRF1. The defect in resection would be expected to result in a lack of 3’ 
overhangs that are used by a-NHEJ to form the SAs. Further studies are required 
to fully understand the role of 53BP1/Rif1 and Exo1 at telomeres lacking TRF1. 
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Chapter 4: Gen1 cleaves fused sister telomeres
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4.1 Introduction 
Results from the previous chapter indicate that SAs are sister telomeres fused 
via a-NHEJ. The level of SAs is around 15-20% and therefore most cells contain 
5-10 SAs after deletion of TRF1 (SV-40 MEFs have variable chromosome 
numbers). If these were covalently fused telomeres, more chromosomal 
instability and mitotic defects would be expected than is reported for TRF1 
deletion (Sfeir et al., 2009). Specifically, when sister telomeres fuse, 
isochromosomes should appear in the next metaphase when the chromosome 
with sister fusions mis-segregates into one daughter cell occurs and is replicated 
(Fig. 3.2b). However, isochromosomes are not prominent upon deletion of TRF1. 
To explain this discrepancy, we considered the possibility that the fused 
sister telomeres are cleaved after metaphase. Fused telomeres are different from 
chromosome internal fusions and translocations, as fusion of the repetitive 
TTAGGG sequence always creates a palindromic sequence. Such palindromes 
can form cruciform DNA structures (Leach, 1994) (Fig. 4.1a), which are similar to 
a Holliday junction and might therefore be subject to cleavage by HJ resolvases. 
Thus, it is possible that fused telomeres (SAs) are cleaved by HJ resolvases 
during mitosis, resulting in their resolution and normal segregation of the two 
sister chromatids. Some evidence for cleavage of fused telomeres exists from 
studies in the budding yeast S. cerevisiae (Pobiega and Marcand, 2010). In these 
experiments, the fate of dicentric chromosomes formed by telomere fusions was 
followed. Interestingly, these dicentrics often break at the telomere fusion site 
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Figure 4.1 A cruciform DNA structure from a telomere fusion and pathways of Holliday 
Junction resolvases in mammalian cells 
(A) Schematic of a fused sister telomere is shown on the left. Fusion junctions in a-NHEJ often 
contain insertions/deletions that are depicted by xxx. The formation of a cruciform structure from a 
telomere fusion is shown on the right. (B) Schematic of the function of mammalian HJ resolvases. 
Based on an image from (Wyatt and West, 2014). BLM can dissolve a dHJ using its helicase 
activity, resulting in only non-crossovers (left). SLX4/SLX1-Mus81/EME1 and Gen1 cleave the 
junction (at arrows). Cleavage can yield crossovers or non-crossovers. The activity of the 
resolvases during cell cycle progression is indicated at the bottom. 
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during mitosis. However, dicentrics with fusions elsewhere in the chromosome 
did not break and remained until after cytokinesis, indicating that a special 
feature of telomeres caused it to be prone to breakage/cleavage (Lopez et al., 
2015). Since fused telomeres can form cruciform structures, HJ resolvases could 
possibly act on them (Pobiega and Marcand, 2010). 
Mammalian cells have three pathways for Holliday Junction processing 
(Fig. 4.1b). The first pathway is mediated by BLM together with TopoIIa and 
RMI1 and RMI2 and (BTR complex) (Wu and Hickson, 2003). This pathway 
involves branch-migration of two HJs to produce a hemicatenane that can be 
untangled by topoisomerase action. This is an error-free pathway resulting in 
non-crossover products during HR. However, the dissolution pathway requires 
double HJs, which are not expected at fused telomeres where only a single HJ 
can be formed (Fig. 4.1a). Therefore, the BLM dissolution pathway is not 
expected to be relevant for fused telomere resolution. In agreement with this, 
shRNA mediated depletion of BLM did not affect the frequency of SAs in a TRF1 
null setting (Fig. 3.15b). If BLM were indeed responsible for cleaving fused 
telomeres, an increase in SAs would be expected in metaphase spreads upon 
loss of BLM, but this is not observed. Furthermore, SAs are not increased in 
TRF1F/FBLMF/F MEFs after Cre confirming the shRNA results (Zimmermann et 
al., 2014). 
 Two additional HJ resolvase pathways function by endonucleolytic 
cleavage of a single HJ structure, specifically Mus81 and Gen1 (Ciccia et al., 
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2003; Ip et al., 2008; Wyatt et al., 2013). Both these pathways can result in 
crossover and non-crossover products. Mus81 belongs to the XPF family of 
nucleases and forms a complex with its regulatory subunit EME1. Mus81 alone is 
inefficient on intact HJs but works well on 3’-flaps, replication forks and nicked 
HJs (Wyatt et al., 2013). Nicked HJs can be created by the nucleases SLX4 and 
SLX1, which form a scaffold for Mus81. Cooperatively, the two complexes can 
thus cleave intact HJs by a nick and counter-nick mechanism. Gen1 is also a 
member of the XPG family of nucleases but unlike Mus81, it cleaves HJs 
symmetrically (Ip et al., 2008; Rass et al., 2010). Contrary to Mus81, Gen1 has 
no known interaction partners. 
Recent studies have shown the temporal and spatial organization of HJ 
resolvases during the cell cycle (Fig. 4.1b). Since dissolution of dHJs by BLM 
results only in harmless non-crossovers, this appears to be the pathway of 
choice for cells. BLM is active throughout S/G2 to untangle any dHJs that arise 
through replication. However, BLM does not act on single HJs that are formed 
during DNA repair and some dHJs might be refractory to its action. These HJs 
require processing by Mus81 or Gen1. Since these resolvases can result in 
crossovers, their action is limited to later stages of the cell cycle, possibly to allow 
most processing to be done by BLM. At the onset of mitosis, high CDK1 activity 
triggers the association of Mus81 with SLX4/SLX1 (Wyatt et al., 2013). How this 
association is formed precisely is unclear but SLX4, Mus81 and EME1 are all 
phosphorylated in a CDK1-dependent manner. Gen1 is even more restricted than 
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Mus81, being actively excluded from the nucleus by a nuclear export signal 
(Matos et al., 2011; Chan and West, 2014). Only upon nuclear envelope 
breakdown does Gen1 gain access to any remaining HJs. This spatial and 
temporal regulation of Gen1 and Mus81 may have evolved to ensure that dHJs 
are preferentially untangled by dissolution (BLM) to prevent crossover formation 
and potential loss of heterozygozity. 
This chapter is focused on examining the function of the Holliday junction 
resolvase Gen1, and to a lesser extent Mus81, at telomeres lacking TRF1 to 
investigate whether they can cleave fused telomeres. 
4.2 Results 
4.2.1 Gen1 loss induces chromatin bridges after TRF1 loss 
To examine the role of Gen1 at telomeres lacking TRF1, CRISPR/Cas9 was used 
to edit the Gen1 locus in TRF1F/F cells. The gRNAs were designed to target exon 
2 of the mouse Gen1 locus on chromosome 12 (Fig. 4.2a). Gen1 contains a 
XPG-N terminal (XPG-N), XPG-Internal (XPG-I) and helix-hairpin-helix domain in 
its N-terminus that are required for nuclease activity (Rass et al., 2010). The C-
terminus of Gen1 contains a nuclear export signal but otherwise has no known 
function (Chan and West, 2014). The designed gRNAs target the XPG-N domain 
in the N-terminus and are thus expected to inactivate Gen1 even if an in-frame 
deletion is generated (Fig. 4.2a). TRF1F/F cells were transiently infected with 
Cas9 and two distinct gRNAs and then subcloned.  Analysis of isolated clones by 
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Figure 4.2 CRISPR/Cas9 editing of Gen1 in TRF1F/F MEFs 
(A) Schematic of the functional domains of mouse Gen1 with the nuclease domains in red and 
blue boxes is shown on the left. A nuclear export signal (NES) is shown in yellow. A schematic of 
the mouse Gen1 locus is shown on the right. The gRNAs 2 and 3 target exon 2, which 
corresponds to part of the XPG nuclease domain. (B) Immunoblot for Gen1 in clones from 
TRF1F/F cell line 20.6 targeted with gRNA 2 or 3. Clones in blue (control) and red (null) were used 
for experiments. (C) DNA sequencing of control clone g2#7 and TRF1F/FGen1-/- clones g3#11, 
g2#8 and g3#20, the total number of sequences identified is shown on the right. The reference 
sequence shows the untargeted DNA with the gRNA sequence (red) and PAM (green). No PCR 
product was generated from clone g3#20, possibly because the deletions were too large.  
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Figure 4.3 Growth curve 
Growth curve of the TRF1F/F20.6Gen1 WT (blue) or TRF1F/F20.6Gen1-/- (red) clones before (solid 
line) and after (dashed line) deletion of TRF1. Cre virus was added at day 1. The means and 
SEM of two experiments is shown. 
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Figure 4.4 Gen1 null cells display increased chromatin bridges after deletion of TRF1 
(A) Example of chromatin bridges in TRF1F/F20.6Gen1-/- clones g2#8 (left) and g3#11 (right). Cells 
were analyzed by IF-FISH 72 h after deletion of TRF1. Bridges often contain telomeric signals 
(TelC, red). DNA is stained with DAPI and γH2AX in green. (B) Quantification of the percent of 
cells with chromatin bridges in the indicated cell clones before and 72 h after the deletion of 
TRF1. Clones in red are Gen1 null whereas the control is in blue. Results represent means and 
SDs from three independent experiments. At least 200 cells were counted for each condition. P-
values determined by a two-sided Student’s t-test (* p<0.05, ** p<0.01). (C) Immunoblot with 
antibodies specific for TRF1, Gen1 and γTub from the cells in B. Cells were harvested 72 h after 
deletion of TRF1. 
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western blot indicated efficient editing of Gen1 (Fig. 4.2b). One 
TRF1F/F20.6Gen1+/+ control clone and three TRF1F/F20.6Gen1-/- clones from the 
parental cell line 20.6 were selected for analysis and targeting of the Gen1 locus 
was verified by sequencing (Fig. 4.2c). All TRF1F/F20.6Gen1-/- clones grew well 
and showed no obvious phenotype (Fig. 4.3). This was expected, as Gen1 loss is 
only lethal when combined with SLX4 or Mus81 depletion (Wechsler et al., 2011; 
Garner et al., 2013).  
TRF1 was deleted from the TRF1F/F20.6Gen1-/- and control clones and 
cells were analyzed by IF-FISH for DNA damage markers 72 h later. 
Interestingly, the TRF1F/F20.6Gen1-/- clones displayed significantly higher levels 
of chromatin bridges after TRF1 deletion compared to the Gen1-proficient cells 
(Fig 4.4a-c). Between 25-30% of Gen1 null cells contained these bridges 
compared to only 10% of Gen1 positive control cells. Without TRF1 deletion, 
chromatin bridges were rarely seen in any of the cells analyzed. The chromatin 
bridges were different from the mitotic anaphase bridges described earlier as the 
chromatin bridges in Gen1 null cells remained after mitosis into the next G1 and 
were visible by a thin DAPI or Hoechst positive bridge (Fig.4.4a).  
A second TRF1F/F parental cell line (9.3) was edited with the same gRNAs 
targeting the Gen1 locus to verify the results in an independent cell line. Two 
control TRF1F/F9.3Gen1+/+ and three TRF1F/F9.3Gen1-/- clones were picked based 
on Gen1 expression analyzed by western blot (Fig. 4.5a). Targeting of the Gen1 
locus was verified by sequencing (Fig. 4.5b). Again, 72 h after deletion of TRF1  
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Figure 4.5 CRISPR/Cas9 editing of Gen1 in TRF1F/F cell line 9.3 
(A) Immunoblot of isolated clones from TRF1F/F cell line 9.3 with antibodies specific for Gen1 or γ-
tubulin control. Clones in blue (control) and red (Gen1-/-) were picked for further analysis. (B) 
Schematic of the mouse Gen1 locus, as in Fig. 4.2. DNA sequencing of control clones (blue) and 
Gen1-/- clones (red) is shown below. The reference sequence displays the untargeted DNA with 
the gRNA sequence (red) and PAM (green). No PCR products were generated from clones g2#17 
and g3#17, possibly because the deletion was too large. (C) Quantification of chromatin bridges 
in the indicated cell clones before and 72 h after deletion of TRF1. Clones in red are Gen1 null 
cells and controls are blue. Values represent means and SDs from three independent 
experiments, at least 200 cells were counted per condition. P-values determined by a two-sided 
Student’s t-test (* p<0.05, ** p<0.01, ns: not significant). 
142 
143 
the clones without Gen1 displayed a higher level of chromatin bridges (Fig. 4.5c). 
The bridges were specific to the deletion of TRF1 as no defect was seen in 
clones not treated with Cre. The chromatin bridges were often (partially) covered 
by γH2AX staining indicating DNA damage signaling. A telomeric signal could 
frequently be observed in these bridges, suggesting the presence of fused 
telomeres (Fig. 4.4a). The results suggest that Gen1 indeed has an important 
role in resolving chromatin bridges formed after deletion of TRF1 
4.2.2 Aphidicolin does not induce chromatin bridges 
To examine whether the chromatin bridges in Gen1 null cells are the result of 
general replication stress at telomeres or specific to a particular phenotype that 
occurs upon deletion of TRF1, cells were treated with the DNA polymerase 
inhibitor aphidicolin. It is known that aphidicolin leads to CFS expression and 
exacerbates the telomere fragility seen upon TRF1 deletion (Glover et al., 1984; 
Martinez et al., 2009; Sfeir et al., 2009). Additionally, aphidicolin treatment 
induces telomere fragility even in presence of TRF1. However, aphidicolin has no 
effect on SAs and they remain absent when TRF1F/F cells are treated with 
aphidicolin without TRF1 deletion (Sfeir et al., 2009). Therefore, this treatment 
allows separating the effect of general replication stress at telomeres from the 
SAs seen upon TRF1 deletion. 
TRF1F/F20.6Gen1 CRISPR clones were treated with 0.5 μM aphidicolin for 
16 h and harvested for IF analysis immediately after. Cells displayed a strong 
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Figure 4.6 Aphidicolin treatment does not induce chromatin bridges in TRF1F/FGen1-/- 
MEFs 
(A) Representative images of indicated TRF1F/F20.6Gen1-/- (red) or control clones  (blue) before 
and 16 h after aphidicolin treatment (CRISPR clones from Fig. 4.2). Cells were stained with 
Hoechst, 53BP1 (red) and γH2AX (green). (B) Quantification of chromatin bridges after 
aphidicolin treatment. Clones in red are Gen1 null clones and blue are controls. Values represent 
means and SDs from three experiments; at least 200 cells were counted per condition. 
Differences are not significant. 
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increase in the level of γH2AX upon aphidicolin treatment, indicative of 
replication stress (Fig. 4.6a). However, chromatin bridges were not induced by 
aphidicolin treatment (Fig. 4.6b). This suggests that the chromatin bridges seen 
in TRF1F/FGen1-/- cells after Cre are the result of a TRF1 specific phenotype, in 
agreement with the hypothesis that Gen1 acts on SAs. 
4.2.3 Gen1 loss does not affect the frequency of SAs or telomere fragility 
To determine whether the increase in chromatin bridges in Gen1 null cells is due 
to an increase in SAs, metaphase spreads from TRF1F/F20.6Gen1 -/- clones were 
analyzed 96 h after deletion of TRF1. A difference in the percentage of SAs was 
observed between the different clones analyzed (Fig. 4.7a). However, the 
difference did not correlate with the presence or absence of Gen1. For example, 
Gen1-/- clone g3#11 had a higher level of SAs than the control clone whereas 
Gen1-/- clone g3#20 had lower levels. This suggests that there is clonal variation 
in the level of SAs but that Gen1 itself has no effect on their prevalence. Gen1 is 
actively excluded from the nucleus until nuclear envelope breakdown and 
therefore not expected to gain access to SAs before metaphase. Thus, the 
absence of an effect of Gen1 on the level of SAs in metaphase is likely due to its 
late action in the cell cycle. Telomere fragility was also analyzed on the same 
metaphase spreads (Fig. 4.7b). As expected, Gen1 did not affect the level of 
telomere fragility. 
146 
Figure 4.7 SAs and telomere fragility in TRF1F/F20.6Gen1-/- clones 
(A) Frequency of SAs in metaphase spreads 96 h after Cre. Clones in red are TRF1F/F20.6Gen1-/- 
cells and those in blue are control (CRISPR clones from Fig. 4.2).  Bars represent the median % 
of SAs from 3 independent experiments; each dot represents a metaphase spread. (B) Analysis 
of telomere fragility on the metaphase spreads from A. Values represent mean and SDs from 
three independent experiments. SAs and fragility were counted on the long arm only. P-values 
determined by a two-sided Student’s t-test (* p<0.05, ** p<0.01, *** p<0.001, ns: not significant). 
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4.2.4 Gen1 loss increases the frequency of isochromosomes 
As argued in the introduction of Chapter 3, sister telomere fusions are expected 
to result in isochromosomes in the following metaphase, but these are not 
commonly observed after TRF1 loss (Sfeir et al., 2009). Their absence can be 
explained if Gen1 cleaves the sister fusions to allow faithful chromosome 
separation (Fig. 4.8a). If this model is correct, isochromosomes are expected to 
arise in TRF1F/FGen1-/- cells, since cleavage of SAs would not occur. In absence 
of Gen1, a chromosome with fused sister telomeres would have two fates (Fig. 
4.8b). If the spindle forms correct attachments to the centromere, it will try to 
separate this chromosome into two daughter nuclei resulting in an 
anaphase/chromatin bridge at the fused telomere, as frequently observed in 
TRF1F/FGen1-/- cells. But if the spindle forms incorrect attachments or when for 
another reason the entire chromosome is missegregated into one daughter cell, 
an isochromosome would be formed after the next DNA replication (Fig. 4.8b). To 
test whether the level of isochromosomes is indeed higher in Gen1 null cells, 
metaphase spreads were analyzed in TRF1F/F20.6Gen1-/- cells after deletion of 
TRF1. 
Discriminating between isochromosomes and other types of chromosome 
fusions in MEFs is not straightforward as many mouse chromosomes are of 
similar size and all mouse chromosomes are acrocentric. The following criteria 
were applied to identify isochromosomes.  They should show either long arm to 
long arm (L-L) fusions or short arm to short arm (S-S) fusions and the two long 
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Figure 4.8 Faith of a sister fusion in absence of Gen1 
(A) Upon deletion of TRF1, anaphase bridges can form when a chromosome with a sister 
telomere fusion (red) is separated (top). Cleavage of the telomere fusion by Gen1 still allows 
faithful chromosome segregation. When the spindle forms an incorrect attachment or loses its 
connection (bottom), the entire chromosome is missegragated into one daughter cell. Cleavage 
by Gen1 can prevent the formation of isochromosomes. (B) In absence of Gen1, a chromosome 
with a sister fusion can follow two fates in mitosis. If the spindle forms a correct attachment, the 
fused chromosome will form a chromatin bridge (top). When the spindle forms an incorrect 
attachment or loses its connection, the entire chromosome is missegragated into one daughter 
cell (bottom). Replication in the next S-phase will result in the formation of an isochromosome 
(red). 
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Figure 4.9 Verification of isochromosome analysis 
(A) Schematics of different forms of fusions detected. Chromosomes fused via Long arm-Short 
arm (L-S) are always regular fusions (left panel). Long arm-Long arm (L-L) or Short arm-Short 
arm (S-S) are regular fusions if the arm lengths are unequal (left). However, S-S and L-L fusions 
are scored as isochromosomes if the arm lengths are equal (right panel). (B) Examples of 
different forms of fused chromosomes. The lines represent the arm lengths measured in image J, 
which were used to calculate arm length ratio. (C) An example calculation of arm ratios from A is 
shown in the table. For each chromosome, the values of arm A and B used to determine the ratio 
between the longer and shorter arm (values >1). (D) The arm ratios of chromosome arms from 
three independent experiments are shown. Long arm sister chromatids were compared on 
unfused chromosomes as a control for the accuracy of the imageJ measurements. Chromosome 
fusions after deletion of TRF2 were used to display the variability in arm length in regular fusions. 
The blue dots represent the arm ratio of regular fusions in the indicated Gen1 WT (blue) or Gen1-
/- (red) cells 96 h after deletion of TRF1, which are either L-L, S-S or L-S as explained in A. The 
arm ratio of chromosomes counted as isochromosomes is shown in green dots for each clone, 
which are either L-L or S-S with equal arm length. Every dot represents a (fused) chromosome. 
The average, SD and numbers (n) are shown in top of the graph. (E) The mean and SDs of the 
arm ratios from D is shown. Values are from 3 independent experiments and 10 metaphase 
spreads were analyzed per condition for the Gen1 CRISPR clones. For unfused and TRF2 
fusions, only 2-5 metaphase spreads were analyzed per experiment since the number of 
analyzable chromosomes (unfused or TRF2 fused resp) is much higher per spread. P-values 




arms in the fusion should be of the same length (Fig. 4.9a). Fusion chromosomes 
that fit these two criteria are scored as isochromosomes in this study. By 
contrast, a chromosome that is fused long arm to short arm (L-S) is classified as 
a regular type fusion as are L-L or S-S fusions with unequal arm length (Fig. 
4.9a). 
Isochromosomes were counted according to these visual criteria. To 
ensure that the chromosomes visually counted as an isochromosome indeed 
have equal arm lengths, these lengths were measured using Image J. A subset 
of the analyzed metaphase spreads from TRF1F/F20.6Gen1-/- clone g3#11 and 
control clone g2#7 were used for this Image J analysis. The measurements were 
made using the following method. First, the arm length of both long arm (sister) 
chromatids of unfused chromosomes was measured to identify the variability in 
measuring arm length with imageJ (Fig. 4.9b-e) and the ratio between the longer 
and the shorter value of the two sister chromatids was calculated (Fig. 4.9c).  As 
seen in Figure 4.9d, the ratio of the sister chromatids of unfused chromosomes is 
close to 1 (average 1.067, SD 0.060 n=113). This controls for the variability in 
measuring arm length using Image J. Next, the chromosome arm length of 
telomere fusions detected upon TRF2 deletion were analyzed to visualize the 
distribution of regularly fused chromosomes (Fig. 4.9b-e). As telomere fusion 
after TRF2 deletion occurs primarily in G1, sister fusions and thus 
isochromosomes will be infrequent. The length of the arms on either side of the 
fusion was measured and the ratios calculated (Fig. 4.8c). As seen in Figure 4.8c 
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and d, the ratios are widely distributed (average 1.488, SD 0.48, n= 94) as 
expected based on random fusion of the telomeres of different chromosomes. 
Next, fusions from TRF1F/F20.6Gen1-/- or TRF1F/FGen1+/+ MEFs were analyzed. 
In these metaphase spreads, both regular fusions and isochromosomes are 
observed, although TRF1F/FGen1+/+ MEFs have fewer isochromosomes. The arm 
length on either side of the fusion was measured, similar as for the telomeres 
fusions after TRF2 deletion (Fig. 4.9c). In the chromosomes that were considered 
an isochromosome (L-L or S-S as explained in Figure 4.9a), the ratio is very 
close to 1 similar to the unfused chromosomes suggesting that these are indeed 
isochromosomes (Fig. 4.9d and e). Furthermore, arm ratios of regularly fused 
chromosomes in these TRF1F/FGen1-/- or TRF1F/FGen1+/+ MEFs were analyzed 
as well. A distinction was made between L-S fusions and L-L or S-S, as the latter 
type of fusion could possibly be an isochromome (schematic 4.9a). However, the 
ratios of L-L, S-S and L-S are widely distributed similarly to fused chromosomes 
observed after TRF2 deletion, indicating that none of these are isochromosomes 
(Fig. 4.9d and e). This approach verifies that the chromosomes visually counted 
as isochromosomes indeed have arm ratios similar to unfused chromosomes, 
strengthening assumption that they represent real isochromosomes. While the 
isochromosomes measured using this method visually appear as 
isochromosomes, this cannot definitely be ascertained without chromosome paint 
(SKY) analysis. Some of the chromosomes counted as isochromosomes might 
therefore be regular fusions of two chromosomes of similar length. It is therefore 
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Figure 4.10 Isochromosomes are increased in Gen1 null cells 
(A) Examples of normal chromosome type fusions (left) and isochromosomes (right) in 
metaphase spreads. Telomeres are in green, DAPI in red. (B) Percentage of telomeres in 
isochromosomes in TRF1F/F20.6Gen1 CRISPR clones. The values represent mean and SDs 
from 5 independent experiments. (C) Representation of the values from D as percent fusions in 
isochromosomes, to correct for differences in overall telomere fusion rate. The values represent 
mean and SDs from 5 experiments. Detailed explanation of isochromosome count can be found 
in Figure 4.9. P-values determined by a two-sided Student’s t-test (* p<0.05, ** p<0.01, *** 
p<0.001, ns: not significant). 
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required to correct for the total number of chromosome type fusions between 
clones, as this can influence the analysis. Accordingly, isochromosome 
frequencies are given both as the percent of telomeres present in 
isochromosomes and as the percent of chromosome fusions that are 
isochromosomes. 
Using the described approach and rules, isochromosomes were counted 
on metaphase spreads from the TRF1F/F20.6Gen1 CRISPR clones after deletion 
of TRF1 (Fig. 4.10a-c). Interestingly, a 1.5-2fold increase in the number of 
isochromosomes was observed in Gen1-/- clone g3#11 and g3#20 compared to 
control cells. Clone g2#8 also showed an increase in the number of 
isochromosomes but this increase was not significant. Possibly, this is due to the 
slower growth of this particular clone, since the detection of isochromosomes 
depend on the rate at which cells progress to the next mitosis (Fig. 4.3). 
Combined, the results suggest that isochromosome formation in TRF1 KO cells 
is indeed increased in absence of Gen1. 
4.2.5 TRF1F/FGen1-/- cells display increased mitotic failure 
The experiments using live cell imaging from chapter 3 showed that TRF1F/F cells 
display high numbers of mitotic abnormalities when TRF1 is deleted from cells 
(Fig. 3.7b). To examine the behavior of TRF1F/FGen1-/- cells during mitosis, 
TRF1F/F9.3Gen1-/- clones were examined by live cell imaging. Cells were 
retrovirally infected with the H2B-venus construct and a population of high 
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Figure 4.11 Anaphase bridges in TRF1F/FGen1-/- cells persist longer 
Analysis of a live cell imaging experiment of indicated TRF1F/F9.3Gen1-/- or control clones 
expressing H2B-venus (CRISPR clones from Figure 4.5). Cells were imaged on a spinning disk 
confocal microscope and Z-stacks taken 4 minutes apart. At least 50 mitotic cells were followed 
per condition and the time counted until an anaphase bridge disappeared. Mitotic cells without 
anaphase bridges are counted as bridge resolved under 8 minutes.  
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expressing cells isolated using FACS sorting to allow visualization of 
chromosome dynamics. Cells were imaged with the same experimental setup as 
used for the analysis of mitotic cells after TRF1 deletion (Chapter 3.2.4). Briefly, 
cells were imaged 72 h after Cre using a Yokogawa spinning-disk confocal 
system and images (Z-stacks) were acquired every 4 minutes. Analysis of mitotic 
cells in the movies showed that there was no difference in the prevalence of 
anaphase bridges between the Gen1 positive and negative clones, which is not 
surprising given that they occur at 80% in Gen1 positive cells. However, there 
was a substantial increase in the persistence of the bridges in Gen1 null cells 
(Fig. 4.11). Whereas in two TRF1F/F9.3Gen1+/+ control clones the majority of the 
bridges were resolved under 40 minutes, the majority of anaphase bridges in 
TRF1F/F9.3Gen1-/- clones remained much longer or did not disappear for the 
duration of the movie (Fig. 4.11).  This supports the observation that chromatin 
bridges are frequently observed between post-mitotic interphase cells in 
TRF1F/FGen1-/- clones after deletion of TRF1 (Figs. 4.4b and 4.5c).  
4.2.6 Overexpression of mutant Gen1 alleles in TRF1F/FGen1-/- MEFs 
The persistent chromatin bridges in TRF1F/FGen1-/- cells upon deletion of TRF1 
are a striking phenotype. This phenotype was observed in two separate cell lines 
with two independent gRNAs against Gen1, strongly suggesting that the bridges 
are due to the loss of Gen1 and not an off-target effect of the CRISPR/Cas9. 
However, an attempt was made to rescue the phenotype by overexpressing 
157 
Gen1 in the TRF1F/F20.6Gen1-/- cells. The catalytic activity of Gen1 is dependent 
on its N-terminal XPG nuclease domain and a flanking helix-hairpin-helix domain 
(Ip et al., 2008) (Fig. 4.12a, top). Previous in vitro experiments with a truncated 
form of Gen1 (aa 1-527) indicated that the N-terminus contains all Holliday 
junction resolvase activity (Rass et al., 2010). Although the C-terminus is not 
needed for catalytic activity, it contains a nuclear export signal (NES) that is 
required to actively keep Gen1 from accessing chromatin until nuclear envelope 
breakdown in mitosis (Chan and West, 2014). Access of Gen1 to the nucleus in 
interphase was accomplished by mutating both the NES and addition of a nuclear 
localization signal. 
To attempt to rescue the chromatin bridge formation in TRF1F/F20.6Gen1-/-
cells, plasmids were cloned containing an N-terminal RFP or GFP tag followed by 
a catalytically active or inactive mouse Gen1 (mGen1) (Fig. 4.12a). For inactive 
Gen1, either the E30A mutant or E134/E136A (EEAA) mutations was created 
since these sites were previously shown to be required for the catalytic activity 
(Chan and West, 2014). However, none of these constructs expressed well upon 
retroviral infection of MEFs. Cells quickly lost the construct or died in antibiotic 
selection medium. Since previous publications used human Gen1 (hGen1) in 
overexpression experiments, N-terminal GFP tagged constructs were cloned with 
hGen1, either the active or an inactive (EEAA) form. However, overexpression of 
these constructs in MEFs resulted in a similar defect in expression. Since a 
truncated version of Gen1 (Gen1527) contains all catalytic activity and was  
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Figure 4.12 TRF1F/FGen1-/- cells with overexpressed Gen1 
(A) Schematic of wild type mouse Gen1 and a variety of tagged constructs (mouse and human). 
Red and blue boxes in the schematic on top represent the domains of Gen1 required for nuclease 
activity (XPG-N-terminal, XPG-Internal and Helix-hairpin-Helix). The EEAA mutants have 
residues E134 and E136 mutated to alanine, the D30A has active site D30 mutated to alanine. 
The constructs with a shorted Gen1 contain amino acids 1-527. Most constructs did not express 
well, as indicated on the right. (B) Immunoblot showing the expression of a short form of hGen1 
containing an N-terminal GFP tag in TRF1F/F20.6Gen1-/- clones g3#11 and g3#20 (CRISPR 
clones from Figure 4.2). Cells were harvested 72 h after Cre. (C) Quantification of chromatin 
bridges 72 h after Cre mediated deletion of TRF1 in TRF1F/F20.6Gen1-/- clones g3#11 and g3#20, 
expressing the indicated hGen1 construct. Results represent the mean and SD from 4 
experiments Expression level of constructs and the number of bridges varied widely and the 
results are not significant. 
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previously shown to rescue human Gen1-/- cells, this construct was cloned with 
an N-terminal GFP tag. Upon retroviral infection of TRF1F/F20.6Gen1-/- clone 
g3#20 and g2#8, the active and inactive versions of this construct were weakly 
expressed (Fig. 4.12b). TRF1 was deleted in these cells using H&R Cre virus and 
chromatin bridges analyzed by IF 72 h later. Interestingly, a slight rescue was 
seen with the active version of Gen1 but not Gen1EEAA (Fig. 4.12c). However, 
these experiments were not reproducible and expression levels of the constructs 
varied indicating that cells still struggled keeping these constructs expressed.  
 Possibly, the N-terminal GFP or RFP tag interferes with the expression of 
Gen1. Previous studies used C-terminally tagged protein and thus a construct 
was cloned with a C-terminal myc tag. The truncated version of Gen1 was used 
in this construct. Additionally, a 3xNLS was added to promote nuclear localization 
of the construct (Chan and West, 2014). However, upon infection of MEFs with 
this construct, no signal for myc was detected on Western blot (Fig. 4.12b). 
Furthermore, no reduction in chromatin bridges was detected indicating that this 
construct was not functional. Further attempts to rescue the TRF1F/FGen1-/- 
clones were halted. 
 
4.2.7 Chromatin bridges are not an SV40 artifact 
Since rescue of the TRF1F/FGen1-/- clones was not possible, an additional control 
experiment was done to verify that the chromatin bridges observed in Gen1 null 
cells are not due to the experimental conditions used. Both TRF1F/F cell lines that 
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were used for CRISPR/Cas9 mediated editing of the Gen1 locus were 
immortalized using SV40 large T antigen. Since SV40 large T antigen may have 
uncharacterized functions, it is not excluded that the phenotypes we detect are 
due to the combined effect of TRF1 loss, Gen1 deficiency and SV40 
immortalization. Therefore, an additional Gen1 knockout cell line was created in a 
parental cell line that lacks p53 but does not express SV40 large T antigen. The 
same gRNAs were used as described previously and several Gen1 null and 
control clones were isolated from this TRF1F/Fp53-/- cell line (Fig. 4.13a,b). 
Sequencing confirmed efficient targeting of the Gen1 locus in the Gen1-/- clones 
g2#12, g2#13 and g3#12 whereas no PCR product was amplified from clone 
g3#5, likely because the deletion is too large (Fig. 4.13c). Sequencing of the 
control clone g3#8 confirmed that this clone only contains the unedited Gen1 
sequence. However, control clone g2#1 is not completely wild type as it has lost 
one allele due to a 7-nucleotide deletion and the other allele in this clone contains 
a 9-nucleotide deletion. This 9 nt deletion does not disrupt protein expression but 
the western blot signal for Gen1 in this clone is lower then in the other control 
clones, confirming the loss of one allele. Next, TRF1 was deleted in these 
TRF1F/Fp53-/-Gen1 clones and cells harvested for analysis of chromatin bridges 
72 h later. Two separate experiments were done and although there was 
variability between the experiments, the TRF1F/Fp53-/-Gen1-/- cells displayed a 
higher frequency of bridges than the control clones (Fig. 4.13d and e). These 
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Figure 4.13 CRISPR/Cas9 editing of Gen1 in TRF1F/Fp53-/- MEFs 
(A) Schematic of the Gen1 locus on chromosome 12, exon 2 was targeted with the same gRNAs 
as in Fig. 4.2. (B) Western blot of indicated TRF1F/Fp53-/- clones targeted with gRNA2 or gRNA3, 
showing the deletion of Gen1. Clones in blue (control) and red (null) were used for experiments. 
(C) DNA sequencing of the indicated clones showing targeting of the Gen1 locus. Clones g2#1 
and g3#8 are control clones whereas clones g3#5, g3#12, g2#12 and g2#13 are Gen1-/-. (D) 
Analysis of chromatin bridges in indicated Gen1 control (blue) and Gen1-/- (red) clones, 72 h after 
Cre mediated deletion of TRF1. The percentage of bridges from two experiments is shown side 
by side. The baseline levels of chromatin bridges between these experiments varied greatly thus 
the results are shown separate. At least 200 cells were analyzed per condition. (E) The percent 
chromatin bridges of Gen1 control (blue) and Gen1-/- (red) clones from the two experiments in D 
were pooled as WT and Gen1-/-. The percent chromatin bridges of each clone were compared to 
the level in control clone g3#8, which was set to 100. The values represent the mean and SDs of 




experiments indicate that the phenotype of the Gen1-/- cells is unlikely due to 
confounding effects of the SV40 immortalization. 
4.2.8 PARP1 deletion rescues chromatin bridge formation 
The results so far suggest that Gen1 plays a critical role at telomeres, where it is 
required to cleave a structure formed upon deletion of TRF1 but not in response 
to telomere fragility induced by aphidicolin. This suggests that Gen1 cleaves SAs 
since they are induced specifically when TRF1 is deleted but not after aphidicolin 
treatment. To further examine this, TRF1F/F20.6Gen1-/- cells were treated with 
shRNAs against PARP1. As described in Chapter 3, SAs are formed via a-NHEJ 
in a process dependent on PARP1 (Figs. 3.3b and e). Thus, blocking a-NHEJ in 
TRF1F/FGen1-/- cells should reduce the prevalence of SAs. If Gen1 indeed acts by 
cleaving SAs, chromatin bridges should be reduced upon treatment with PARP1 
shRNAs. For these experiments, TRF1F/F20.6Gen1-/- clone g3#11 and control 
clone g2#7 were used. In both cell lines, shPARP1 efficiently depleted PARP1 as 
gleaned from western blot (Fig. 4.14a). Chromatin bridges were analyzed 48 or 
72 h after deletion of TRF1. Interestingly, shPARP1 drastically reduced the 
chromatin bridges, not only in the TRF1F/F20.6Gen1-/- cells but also partly in the 
control cells (Fig. 4.14b). The results were more pronounced 72 h after deletion 
of TRF1, when the percent of chromatin bridges was reduced to 10% in both 
control and Gen1 null cells after PARP1 depletion. Metaphase spreads were 
analyzed 96 h after Cre and as expected, shPARP1 significantly reduced the 
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Figure 4.14 Knockdown of PARP1 reduces chromatin bridge formation in TRF1F/FGen1-/- 
cells 
(A). Immunoblot for PARP1 and TRF1 after shRNA mediated depletion of PARP1 (sh353). Cells 
from TRF1F/F20.6Gen1-/- clone g3#11 (red) and control clone g2#7 (blue) were harvested 72 h 
after deletion of TRF1 (CRISPR clones from Figure 4.2). (B) Frequency of chromatin bridges in 
TRF1F/F20.6Gen1-/- clone g3#11 (red) and control clone g2#7 (blue). Bridges were analyzed in 
fixed cells at different time points after Cre (0, 48, 72 h). Values represent mean and SDs from 4 
independent experiments and at least 200 cells were counted per condition. (C) Frequency of 
SAs in the indicated Gen1 clones treated with shRNA against PARP1. Metaphase spreads were 
harvested 96 h after Cre. Bars represent median % of SAs from 3 independent experiments and 
every dot represents a metaphase spread. SAs were counted on the long arm only. (D) Growth 
curve of TRF1F/F20.6Gen1-/- clone g3#11 and control clone g2#7 after deletion of TRF1 and 
depletion of PARP1. Values represent the means and SEMs from 4 experiments. (E) Mitotic index 
of indicated cell clones before and 48 or 72 h after deletion of TRF1, treated with shRNA against 
PARP1. Mitotic index was scored by IF in two experiments by staining with a pH3 specific 
antibody. The values represent mean and SEM.  




prevalence of SAs in both cell lines (Fig. 4.14c). These results strongly suggest 
that Gen1 indeed cleaves SAs. One potential caveat of these experiments is that 
the shRNA against PARP1 affects cell viability and defective cell cycle 
progression could explain the reduced levels of chromatin bridges, as cells need 
to go through mitosis for these bridges to form (Fig. 4.14d). However, the mitotic 
index of cells treated with the shRNA, analyzed by counting pH3 positive mitotic 
cells, showed no difference upon PARP1 depletion (Fig. 4.14e). Thus, although 
there were fewer cells after treatment with the shRNA, there was no difference in 
the percentage of cells in mitosis confirming that the reduced chromatin bridges 
are the result of PARP1 loss. Combined, the results further confirm the 
hypothesis that Gen1 cleaves SAs. 
4.2.9 Mus81 depletion aggravates the Gen1-/- effect 
Mammalian cells have another pathway that resolves HJs and replication 
intermediates in mitosis that is dependent on Mus81 and not Gen1. As described 
in the introduction to this chapter, the substrates for Mus81 are nicked HJs but 
combined with the endonuclease activity of SLX4-SLX1, it is able to cleave intact 
HJs. Interestingly, SLX4 is associated with telomeres through an interaction with 
TRF2 (Svendsen et al., 2009). 
To examine whether Mus81 can cleave SAs similar to Gen1, shRNAs 
were used to deplete Mus81. This was done both in Gen1-proficient and deficient 
cell lines. Antibodies to detect mouse Mus81 on western blot were not effective 
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and knockdown of Mus81 was therefore analyzed by qPCR. Two primer pairs 
showed substantial (60-80%) knockdown of Mus81 with two different shRNAs, 
both in TRF1F/F20.6 Gen1-/- clone g3#11 and control clone g2#7 (Fig. 4.15a,b). 
Cell viability was affected by the shRNAs against Mus81 as can be seen in a 
growth curve (Fig. 4.16). However, this effect was not specific for deletion of 
TRF1 as MEFs not treated with Cre show this loss of viability as well. 
Next, chromatin bridges were analyzed by Hoechst staining, 72 h after 
deletion of TRF1 (Fig. 4.17a-c). Interestingly, chromatin bridges were slightly 
increased in both TRF1F/FGen1+/+ and TRF1F/FGen1-/- cells upon Mus81 
depletion, although the increase was not statistically significant. Possibly, the 
level of knockdown is not high enough to obtain higher levels of chromatin 
bridges. However, the Mus81 depleted cells show a clear phenotype after 
deletion of TRF1. Many cells appeared to have a clear segregation defect 
containing multiple nuclei (Fig. 4.17a). This effect is seen both in TRF1F/FGen1+/+
and TRF1F/FGen1-/- clones although it was more apparent in TRF1F/FGen1-/- cells. 
The observation that shMus81 increased the levels of chromatin bridges 
and affects nuclear morphology in both TRF1F/FGen1+/+ and TRF1F/FGen1-/-
clones, suggests that it functions independently of Gen1. The activity of Mus81 is 
induced at the onset of mitosis by high CDK1 activity, prior to nuclear envelope 
breakdown (Wyatt et al., 2013). Therefore it is possible that Mus81 cleaves a 
subset of the SAs and that Gen1 cleaves the remaining fusions after nuclear 
envelope breakdown, explaining the additive effect. 
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Figure 4.15 Quantification of Mus81 knockdown by qPCR 
(A) qPCR for Mus81 in the indicated MEF clones treated with the indicated shRNA against Mus81 
(sh64 or sh67, green bars). Two different exon spanning primer pairs were used and values were 
normalized to GAPDH expression. RNA was isolated from samples before and 72 h after Cre 
mediated deletion of TRF1 from TRF1F/F20.6Gen1-/- clone g3#11 (red) and control clone g2#7 
(blue) as indicated (CRISPR clones from Figure 4.2). (B) Agarose gel with three samples of qPCR 
amplified DNA from each primer pair, showing a single band of the expected size for GAPDH and 
the Mus81 primer pairs indicating the specificity of the qPCR. 
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Figure 4.16 Growth curve of Gen1 clones after depletion of Mus81 
Growth curve of TRF1F/F20.6Gen1+/+ (g2#7, blue) and TRF1F/FGen1-/- (g3#11, red) cells before 
(left panel) and after (right panel) deletion of TRF1. The shRNAs against Mus81 (dashed lines) 
affect cell growth in both cell lines. The means and SEM of three experiments are shown. 
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Figure 4.17 Chromatin bridges are increased after depletion of Mus81
(A) Examples of IF-FISH images from Gen1 positive (g2#7, left) and negative (g3#11, right) 
TRF1F/F20.6 CRISPR clones, treated with the indicated shRNA against Mus81 (CRISPR clones 
from Figure 4.2). Cells were fixed 72 h after deletion of TRF1. Cells were stained with Hoechst 
(blue), γH2AX (green) and telomere FISH (red). Arrows point to chromatin bridges between cells. 
(B) Example of a chromatin bridge in TRF1F/F20.6Gen1-/- clone g3#11 after Mus81 depletion with 
sh64, 72 h after deletion of TRF1. The chromatin bridge is fully covered in γH2AX and contains 
multiple telomeric signal, as is clear from the magnification on the right. (C) Quantification of 
chromatin bridges in the indicated cell clones before and 72 h after deletion of TRF1. The values 
represent mean and SDs from 4 independent experiments. At least 200 cells were analyzed per 
condition. P-values determined by a two-sided Student’s t-test (* p<0.05, ns: not significant). 
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To further understand whether Mus81 might cleave SAs, metaphase spreads 
were analyzed. Since the activity of Mus81 is already induced at the onset of 
mitosis, it should increase the prevalence of SAs in metaphase. Metaphase 
spreads from TRF1F/FGen1-/- clone g3#11 and control clone g2#7 were analyzed 
96 h after deletion of TRF1 (Fig. 4.18a). However, no difference in the level of 
SAs was observed in either of the cell lines tested. There are several possible 
explanations why no difference in SAs occurs. The most obvious explanation is 
that Mus81 is not active on SAs. Mus81 cannot cleave intact HJs and needs its 
associated SLX4 to create a nicked template. Possibly TRF2 blocks the nuclease 
activity of SLX4 at telomeres since TRF2 is a known interacting factor (Svendsen 
et al., 2009).  Another explanation could be that the full activation of SLX4-Mus81 
does not occur before metaphase. The precise timing of SLX4-Mus81 activity is 
not very well understood. Experiments with nocodazole arrested cells suggested 
that the complex is active at the time of prometaphase but this has not been 
further studied (Wyatt et al., 2013). Therefore it cannot be excluded that Mus81 
acts later in mitosis on SAs. It is also possible that the level of knockdown with 
shRNAs was not sufficient to detect a phenotype on metaphase spreads. A 
CRISPR/Cas9 knockout cell line would be useful but the combined deletion of 
Gen1 and Mus81 is expected to affect cell viability and was therefore not 
attempted (see growth curve Fig. 4.16 and (Wechsler et al., 2011)).  
 Telomere fragility was also assessed on the metaphase spreads from 
Mus81 depleted cells. There was no difference in telomere fragility 96 h after  
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Figure 4.18 Telomere SAs, fragility and isochromosomes after Mus81 depletion 
(A). Frequency of SAs in metaphase spreads from TRF1F/F20.6 control (blue) and Gen1-/- (red) 
MEFs before and 96 h after Cre, treated with the indicated shRNA against Mus81. Bars represent 
the median % of SAs from 4 experiments and each dot represents a metaphase spread. (B) 
Analysis of telomere fragility on the metaphase spreads from A. Bars represent the median % of 
telomere fragility from 3 experiments. SAs and fragility were counted on the long arm only. (C) 
Frequency of isochromosomes 96 h after deletion of TRF1 from the indicated Gen1 CRISPR 
clones, given as a percentage fusions in isochromosome. Detailed explanation of isochromosome 
count can be found in Figure 4.8. P-values determined by a two-sided Student’s t-test (* p<0.05, 
*** p<0.001, **** p<0.0001, ns: not significant). 
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deletion of TRF1 (Fig. 4.18b). Unexpectedly however, knockdown of Mus81 
significantly increased telomere fragility when TRF1 was present. The levels 
increased from around 3% to just below 10%. This increase in telomere fragility 
was similar in Gen1 proficient and deficient cells and is reminiscent of a similar 
defect seen in human cells upon deletion of Mus81 (Saint-Leger et al., 2014). 
The reason for this increase in telomere fragility is not well understood. Possibly, 
it is due to the ability of Mus81 to cleave stalled replication forks during S-phase 
(Forment et al., 2011). Mus81 was shown to generate DSBs at stalled forks in 
absence of ATR/Chk1 signaling or upon prolonged replication stress. At 
telomeres, POT1a/b blocks ATR signaling under TRF1 proficient conditions, 
possibly allowing Mus81 mediated cleavage and DSB dependent fork restart 
when the replication machinery encounters a barrier (Zimmermann et al., 2014). 
Absence of Mus81 could therefore result in abnormal fork restart at telomeres 
resulting in fragility. 
4.3 Summary of findings 
A prominent phenotype observed after the deletion of TRF1 are SAs, which 
represent telomeres fused via a-NHEJ, as shown in Chapter 3. The results in this 
chapter describe an essential role for Gen1 in the resolution of these telomere 
fusions. The results are consistent with the proposition that fused telomeres can 
form cruciform DNA structures due to their repetitive nature, which are a 
substrate for the Holliday junction resolvases Gen1 (Fig. 4.1). Absence of Gen1 
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resulted in the appearance of chromatin bridges upon deletion of TRF1 (Fig. 4.4 
b and 4.5c). These chromatin bridges were not induced by treatment of 
TRF1F/FGen1-/- cells with aphidicolin, which results in fragile telomeres (Fig. 4.6) 
(Sfeir et al., 2009). This suggests that the chromatin bridges are not related to the 
telomere fragility seen in absence of TRF1 but due to SAs. Further evidence that 
Gen1 cleaves SAs is provided by the observation that the percentage of 
isochromosomes was increased upon TRF1 deletion in TRF1F/FGen1-/- cells (Fig. 
4.10a-c). This indicates that Gen1 normally cleaves SAs thereby preventing the 
accumulation of isochromosomes in wild type conditions. 
As SAs are formed by a-NHEJ, the role of PARP1 on chromatin bridges in 
Gen1 null cells was assessed. Since deletion of PARP1 reduces the level of SAs, 
chromatin bridges should be reduced when PARP1 is deleted from TRF1F/FGen1-
/- cells if Gen1 is responsible for cleaving these structures (Chapter 3.2.1, Figs. 
3.3b and e). Indeed, deletion of PARP1 from TRF1F/FGen1-/- cells significantly 
reduced the presence of chromatin bridges (Fig. 4.14b). This indicates that Gen1 
is truly capable of cleaving SAs. 
A second Holliday junction resolvase that could act on SAs is Mus81 (Fig. 
4.1b). This nuclease was depleted using shRNA to analyze whether a similar 
phenotype is observed as upon deletion of Gen1. Chromatin bridges were indeed 
increased when Mus81 was depleted an additive effect was seen with the 
combined deletion of Mus81 and Gen1 (Fig. 4.17c). The results were insignificant 
however, possibly due to the limited knockdown of Mus81. This might also have 
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affected the analysis of SAs on metaphase spreads, as no difference could be 
seen in their levels upon depletion of Mus81 (Fig. 4.18a). Isochromosomes were 
slightly increased upon the combined deletion of Mus81 and Gen1, but again, the 
results were not significant (Fig. 4.18c). The data suggest that it is indeed 
possible for Mus81 to cleave SAs in a similar fashion to Gen1, since chromatin 
bridges are increased. However, the effect of Mus81 deletion upon TRF1 deletion 
merits further analysis with better knockdown levels of the protein. 
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Chapter 5: Discussion 
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5.1 Dissociation of function mutants of 53BP1 
5.1.1 Rif1 is the only factor downstream of 53BP1 inhibiting resection 
Analysis of a panel of 53BP1 alleles with subsets of N-terminal S/TQ sites 
mutated to alanine revealed insights into the mechanisms by which 53BP1 
promotes NHEJ (Fig. 2.2). It has previously been shown that 53BP1 recruits Rif1 
to inhibit CtIP-dependent and -independent resection at DSBs and dysfunctional 
telomeres (Chapman et al., 2013; Di Virgilio et al., 2013; Escribano-Diaz et al., 
2013; Feng et al., 2013; Zimmermann et al., 2013; Kibe et al., 2016). 
Additionally, PTIP has been suggested to play a role in blocking the resection 
pathway downstream of 53BP1 at DSBs in PARPi-treated BRCA1-/- cells (Callen 
et al., 2013). However, the results described here suggest that Rif1 is the only 
factor downstream of 53BP1 required to inhibit resection at telomeres (Fig. 2.6b). 
53BP1ΔRif1 displayed similar levels of resection upon deletion of TRF2 as the 
53BP1Δ28 allele (Fig. 2.6b). Furthermore, 53BP1ΔPTIP behaved as wild type 53BP1 
with regards to inhibition of resection. This is consistent with a recent study of 
TRF2F/FPTIP-/- MEFs which did not show a telomere hyper-resection phenotype 
(Lottersberger et al., 2015). Even though resection was not altered by PTIP, the 
telomere fusions were slightly delayed in 53BP1ΔPTIP expressing cells lacking 
TRF2 compared to cell with wild type 53BP1, similar to the situation in 
TRF2F/FPTIP-/- MEFs (Fig. 2.7c) (Lottersberger et al., 2015). It is possible that this 
reduction is due to the role of PTIP in recruiting the Artemis nuclease, which has 
been shown to mediate end-trimming of obstructed ends (Wang et al., 2014). The 
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Artemis nuclease activity can open hairpins at DNA ends during V(D)J 
recombination to promote c-NHEJ (Ma et al., 2002). However, the telomeric 
sequence is unlikely to form hairpins at the DNA end, suggesting this activity is 
not responsible for the reduced level of telomere fusions in absence of PTIP. 
Possibly, PTIP and Artemis are required for other types of nucleolytic processing 
such as the removal G4 structures in the 3’ overhang, which can block Ku 
loading and NHEJ. Importantly, the absence of PTIP merely caused a delay in 
telomere fusions that is no longer observed at later time points after TRF2 
deletion, suggesting that the activity of PTIP is redundant with other pathways 
(Lottersberger et al., 2015).  
It is unclear by which mechanism Rif1 prohibits end resection. It is unlikely 
that Rif1 directly inhibits individual components of the resection pathway, such as 
BLM, Exo1 or CtIP. First, Rif1 blocks resection at shelterin free telomeres 
mediated by CtIP as well as BLM and Exo1 (Sfeir and de Lange, 2012; 
Zimmermann et al., 2013). It could be argued that Rif1 only needs to inhibit the 
initial resection step mediated by CtIP. However, this is unlikely since Rif1 was 
also shown to inhibit CtIP-independent resection at telomeres after loss of TPP1 
(Kibe et al., 2016). Thus, it is likely that the inhibition of resection by Rif1 occurs 
on a broader scale, such as changes in the chromatin landscape or by binding 
dsDNA as has been recently suggested by David Shore and colleagues (pers. 
comm.). 
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Recent papers have described Rev7 (also known as MAD2L2), a subunit 
of the translesion polymerase zeta (polζ), as a factor required for inhibition of 
resection downstream of 53BP1 and Rif1 (Boersma et al., 2015; Xu et al., 2015). 
This was independent of the role of Rev7 in translesion synthesis, as depletion of 
Rev3 or Rev1, the other polζ components, did not recapitulate the resection 
phenotype. Rev7 was recruited to DSBs in a 53BP1- and Rif1-dependent manner 
but a direct interaction could not be detected (Xu et al., 2015).  However, loss of 
Rev7 resulted in a similar reduction in telomere fusions after depletion of TRF2 
as loss of 53BP1/Rif1 (Boersma et al., 2015). Furthermore, its knockdown 
restored PARPi resistance in BRCA1 deficient cells similar to Rif1, providing 
further evidence that Rev7 and Rif1 operate in the same pathway (Xu et al., 
2015). But the molecular mechanism by which Rif1 and Rev7 inhibit resection 
remains the subject of ongoing investigation. 
5.1.2 The connection between 53BP1 and the LINC complex 
53BP1 promotes the mobility of telomeres after deletion of TRF2 (Dimitrova et 
al., 2008). Experiments in the lab have shown that this mobility is dependent on 
the LINC complex and kinesin-mediated movement on microtubules (explained in 
Chapter 1.2.5). However, the question remains how 53BP1 mediates chromatin 
mobility through Sun proteins and the rest of the LINC complex. The results 
described here identified a 53BP1 dissociation of function mutant that harbors the 
S/TQ sites needed to induce chromatin mobility (Fig. 2.8b-d). Dysfunctional 
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telomeres in cells expressing 53BP1ΔMOB were unable to fuse to the same extent 
as in cells expressing the wild type allele. Furthermore, this delay in fusion 
frequency was dependent on Sun1 and Sun2 (Fig. 2.8c and d). Additionally, time-
lapse imaging showed that 53BP1ΔMOB was unable to promote the mobility of 
dysfunctional telomeres, similar to 53BP1Δ28, confirming that this mutant is 
deficient in inducing chromatin mobility (2.9c). The results also indicated that 
53BP1ΔPTIP behaves as wild type 53BP1 with regards to mobility, similar to results 
obtained in TRF2F/FPTIP-/- MEFs (Lottersberger et al., 2015).  
It is unknown whether 53BP1 associates with the LINC complex. The fact 
that uncapped telomeres do not show an obvious localization to the nuclear 
periphery argues against a interaction. However, the MEFs analyzed are flat and 
the precise localization of DSBs is difficulty to assess. Furthermore, nuclear 
invaginations can position an internal telomere close to the nuclear envelope and 
a connection can thus be envisioned (Fig. 5.1a). However, multiple co-IP 
experiments, telomere ChIP, and co-IPs of crosslinked complexes failed to detect 
an interaction between 53BP1 and Sun1, raising the possibility that there is no 
physical interaction between 53BP1 and the Sun proteins (Fig. 2.10 to 2.13). 
It is therefore possible that the influence of the LINC complex on DSB 
mobility is indirect (Fig. 5.1b). One hypothesis is that the mobility domain of 
53BP1 interacts with factor(s) that increase the flexibility of the chromatin 
surrounding the uncapped telomere. Chromatin containing DSBs has been 
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Figure 5.1 Models for the interaction between 53BP1 and Sun1 
(A) The direct interaction model predicts an interaction between 53BP1 (red) and the LINC 
complex (yellow) to permit the transfer of microtubule forces to the DSB. (B) In the indirect 
interaction model, 53BP1 alters the chromatin structure surrounding the DSB, rendering it more 
flexible. Random forces transmitted from the cytoplasm into the nucleus through the LINC 
complex result in increased mobility at the DSB site, due to the altered chromatin structure. 
Figure provided by F. Lottersberger. 
185 
suggested to expand, as evidenced by EM experiments (Kruhlak et al., 2006). If 
the chromatin near a DSB is more flexible, it is conceivable that the forces 
exerted by the microtubules could induce mobility of DSBs whereas other regions 
in the nucleus are less affected (Fig. 5.1). 
It will be of interest to identify proteins that interact with the mobility 
domain of 53BP1. Mass spectrometry could be used to identify proteins that 
interact with this domain in a DNA damage inducible manner, similar to what was 
done previously for the 53BP1 S/TQ sites in B-cells (Di Virgilio et al., 2013). 
Possibly, nucleosome-remodeling complexes could be recruited or activated in a 
process dependent on 53BP1. Alternatively, the pathway could be more 
complicated if this domain interacts with a kinase or ubiquitin ligase, that can 
activate entire signaling cascades. Monitoring the influence of 53BP1 on 
chromatin status at telomeres would be helpful to address these questions. 
Telomeric chromatin is heterochromatic and MNase digestion experiments 
indicated that nucleosome density is not altered in response to DNA damage, 
when measured after TRF2 loss (Wu and de Lange, 2008). This does not 
necessarily argue against changes in chromatin structure surrounding DSBs. It is 
possible that 53BP1 activity affects histone modifications that regulate the 
flexibility of the chromatin fiber. The increased mobility of flexible chromatin at 
DSB could be due to regular cytoskeletal forces transmitter through the LINC 
complex. But it is also possible that DNA damage stimulates an increase in 
forces on the nucleus. Nuclear invaginations and deformations have been 
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observed upon etoposide treatment in human fibroblasts (Dellaire et al., 2009). 
Furthermore, ATM dependent signaling through Chk2 and/or Chk1 could impact 
the LINC complex directly, as was shown for C. elegans meiosis where Chk2 
directly phosphorylates the Sun1 N-terminus (Penkner et al., 2009). 
5.1.3 The function of chromatin mobility in response to damage 
An outstanding question is the functional relevance of increased chromatin 
mobility in response to DNA damage. Certainly the pathway has not evolved to 
fuse dysfunctional telomeres. As discussed in Lottersberger et al. 2015, it is 
possible that the mobility inhibits ectopic repair at sites of damage. In G1, DSBs 
are quickly repaired by c-NHEJ in response to Ku binding. However, at some 
DSBs, Ku binding or synapse might fail, resulting in two loose ends that become 
spatially separated. The 53BP1 dependent mobility might help reconnect these 
ends to promote their repair (Fig. 5.2a). A downside of this model is that it can be 
argued that the mobility increases the chance of generating translocations, if the 
DSB reconnects with an end on another chromosome. However, most cells do 
not contain more than one persistent DSBs unless under an external genotoxic 
insult (Wu et al., 2010). Therefore, the possibility that 53BP1 mediated mobility 
promotes translocations is very limited in biological relevant settings. 
Another setting where DSB mobility might play a protective function is at 
sites of replication stress. A DSB generated at a collapsed fork can be repaired 
by HR using the sister chromatid as a template. However, if the DNA end loses 
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Figure 5.2 Proposed function of 53BP1-dependent mobility of DSBs 
(A) In G1, the mobility of DNA ends that have become disassociated would promote their correct 
rejoining by NHEJ. (B) In S/G2, a DNA end could lose its connection with the sister chromatid at a 
DSB. Ectopic repair on another locus could be prevented by the 53BP1-dependent mobility 
stimulating correct repair using HDR on the sister chromatid. Figure from Lottersberger et al. 
2015 (Lottersberger et al., 2015). 
188 
the connection with the sister chromatid, ectopic repair on another chromosome 
can occur by strand invasion and microhomology. DNA mobility might be 
required to tear apart these low affinity interactions to promote correct repair on 
the sister chromatid (Fig. 5.2b). The use of chromosome mobility to disrupt 
inaccurate chromosome pairing has previously been suggested to play a role in 
C. elegans meiosis (Sato et al., 2009). Pairing and synapsis of chromosomes is 
required to accurately separate homologous chromosomes in meiosis I. Synapsis 
is promoted by a connection between telomeres (pairing centers in C. elegans) 
and Sun1 in the nuclear envelope. Microtubule forces transmitted through the 
LINC complex induce meiotic chromosome movement along the nuclear 
envelope that promotes synapsis (Shibuya and Watanabe, 2014). This 
movement was suggested to improve the accuracy of synapsis since pairing of 
non-homologous chromosomes results in weaker interactions that can be 
disrupted by the movement while paired homologues resist this force (Sato et al., 
2009). The situation at DBSs is different from meiosis since the damage sites do 
not appear to connect directly at the nuclear envelope. However, the underlying 
molecular mechanism to promote accurate pairing could be similar. 
5.2 The fusion of sister telomeres by a-NHEJ and cleavage by Gen1 
5.2.1 Telomeres are prone to a-NHEJ in absence of TRF1 
It was long unknown what structure underlies the manifestation of SAs in 
metaphase chromosomes. They are not dependent on c-NHEJ, since absence of 
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Lig4 does not affect their prevalence. Furthermore, they are not related to the 
telomere fragility that is observed after deletion of TRF1, as explained in detail in 
Chapter 3.1. The results presented here strongly indicate that SAs are formed via 
the a-NHEJ pathway since they are dependent on Lig3 and PARP1 (Fig. 3.2 and 
3.3). Supporting this finding, SAs are also reduced from ~12% to ~5% in 
TRF1F/FTRF2F/FLig4-/- MEFs after deletion of the entire shelterin complex in 
response to shLig3 depletion (unpublished experiments from A. Sfeir). This 
reduction is similar to the results reported here (Fig. 3.3). Furthermore, anaphase 
bridges are seen in mitotic cells after loss of TRF1, indicating chromosome fusion 
events (Fig, 3.7b). Unexpectedly, telomere fusions are not prominently detected 
upon analysis of the telomeric restriction fragments from Cre-treated TRF1F/F 
MEFs, even when mitotic cells are enriched (unpublished experiments from de 
Lange lab). The absence of molecular evidence for telomere-telomere fusions 
could be due to several reasons. First, the abundance of SAs might be too low 
for detection. Upon TRF2 loss, telomere fusions are clearly visible in gels but the 
percentage of fused telomeres is much higher in those cells (60% in TRF2F/F 
versus 15% in TRF1F/F). Secondly, if SAs are resolved by Gen1 (or other 
nucleases), their number would be reduced even further because the fusions 
would be transient. Third, fusions via a-NHEJ are known to produce mutations at 
the fusion site. Telomeric DNA is digested with AluI and MboI prior to PFGE, 
which normally do not cleave fused telomeres. But after a-NHEJ, cleavage sites 
for these enzymes may appear at the fusion site resulting in their cleavage due to 
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de novo sequence insertions by PolQ (Mateos-Gomez et al., 2015). Therefore, 
this observation that fused telomeres are not visible in telomeric gels does not 
argue against a-NHEJ mediated fusion of sister telomeres upon loss of TRF1. 
5.2.2 Incomplete DNA replication does not explain the appearance of SAs 
Different models have previously been proposed for the events resulting in the 
formation of SAs. It can be argued that SAs are sites of incomplete DNA 
replication. Telomere replication is initiated primarily in the subtelomere from 
where the replication fork progresses into the telomeric DNA. Replication 
initiation within the telomeric sequence is infrequent (Sfeir et al., 2009). Telomeric 
replication is furthermore not a late event but occurs throughout S phase (Ten 
Hagen et al., 1990; Wright et al., 1999). It can be argued that the replication fork 
in some replicating telomeres does not reach the telomere end, particularly upon 
replication fork stalling in absence of TRF1, resulting in unfinished replication 
leaving the sister chromatids bound together. A similar model for incomplete 
replication exists for common fragile sites (CFS), regions of the genome that are 
difficult to replicate and manifest as breaks and gaps on metaphase spreads 
(Durkin and Glover, 2007). Replication at CFS was recently shown to continue 
into the prophase, as evidenced by EdU incorporation after entry into mitosis 
(Minocherhomji et al., 2015). Mitotic DNA synthesis was dependent on 
Mus81/SLX4, Rad52 and POLD3, resulting in a model where cleavage of the 
replication fork by Mus81/SLX4 allows D-loop formation by Rad52 on the sister 
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template and initiation of DNA synthesis by POLD3 (Minocherhomji et al., 2015; 
Bhowmick et al., 2016). It is possible that SAs at telomeres represent similar 
areas of incomplete replication after deletion of TRF1, resulting in the 
appearance of ‘fused’ telomeres. However, several arguments counter this 
hypothesis.  
First, in contrast to telomeres, most CFSs replicate late in S-phase 
explaining why they remain incompletely replicated, especially after aphidicolin 
treatment (Le Beau et al., 1998). Telomeric replication is likely to be finished at 
the end of S-phase, since they replicate throughout S-phase, even in absence of 
TRF1 (Wright et al., 1999; Sfeir et al., 2009).  
Secondly, EdU incorporation in mitosis could not be detected at telomeres, 
in absence of TRF1 suggesting that DNA replication has finished in this setting 
(unpublished experiments). It is possible that the amount of EdU incorporation at 
telomeres was too limited for detection. However, treatment of cells with 
aphidicolin treatment did result in EdU signals at or near telomeres (unpublished 
data Z. Yang). This further suggests that telomeres are fully replicated after TRF1 
deletion, except when cells are treated with aphidicolin. Since SAs are not seen 
at telomeres after aphidicolin treatment, this argues that they do not represent 
sites of unfinished replication (Sfeir et al., 2009). 
Third, Mus81 was shown to be required for mitotic DNA replication, which 
occurs in prophase but before prometaphase (Minocherhomji et al., 2015). If SAs 
represent areas of unfinished replication, depletion of Mus81 should have some 
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effect on the prevalence of SAs since they are visualized in metaphase after 
mitotic DNA replication has occurred. But the frequency of SAs was not altered in 
MEFs in absence of Mus81 upon deletion of TRF1 (Fig. 4.16a). 
Finally, CFS expression as a consequence of incomplete replication is 
associated with an increase of UFBs in anaphase cells (Ying et al., 2013). Thus, 
UFBs should be clearly visible in anaphase cells after deletion of TRF1, if SAs 
indeed represent sites of unfinished replication. Although the resolution of the 
microscope was not ideal, there was no indication for high levels of UFBs in 
TRF1F/F MEFs after deletion of TRF1, as gleaned from PICH recruitment in time-
lapse imaging experiments (Fig. 3.8). Although many anaphase bridges were 
detected upon loss of TRF1, they were almost always DAPI positive suggesting 
that they represent real fusions instead of sites of unfinished replication (Fig. 3.7b 
and 3.8d). 
Additionally, whereas the reduction of SAs by PARP1 inhibition could 
potentially be explained by its many distinct functions at the replication fork, the 
reduction of SAs by Lig3 does not make sense if the SAs represent incompletely 
replicated telomeres. Combined, the results argue that (at least some of the) SAs 
are telomeres fused by a-NHEJ and do not represent sites of unfinished 
replication. 
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5.2.3 Cohesin defects cannot explain SAs 
Another possible model for the molecular nature of SAs could be defective 
removal of cohesin at telomeres in absence of TRF1. Sister chromatids are held 
together after replication by cohesin until their separation in mitosis (Nasmyth 
and Haering, 2009). Most cohesin is removed during prophase but a small 
amount remains at the centromeres to allow accurate chromosome alignment 
and spindle formation. At the onset of anaphase, all sister chromatid cohesion is 
destroyed by the action of separase, allowing chromosomes to fully separate 
(Nasmyth and Haering, 2009). Telomeres are held together by the SA1-cohesin 
complex, which in human cells requires the shelterin associated protein 
tankyrase for its removal from telomeres. Absence of tankyrase-1 was shown to 
result in persistent telomere associations mediated by SA1 (Dynek and Smith, 
2004; Canudas et al., 2007). It is therefore possible that SAs represent sister 
telomeres from which SA1-cohesion has not properly been removed. Indeed, 
sister chromatid fusions were seen in human cells after tankyrase depletion 
(Hsiao and Smith, 2009). However, other studies argue against SAs being merely 
cohered telomeres. Sister telomere coherence mediated by SA1 is a non-
covalent interaction that is destroyed by the hypotonic treatment used for 
metaphase spread analysis (Dynek and Smith, 2004). This coherence is 
therefore only seen upon direct fixation of mitotic cells. However, SAs upon TRF1 
loss are refractory to hypotonic swelling since they are detected in regular 
metaphase spreads, indicating that they do not represent associations mediated 
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by SA1-cohesion. Furthermore, the tankyrase-SA1 mediated telomere 
associations in human cells are dependent on an interaction between tankyrase 
and TRF1. However, mouse TRF1 does not interact with tankyrase, indicating 
that SAs are distinct from a telomere cohesion defect (Donigian and de Lange, 
2007). 
Interestingly however, telomeric cohesion is required for accurate telomere 
replication. An SA1 knockout mouse displayed defective telomere replication 
indicated by the appearance of fragile telomeres (Remeseiro et al., 2012). Loss 
of SA1 did not affect centromeric cohesion but telomeres are seen as doublets in 
IF analysis representing defective coherence. The level of telomere fragility is of 
a similar level as induced by TRF1 deletion (20-25%), but SAs were not 
described. Telomeric sister chromatid exchanges (T-SCE) are decreased in 
absence of SA1. The reduced level of T-SCE suggests that SA1 facilitates HR-
mediated repair of stalled forks by keeping sister telomeres close together. It 
would be interesting to analyze SAs in TRF1F/F MEFs after depletion of SA1 to 
see if their levels are altered by loss of cohesion. 
5.2.4 Telomere entanglements in yeast 
The anaphase bridges seen upon loss of TRF1 are reminiscent of the telomere 
‘entanglements’ observed on gel analysis of fission yeast cells lacking the 
TRF1/2 ortholog taz1 (Miller and Cooper, 2003). When taz1Δ cells are exposed 
to cold temperatures (20°C) they undergo replication stress similar to the 
 195 
situation in TRF1 knockout MEFs (Miller et al., 2006). Importantly, taz1Δ cells 
display segregation defects such as anaphase bridges, which are dependent on 
progression through S-phase (Miller and Cooper, 2003). This segregation defect 
was independent of Ku or Lig4, indicating that the defect is not the result of 
telomere fusion by c-NHEJ. It is possible that the telomere entanglements 
represent telomeres fused by a-NHEJ similar to the SAs in MEFs, but deletion of 
Lig3 was not tested in these yeast experiments. The cold-sensitivity of taz1Δ 
cells was improved by deletion of topoisomerase II and it was suggested that 
inappropriate cleavage and rejoining of DNA strands was a causative factor for 
the appearance of entangled telomeres (Miller and Cooper, 2003). But telomere 
fusions were not observed in PFGE electrophoreses gels, suggesting that the 
telomere entanglement were not covalently attached. The molecular nature of 
these entanglements thus remains unknown.  
 Intriguingly, subsequent experiments showed that deletion of yeast Rif1 
(rif1+) rescued the cold sensitivity of taz1Δ cells implicating rif1+ contributes to 
the formation of telomere entanglements (Miller et al., 2005; Zaaijer et al., 2016). 
Fission yeast Rif1+ is different from mammalian Rif1 in that is does not affect c-
NHEJ or the 3’ overhang at the telomere end. Furthermore, Rif1+ binds to yeast 
telomeres in a taz1 dependent manner indicating that its role in preventing the 
cold sensitivity of taz1Δ cells is independent of its localization to telomeres. Later 
experiments showed that Rif1+ localizes to the anaphase mid-region in fission 
yeast during mitosis suggesting that it prevents untangling at this site (Zaaijer et 
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al., 2016). Recently, Rif1 was also detected at UFBs during mitosis in 
mammalian cells (Hengeveld et al., 2015). However, in contrast to telomere 
entanglements, resolution of UFBs was worse in absence of Rif1 suggesting that 
Rif1 performs a function that helps resolve UFBs (Hengeveld et al., 2015; Zaaijer 
et al., 2016). These contradicting functions of Rif1 at telomeres and UFBs could 
be explained if the telomere entanglements are structurally different from UFBs, 
for example, if the telomere entanglements actually represent fused sister 
telomeres, similar to the SAs in TRF1 null cells. In agreement with this 
hypothesis, SAs were prevented in TRF1F/F53BP1-/- MEFs expressing the 
53BP1ΔRif1 allele, suggesting a similar function of mammalian Rif1 in promoting 
telomeric SAs as in fission yeast (Fig. 3.13 and 3.14). However, the role for Rif1 
described in this thesis is downstream of 53BP1 in contrast to fission yeast, 
where Rif1+ localizes independently. It is possible that the 53BP1 dependent 
recruitment of mammalian Rif1 evolved later, in agreement with the observation 
that fission Rif1+ does not play a role in telomeric overhang regulation. Further 
experiments are needed to determine whether yeast telomere entanglements are 
similar to the SAs in TRF1 null cells and what function Rif1 plays at these sites. It 
is possible that Rif1 is required to promote topoisomerase mediated untangling of 
UFBs during mitosis. This could explain why Rif1 promotes untangling of 
replication intermediates but has detrimental consequences at entangled 
telomeres if these sites represent telomere fusions, since topoisomerase function 
would not resolve these structures (Hengeveld et al., 2015; Zaaijer et al., 2016). 
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Intriguingly, Rif1 is known to interact with BLM at stalled replication forks, 
independent from 53BP1, where it prevents the accumulation of stalled forks (Xu 
et al., 2010). Although the recruitment of Rif1 to UFBs is independent of BLM, it 
is possible that they act in the same pathway to untangle replication 
intermediates (Hengeveld et al., 2015). 
5.2.5 What is the substrate for a-NHEJ at sister telomeres? 
A major question arising from this work is what specific substrate allows a-NHEJ 
to take place between sister telomeres after deletion of TRF1. SAs are not seen 
after TRF2 loss, even when fusions are limited to S/G2 such as in TRF2F/FATMF/F 
or TRF2F/FNBS1F/F MEFs (Dimitrova and de Lange, 2009). Instead, leading-
leading chromatid type fusions are observed in these cells. Lagging strand 
telomeres are protected from these fusions since telomere processing, formation 
of the 3’ overhang, and binding of the POT1 proteins are thought to be 
incompatible to c-NHEJ. However, replication of the leading strand telomere 
yields a blunt end. Normally, ATM activation in response to TRF2 removal results 
in resection of the leading end, providing a 3’ overhang incompatible to c-NHEJ 
in S/G2. But in TRF2F/FATMF/F (or NBS1F/F) MEFs, ATM dependent-resection is 
inhibited leaving blunt ended telomeres resulting in leading-leading chromatid 
fusions. Nevertheless, SAs are not observed upon loss of TRF2 indicating that a 
TRF1 specific event is required. Given that TRF1 is required for telomere 
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Figure 5.3 Model for the fork stabilization in absence of TRF1 
(A) When the replication fork reaches the end of the telomere, TRF1 might promote the 
disassembly of the replisome. (B) In absence of TRF1, the disassembly of the replisome might 
not occur efficiently. Furthermore, activation of ATR stabilizes the replication fork even more, 
which could lead to fork regression. 
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replication, possibly an event at the terminal replication fork provides the 
substrate for a-NHEJ. 
While many studies focus on understanding the initiation of replication, 
termination of the fork is not very well understood. It is thought to require 
topoisomerase function and polyubiquitiniation, suggesting an active process 
(Fachinetti et al., 2010; Moreno et al., 2014; Bailey et al., 2015). This has mainly 
been studied at converging forks at chromosome internal locations. How 
replication fork dismantling occurs at a DNA end such as a telomere is unknown. 
Possibly, one of the functions of TRF1 is to promote replication fork disassembly 
once the fork has reached the end of the DNA (Fig. 5.3a and b). In absence of 
TRF1, ATR is activated which has a stabilizing function on the replisome (Lopes 
et al., 2001; Tercero and Diffley, 2001; Cobb et al., 2003; Lucca et al., 2004). It is 
therefore possible that the replisome remains associated at the telomere after 
DNA replication in TRF1 null cells. Stalled replication forks can give rise to 
abnormal DNA structures such as reversed forks, which form cruciform structures 
(Neelsen and Lopes, 2015). At chromosome internal locations, the reversed forks 
can help replication fork restart or bypass of DNA lesions. But at the telomere 
there is just the DNA end and repair would not be possible. 
What could occur at these terminal forks was assessed in a study 
examining the fate of a replication fork reaching a DSB, not unlike the situation at 
a chromosome end (Doksani et al., 2009). It was speculated that the combined 
action of MRN, CtIP and ATM prevents the formation of pathological chicken-foot 
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structures at the stalled fork encountering the DSB, allowing disassembly of the 
replication complex. In absence of these proteins, fork reversal and the 
accumulation of cruciform structures were observed at the fork, which was 
speculated to be a substrate for sister fusion. Although the situation at telomeres 
is not exactly similar to internal DSBs, it is possible that a comparable process 
occurs in absence of TRF1 (Fig. 5.4). Initially, the situation is similar to fork 
reversal at replication forks elsewhere in the genome, resulting in a regressed 
fork. Resection of the newly replicated 5’ end by nucleases such as Exo1, Dna2 
or WRN takes place, creating a 3’ overhang at the reversed end. What is unique 
at telomeres is that this overhang generates a potential substrate for a-NHEJ 
because there is already a 3’ overhang present nearby at the unreplicated 
telomere end. This ssDNA at the chromosome end contains microhomology with 
the newly generated overhang (AT-TA).  When these 3’ overhangs anneal, fusion 
by a-NHEJ could occur resulting in sister telomere fusion (Fig. 5.4). An 
interesting experiment to test the requirement for TRF1 loss in the formation of 
SAs would be to treat Pot1a null cells with aphidicolin. This would result in ATR 
activation, due to the unprotected 3’ overhang, together with aphidicolin induced 
replication stress at the telomere. An increase in SAs in this setting would argue 
against a direct effect of TRF1 on the terminal replication fork, but indicate that 
ATR activation at the terminal fork by itself is sufficient to induce sister fusions.  
Interestingly, there is experimental evidence suggesting that sister 
telomere fusions occur when there is complementarity in the telomeric sequence 
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Figure 5.4 Model for the formation of sister telomere fusions upon TRF1 loss 
A schematic of the terminal replication fork is shown (Shelterin and replisome are not included for 
clarity). In absence of TRF1, the replication fork would stall at the telomere end. Unwinding of the 
newly synthesized DNA strands would occur resulting in fork regression. At the reversed fork, the 
nucleases (Exo1/Dna2 or WRN) would act on the 5’ end resulting in a 3’ overhang. Since there is 
already a 3’ overhang present at the telomere end, annealing can occur between the overhangs 
due to the microhomology present in the telomeric sequence, resulting in a-NHEJ mediated by 
PARP1 and Lig3. How and where PARP1 is activated is not known.  
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(Stohr et al., 2010). An experiment with a mutated telomerase enzyme that 
incorporates different ‘telomeric’ sequences to the DNA end than the typical 
TTAGGG sequence has provided evidence for this. A telomerase enzyme 
incorporating “TATATATA” caused sister telomere fusions and isochromosomes, 
which occurred in an ATM independent manner. However, incorporation of 
TTTGGG sequences did not have this effect and solely led to chromosome type 
telomere fusions, that required ATM (likely because telomeres become uncapped 
since TRF2 does not bind this sequence). These experiments suggest that 
microhomology within the telomeric sequence might indeed be required for SAs, 
in support of the model presented here. 
While this model can explain how sister fusions are formed, several 
questions remain unanswered. How is PARP1 activated at the regressed fork 
and why is its activation not inhibited by TRF2? Does TRF1 indeed promote the 
disassembly of the replication fork? And if so, does TRF1 promote replisome 
disassembly through preventing ATR activation? Is the RNA primer at the lagging 
strand removed prior to fork stalling? How is 53BP1/Rif1 involved in this 
process? Future experiments should attempt to answer these questions. 
5.2.6 The role of Ku in preventing a-NHEJ at telomeres 
An interesting observation is that Ku70/80 did not prevent SAs after 
deletion of TRF1 (Fig. 3.6b). This was surprising given that Ku can block a-NHEJ 
upon loss of TRF2 or the entire shelterin complex (Celli et al., 2006; Sfeir and de 
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Lange, 2012). Ku is thought to block a-NHEJ by competing with PARP1 for DNA 
ends (Wang et al., 2006). One explanation for why Ku does not inhibit a-NHEJ in 
the TRF1 null setting is that TRF2 is still present. In vitro experiments suggested 
that TRF2 directly interacts with Ku to prevent it from stimulating NHEJ. Thus, 
upon deletion of TRF1, Ku may still be inhibited by TRF2 explaining why loss of 
Ku does not result in higher levels of SAs. Arguing against this hypothesis is the 
fact that Ku appears to prevent SAs in a TRF1F/FTPP1F/F setting. When Ku is 
deleted from these MEFs, the level of SAs increases from 13 to 30% 
(unpublished data from T. Kibe). These results raise the possibility that POT1a/b 
limits the activity of Ku in the formation of SAs. Possibly, the ssDNA binding 
capability of POT1a/b limits the accessibility of Ku for the DNA end. Although the 
levels of the TIN2/TPP1/POT1a/b axis of shelterin are reduced when TRF1 is 
missing, enough residual POT1a/b remains to protect the 3’ overhang since a 
POT1a/b null phenotype is not observed in absence of TRF1 (Frescas and de 
Lange, 2014). It would be interesting to analyze the contribution of Ku to SAs in a 
POT1aF/FTRF1F/F setting.  
An alternative explanation for the lack of suppression of SAs by Ku could 
simply be the structure of the DNA end. We do not know on a molecular level 
what structure gives rise to a-NHEJ in absence of TRF1. Possibly, the end is 
incompatible to Ku loading, thus explaining why its loss does not affect SAs. 
However, this cannot explain the increased level of SAs in the 
TRF1F/FTPP1F/FKu-/- setting. 
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5.2.7 Gen1 cleaves SAs 
The results in Chapter 4 revealed a unique mechanism for cleavage of sister 
telomere fusions by the HJ resolvases Gen1 (Fig. 5.5a-c). Since telomere fusions 
create a palindromic sequence, a Holliday junction can be formed which can be 
cleaved by HJ resolvases. The absence of Gen1 results in the accumulation of 
chromatin bridges, but only when TRF1 was removed from telomeres. It is 
unclear from the results presented here whether Gen1 is the only HJ resolvase 
capable of cleaving fused telomeres. Whereas Mus81 loss increased the 
percentage of chromatin bridges, it cannot be ascertained that this is due to a 
TRF1 specific effect or because of its role at CFS throughout the genome. An 
additive effect was seen for Gen1 and Mus81 depletion, but the results were not 
significant. This could be due to the inefficiency of the shRNAs against Mus81, 
which led to only a 60-80% reduction in expression levels. However, it is also 
possible that Mus81 is not as efficient as Gen1 in cleaving telomeres. Mus81 
requires a nicked substrate for HJ cleavage, which might not be efficiently 
generated at telomeres (Wyatt et al., 2013). Interestingly, a recent paper 
analyzed the sequence specificity of Gen1. Even though it shows broad cleavage 
activity on a variety of sequences, it preferentially cleaves TTxGG substrates, 
suggesting that telomeric TTaGGg sequences form an ideal substrate for Gen1 
(Shah Punatar et al., 2017). A remaining question is whether Gen1 cleaves all 
types of telomere fusions or just the ones arising through a-NHEJ. Preliminary 
experiments indicate that Gen1 does not cleave telomere fusions that occur after 
205 
Figure 5.5 Model for the role of Gen1 at telomeres fused by a-NHEJ. 
(A) Schematic of a fused sister telomere is shown on the left. Fusion junctions in a-NHEJ often 
contain insertions/deletions that are depicted by xxx. The formation of a cruciform structure from a 
telomere fusion is shown on the right. (B) Upon deletion of TRF1, anaphase bridges can form 
when a chromosome with a sister telomere fusion (red) is separated (top). Cleavage of the 
telomere fusion by Gen1 still allows faithful chromosome segregation. When the spindle forms an 
incorrect attachment or loses its connection (bottom), the entire chromosome is missegragated 
into one daughter cell. Cleavage by Gen1 can prevent the formation of isochromosomes. (C) In 
absence of Gen1, a chromosome with a sister fusion can follow two fates in mitosis. If the spindle 
forms a correct attachment, the fused chromosome will form a chromatin bridge (top). When the 
spindle forms an incorrect attachment or loses its connection, the entire chromosome is 
missegragated into one daughter cell (bottom). Replication in the next S-phase will result in the 
formation of an isochromosome (red). 
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expression of a dominant negative TRF2 allele, TRF2ΔBΔM, which results in 
chromatid type telomere fusion in human cells (van Steensel et al., 1998). The 
level of telomere fusion was not increased in Gen1 null cells, suggesting it is not 
capable of cleaving these fusions (unpublished data S. Dewhurst). Possibly, 
Gen1 only cleaves fusions formed via a-NHEJ. This pathway is known to 
promote mutations and insertions at the fusion site and the mismatches could 
help to destabilize the helix and promote protrusion of the cruciform DNA 
structure. Cruciform DNA structures are energetically unfavorable and do not 
form easily. However, increasing their length or by introducing negative 
supercoiling, their extrusion can be promoted (Mizuuchi et al., 1982; Gellert et al., 
1983). This opens the possibility that transcription of TERRA, the telomeric RNA, 
promotes the expression of the cruciform, since transcription induces negative 
supercoiling (Gilbert and Allan, 2014). Alternatively, perhaps the activities of BLM 
and PICH during anaphase promote the protrusion of cruciform structures. 
5.2.8 Critically short telomeres in human cells fuse via a-NHEJ 
The results presented here are relevant with regard to telomere shortening in 
human cancer. Studies have shown that fusions of critically short telomeres in 
human cells occur via sister chromatid fusion and are dependent on a-NHEJ 
(Letsolo et al., 2010; Jones et al., 2014; Liddiard et al., 2016). Microhomology is 
also observed at telomere fusion sites in cancer, consistent with a-NHEJ (Lin et 
al., 2010). In a system of experimentally induced telomere erosion, telomere 
208 
fusions in surviving Lig4-/- cells were predominantly intra-chromosomal consistent 
with Lig3-mediated sister chromatid fusion (Jones et al., 2014). Conversely, Lig4 
facilitated inter-chromosomal fusions, indicating they are formed by c-NHEJ. 
Interestingly, the inter-chromosomal fusions often retained telomeric repeats at 
the fusion sites whereas intra-chromosomal fusions (Lig3) involved the 
subtelomeric region (Letsolo et al., 2010; Jones et al., 2014). Given the results 
presented here, it is interesting to speculate that sister telomere fusions by a-
NHEJ in the telomeric region are cleaved by Gen1, until the degradation reaches 
into the subtelomeric region where a substrate for a cruciform DNA structure no 
longer exists. In agreement with this, escape from telomere-driven crisis is 
dependent on a functional Lig3, suggesting that cells with a-NHEJ mediated 
sister fusions have a mechanisms to survive (Jones et al., 2014). 
Liddiard et al. suggested that the basis for intra-chromosomal fusions lies 
in interplay with the DNA replication machinery, consistent with the model 
presented here (Liddiard et al., 2016). Critically short telomeres were inferred to 
contain an average of 6 TTAGGG repeats at the time of stable fusion product 
formation (Capper et al., 2007).  This might not be enough for efficient telomere 
protection by shelterin but telomeres of this size are still thought to contain a 3’ 
overhang (Jones et al., 2014). Therefore it is possible that our model for the 
generation of sister fusions at the terminal replication fork takes place at critically 
short telomeres after DNA replication. The short telomere tract no longer contains 
enough TRF1 to promote disassembly of the replication machinery resulting to 
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fork stalling and reversal. Since the 3’ overhang is still formed at these critically 
short telomeres, a-NHEJ mediated fusion can occur. But further studies are 
required to test this hypothesis. 
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Chapter 6: Materials and Methods 
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6.1 Cell culture techniques 
6.1.1 Mammalian cell culture 
MEFs were cultured in DMEM (GIBCO) supplemented with 15% fetal bovine 
serum (GIBCO), 2 mM L-glutamine, 100 U/ml penicillin (Sigma), 0.1 mg/ml 
streptomycin (Sigma), 0.1 mM nonessential amino acids (Invitrogen), 1 mM 
sodium pyruvate (Sigma) and 50 mM β-mercaptoethanol (Chemicon). Primary 
MEFs were isolated from E13.5 embryos using standard techniques. Primary 
MEFs were immortalized at PD2 or 3 by retroviral infections with pBabe-SV40-LT 
(a gift from G. Hannon) and cultured additionally for 10-15 PDs to achieve 
immortalization. Human 293T and Phoenix packaging cell lines were grown in 
DMEM supplemented with 10% bovine calf serum (Hyclone), 2 mM L-glutamine, 
100U/ml penicillin (Sigma), 0.1 mg/ml streptomycin (Sigma), 0.1 mM 
nonessential amino acids (Invitrogen) and 1 mM sodium pyruvate (Sigma). For 
subculturing, cells were washed with PBS pH 7.4, trypsinized and resuspended 
in fresh serum containing medium to inactivate trypsin. Cells passaged 1:5 or 
plated as required and when necessary, counted with a Coulter Z1 counter. All 
cell lines were grown at 37°C with 5% CO2. 
293T and Phoenix cells were grown in 10% bovine serum (GIBCO), 2 mM 
L-glutamine, 100 U/ml penicillin (Sigma), 0.1 mg/ml streptomycin (Sigma), 0.1 
mM nonessential amino acids (Invitrogen) and 1 mM sodium pyruvate (Sigma). 
Cells were passaged 1:10 or plated as required. Cells were used for a maximum 
of 15-20 passages. A list of cell lines used is found in Chapter 6.4. 
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6.1.2 Calcium phosphate precipitation transfection of 293T and Phoenix cells 
3-5X106 293T or Phoenix cells were seeded in 10 cm dishes 20-24 h prior to 
transfection. For each plate, plasmid DNA (10-20 μg) was combined with 50 μl of 
2.5 M CaCl2 and ddH2O in a total volume of 500 μl. The solution was incubated 
for 1-2 minutes at room temperature after which 500μl of 2x HBS (50 mM HEPES 
pH 7.05, 10 mM KCL, 12 mM dextrose, 280 mM NaCl, 1.5 mM Na2PO4) was 
added dropwise while airing the solution with a pipet. The solution was incubated 
for 1-2 minutes and carefully added to the 10 cm dish containing 293T or Phoenix 
cells. Medium was exchanged 12-16 h after transfection. 
 
6.1.3 Retroviral gene delivery 
For retroviral gene delivery, 3-5X106 Phoenix packaging cells (ATCC) were 
transfected with 10-20 μg of plasmid using calcium phosphate precipitation. After 
12-16 h, medium was replaced by MEF medium. Virus particles were first 
collected 48 h after transfection, filtered through a 0.45 μM filter and 
supplemented with 4 μg/ml polybrene before infecting target MEFs that were 
seeded 12 h prior in a 10 cm dish (3-5X105 cells/plate). The Phoenix cell media 
was replenished and infections repeated every 12 h for a total of 3 or 4 infections.  
For selection, MEFs were collected 12 h after the last infection and 
seeded in fresh medium containing the appropriate antibiotics (1.5-2 μg/ml 
puromycin, 90 μg/ml hygromycin). Cells were maintained in selection until 
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uninfected control cells were dead. A list of shRNA targets is provided in Chapter 
6.5. 
6.1.4 Lentiviral gene delivery of shRNAs 
Lentiviral PLKO vectors were used for shRNA-mediated knockdown of protein 
expression in MEFs, except for BLM as discussed below. Briefly, 4-5X106 293T 
cells were seeded in 10 cm dishes 24 h prior to transfection. Calcium phosphate 
precipitation was used to transfect 10 μg shRNA plasmid together with plasmids 
encoding viral packaging proteins (5 μg RRE, 3 μg VSV, 2.5 μg REV). Medium 
was exchanged 12 h after transfection and replaced with MEF medium. Virus 
was collected as described in Chapter 6.1.3 with the first collection and infection 
36 h after transfection of 293Ts. MEFs were infected 3 times total 12 h apart. 
Selection of MEFs was done as described in 6.1.3, but only when the shRNA did 
not strongly affect cell viability (TopBP1, Ligase 1). When shRNA resulted in a 
rapid drop in cell viability, the selection process was omitted and Cre infection 
done 12 h after the last shRNA infection, to ensure cells remained healthy 
throughout the experiment (Mus81, PARP1, CCDC124, CCDC9, CCDC79). For 
the shRNA against Exo1 and Lig3, the shRNA infection had such a strong effect 
on cell viability that the Cre infection was done prior to shRNA infection. Where 
possible, efficient shRNA mediated knockdown was checked by western blot or 
qPCR. 
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For BLM depletion, a retroviral expression vector was used (pSuperior) as 
described in Zimmermann et al. 2014 (Zimmermann et al., 2014). For the 
experiment, 3-5x106 Phoenix cells were transfected with 10 μg shBLM or control. 
Media exchanged for MEF media 12 h after transfection and virus was collected 
as described in Chapter 6.1.3, with the first collection 36 h after transfection. As 
for shExo1, target MEFs were first infected with Cre virus, immediately followed 
by 2 shRNA infections to increase cell viability after BLM depletion. 
6.1.5 Cre mediated gene deletion 
For Cre recombinase mediated gene deletion, MEFs seeded at 2-5x105 cells in a 
10 cm dish and infected 3 times using a pMMP Hit&Run Cre retrovirus. Infections 
were done 12 h at room temperature in media containing 4 μg/ml polybrene. For 
timed experiments, time point zero was set at the time of the 2nd Cre infection. 
For Cre-ER inducible cell lines, Cre expression was activated by addition of 1μM 
4OH-tamoxifen to the cell growth media and exchanged for regular media 12-24 
h later. Addition of 4OH-tamoxifen was set at time point zero for timed 
experiments. 
6.1.6 Generation of CRISPR/Cas9 knockout cell lines 
Target sequences for CRISPR/Cas9 mediated gene knockouts were identified by 
ZiFit (http://zifit.parners.org, see list below). Targets were cloned into an AfIII-
linearized gRNA cloning vector (Addgene) by Gibson Assembly. gRNA plasmids 
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were transiently co-transfected with a hCas9 expression plasmid into target MEF 
cell lines using nucleofection (Lonza) using the MEF2 nucleofection kit. Briefly, 2-
4X106 cells were collected and mixed with electroporation buffer, 5 μg Cas9 
plasmid and 5 μg gRNA plasmid and electroporated using program A023. Cells 
were rapidly transferred into a 10 cm dish containing pre-warmed media and, 
which was refreshed 12 h afterwards to remove dead cells. The transfection was 
repeated after 48 h to obtain maximum efficiency of the CRISRP/Cas9 system. 
After the second round of transfection, cells were left to recover for 24-48 h and 
subcloned into 96-well plates at several dilutions ranging from 1 to 0.05 cells per 
well. After two weeks, multiple (~30-50) clones were grown to confluence in a 6-
well plate and clones screened for gene deletion by immunoblotting. Targeting 
was further verified by sequencing clones of TOPO-TA cloned PCR products 
according to manufactures’ instructions (Thermo Fisher). 
 









TOPO-TA sequencing primers mouse 53BP1: 
FW: CTCGATCTCACACTTCCGCC, RV: TCTTTGGGATGAATCAGCAGGT 
TOPO-TA sequencing primers mouse Gen1: 
FW: TGTCATATGCTTGCCTGGTCT, RV: TCAAGTCCCTACCACGGGTT 
6.1.7 PARPi treatment of cells 
For PARP inhibitor treatment (olaparib AZD2281 Selleck chemicals), MEFs were 
first infected with Cre virus in 10 cm dished as described previously. Olaparib 
was dissolved in DMSO and added to cells in fresh media at a final concentration 
of 2 μM. Treatment lasted for the final 24-48 h of the experiment until colcemid 
was added for 45 minutes prior to harvest. To control for PARPi efficiency, 
western blot analysis was done in MEFs grown separately in 6 cm dished and 
treated with Olaparib as above. To promote parsylation, MEFs were treated 
with/without H2O2 (2.55 μl in 5 ml media, 5 mM) for 20 minutes immediately prior 
to harvest for western blot. 
6.2 Molecular techniques 
6.2.1 Cloning techniques 
53BP1 mutant alleles were generated via Gibson cloning (Gibson et al., 2009) 
(Fig. 2.1). 53BP1DB (wild type 53BP1 lacking the C-terminal BRCT domains) or 
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53BP1Δ28 in a PMX backbone were used as template for the reactions (Bothmer 
et al., 2011). All PCR reactions were done with PfuUltra II Fusion polymerase 
(Agilent). Briefly, the domain of 53BP1 containing the mutated STQ residues was 
PCR amplified from 53BP1Δ28. The remainder of 53BP1 and the backbone PMX 
vector were PCR amplified from the 53BP1DB plasmid using primers that are the 
reverse complement of the primers used on 53BP1Δ28 creating a homologous 
sequence on either end of the PCR products. PCR products were gel-purified 
and combined using Gibson cloning. This Gibson mix contains
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a 5’ exonuclease that generates ssDNA at the homologous sequences on either 
end of the PCR products enabling them to ligate together. A taq ligase and 
phusion polymerase fills in the gaps creating a full-length plasmid composed of 
both PCR fragments. The 53BP1ΔoligoΔ28 mutant was created in a similar fashion. 
First, a PCR around the 53BP1Δ28 vector was done with primers that were 
targeted to each side of the oligomerization domain (amino acids 1231-1270) 
creating a long PCR product lacking this domain. Next, a second PCR was done 
on the same template using primers with extension that overlapped on either side 
of the deletion. The final PCR product was then ligated together using the Gibson 
mix. The other 53BP1 oligomerization mutants were created as described for the 
53BP1-S/TQ mutants using 53BP1ΔoligoΔ28 and 53BP1DB as templates. 
GFP-PICH and RFP-PICH constructs were created using Gateway cloning 
according to manufacturers protocol (Clontech). Briefly, mouse PICH cDNA was 
amplified and cloned into a pDONR vector. The construct was then shuttled into 
an N-terminal GFP or RFP retroviral destination vector (pQCXIP). Mouse and 
human Gen1 constructs were cloned from cDNA into pQCXIP retroviral vectors 
using Gateway cloning, as described for PICH. Mutations of the active sites were 
made using quickchange mutagenesis on the cDNA in the pDONR vector, prior 
to shuttling to the pQCXIP destination vector. The C-terminally myc tagged 
hGen1-3xNLS-PLPC constructs were made using Infusion cloning (Clontech) 
using the manufactures instructions. First, the 3xNLS sequence was inserted 
upstream of the myc tag using an EcoRI site using annealed oligos to create a 
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PLPC-3xNLS-Myc construct. Then, the PCR amplified hGEN1 amino acids 1-527 
were inserted using BAMH1/EcoRI sites by Infusion cloning. 
6.2.2 Co-immunoprecipitation in 293T cells 
To examine the interaction between Sun1, PTIP and 53BP1, 4-5x106 293T cells 
were plated in a 10 cm dish 20-24 h prior to transfection by CaPO4 precipitation
using 10 μg each plasmid DNA as indicated. Medium was changed 12 h after 
transfection and 24-28 h later cells were incubated with 100 μg/ml zeocin 
(Invitrogen) for 20 min, harvested by scraping in cold PBS on ice, and collected 
by centrifugation. For irradiation experiment, cells were irradiated with 10 Gray, 
left to recover for 1 h and harvested by scraping in cold PBS on ice and collected 
by centrifugation. Cells were lysed in lysis buffer (20 mM Tris pH 8.0, 0.5% NP-
40, 150 mM NaCl, 1 mM CaCl2, 1 mM MgCl2, 1 mM EDTA, Complete protease 
inhibitor mix (Roche) and PhosSTOP phosphatase inhibitor mix (Roche)) for 30 
minutes on ice, and centrifuged at 15,000 rpm in an tabletop eppendorf 
centrifuge for 10 min at 4°C. Lysate was incubated with beads for 
immunoprecipitation for 1 h with 50 μl pre-blocked Protein G beads per 1 ml of 
lysate. For myc: 1.2 μl antibody (9B11) was used per co-IP. For FLAG, 
preconjugated M2-sepharose beads were used (Sigma). For experiments using 
FLAG magnetic beads, M-270 Epoxy beads were conjugated with anti-FLAG M2 
antibody (Sigma) as described (Subbotin and Chait, 2014)). 
An alternative lysis condition was used in some experiments with similar 
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results. After collection, cells were resuspended in 0.5 ml hypotonic lysis buffer 
(10% glycerol, 10 mM KCl, 10 mM Hepes (pH 7.9), 0.1 mM EDTA, 0.5% NP-40, 
1.5 mM MgCl2, Complete protease inhibitor mix (Roche), and PhosSTOP
phosphatase inhibitor mix (Roche)). The KCl concentration was then raised to 
400 mM and samples sonicated for 1 min in water bath solicitor and equal 
amount of lysis buffer, without KCl, was added to reduce KCl concentration to 
200 mM. After centrifugation at 15,000 rpm in a tabletop eppendorf centrifuge or 
10 min at 4°C, the IP was done as described above. Beads were washed 7 times 
with the lysis buffer containing 150 mM KCl and immunoprecipitated proteins 
were eluted with 50 ml of 2xLaemmli buffer. Samples were boiled for 5 min 
before separation on SDS-PAGE. 
To test the interaction between Sun1 and 53BP1, several experiments 
were done using the two cell lysis methods described above with untagged Sun1 
or myc-tagged Sun1 and FLAG tagged 53BP1. Additional, the following lysis 
buffers were tested using the first protocol described above. 
- RIPA lysis buffer (150 mM NaCl, 1% NP-40, 0.5% Sodium deoxycholate, 
0.1% SDS, 50 mM Tris pH 8.0 + Complete protease inhibitor mix and 
PhosSTOP phosphatase inhibitor mix) 
- DNAse treatment (100 mM NaCl, 1.5 mM MgCl2, 1.5 mM CaCl2, 20 mM 
Tris pH 8.0, 0.5% NP-40 + Complete protease inhibitor mix and 
PhosSTOP phosphatase inhibitor mix supplemented with 5 units 
DNaseI/500 μl (Promega) 
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6.2.3 Co-immunoprecipitation of endogenous Sun1 from MEFs 
To test the interaction between FLAG-53BP1 and endogenous Sun1, MEFs were 
infected with 53BP1 constructs as described. Cells were collected 72 h after Cre 
by scraping, one confluent 15 cm dish per condition was used. Where indicated, 
cells were treated prior to scraping with DSP crosslinker for 15 minutes in 10 ml 
media containing 1 mM DSP (Thermo Scientific, 50 mM stock in DMSO), which 
was quenched by addition of 20 ml Tris pH 7.4 buffer. Cells were either lysed 
whole or nuclei pre-isolated prior to lysis. For nuclear isolation, cells were 
incubated for 10 min in hypotonic lysis buffer (10 mM Hepes pH 7.9, 10 mM Kcl, 
0.1 mM EGTA, 10% Glycerol, 1.5mM MgCl2, 0.1% NP-40, Complete protease 
inhibitor mix (Roche), and PhosSTOP phosphatase inhibitor mix (Roche)), and 
centrifuged to collect nuclei. Cells or isolated nuclei were then resuspended in 
500 μl hypotonic lysis buffer (10% glycerol, 10 mM KCl, 20 mM Hepes (pH 7.9), 
0.1 mM EDTA, 0.5% NP-40, 1.5 mM MgCl2, Complete protease inhibitor mix 
(Roche), and PhosSTOP phosphatase inhibitor mix (Roche)) and the KCl 
concentration raised to 400 mM. Cells were lysed by 1-5 min sonication in a 
waterbath. Equal amounts of lysis buffer without KCl, was added to reduce KCl 
concentration to 200 mM and after centrifugation at 16,000 rpm for 10 min at 4°C, 
the IP was done as described in Chapter 6.2.3 using magnetic beads conjugated 
to M2 FLAG antibody. Beads were washed 7 times with the lysis buffer 
containing 150 mM KCl and immunoprecipitated proteins were eluted with 50 ml 
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of 2xLaemmli buffer containing 50 mM DTT. Samples were boiled for 5 min 
before separation on SDS-PAGE. 
6.2.4 Western blotting 
Western blot was performed using standard methods. Briefly, cells were lysed in 
2X laemmli buffer (100 mM Tris pH 6.8, 20% Glycerol, 4% SDS, 0.04% 
bromophenol blue, 5% 2-mercaptoethanol) at 5x103 cells/μl and the lysate 
denatured for 10 min at 100°C before shearing with a 28 ½ gauge insulin needle. 
Lysate was briefly centrifuged to remove debris and subsequently resolved using 
SDS/PAGE and transferred to a nitrocellulose membrane. For large proteins 
(53BP1 and Rif1), transfer was done overnight in a cold room to enhance transfer 
efficiency.  Membranes were blocked in 1-5% milk in PBS with 0.1% Tween-20 
and incubated with primary antibody for 1 h at room temperature or overnight at 
4°C. Membranes were washed 3x in PBS-T and incubated for 1 h at room 
temperature with horse-radish-peroxidase-conjugated sheep anti-mouse or 
donkey anti-rabbit secondary antibodies. After three washes in PBS-T, 
membranes developed using enhanced chemiluminescence (Amersham). For 
phosphor-specific antibodies, TBS-T was used instead of PBS-T and membranes 
were blocked in 5% BSA. 
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6.2.5 List of antibodies used 
TRF1 (1255 de lange lab), TRF2 (1499 de lange lab), Rif1 (de lange lab), 53BP1 
(175933 abcam or 612522 BD Biosciences or 100-304A Novus Biologicals), 
γH2AX (JBW301 Millipore), Ku70 (m19 Santa Cruz), γTubulin (GTU88 Abcam), 
Sun1 (ab74758 Abcam), Sun2 (ab87036 Abcam), Ligase 3 (611876 BD 
Biosciences), Ligase 1 (18051 Proteintech), pSTQ ATR/ATM substrate (2851 
Cell Signaling), BLM (2179 Abcam), Ku70 (m19 Santa Cruz), PARP1 (C2-10 
Enzo life sciences), Anti-Poly(ADP-ribose) (4335 Trevigen), TopBP1 (ab2402 
Abcam), Exo1 (Bethyl), Gen1 (kind gift from Steve West lab), FLAG epitope (M2 
FLAG Sigma), myc tag (9B11 Cell Signaling), GFP tag (50430 Proteintech) 
6.2.6 Chromatin immunoprecipitation (ChIP) 
ChIP was performed as previously described (Loayza and de Lange, 
2003). Briefly, cells were fixed 1% paraformaldehyde/culture medium for 60 min 
at room temperature. Glycine was added to 0.2 M to stop the cross-linking. Cells 
were pelleted by centrifugation and washed with ice-cold PBS, followed by a final 
wash in PBS/1 mM PMSF. The cells were resuspended in cell lysis buffer (1% 
SDS, 10 nM EDTA pH 8.0, 50 mM Tris-HCl pH 8.0, 1 mM PMSF, protease 
inhibitor cocktail from Roche), incubated on ice for 15 min and sonicated for 10 
min (30 sec on/30 sec off) in a water-bath sonicator. Supernatants of lysates 
were incubated with antibody at 4 °C overnight. Following antibodies were used: 
TRF1 (1449 crude serum), 53BP1 (ab175933, Abcam), Sun1 (ab74758, Abcam), 
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Sun2 (ab87036, Abcam). ChIP-grade protein G magnetic beads were added for 
45 minutes (Dynal, Invitrogen). Immunoprecipitated DNA was washed, eluted 
from the beads, and precipitated with ethanol after reversal of the cross-links and 
Proteinase K treatment. The DNA samples were dissolved in water, boiled and 
loaded on dot blots, and hybridized with the Sty11 probe (telomeres) or BAMHI 
probe labeled with 32P-alpha CTP using Klenow. Signal intensity measured by 
ImageQuant software was normalized to the signals of the input DNA on the 
same blot. 
6.2.7 Telomere overhang analysis 
1x106 cells were harvested by trypsinization, resuspended in PBS, mixed 1:1
with 2% agarose in PBS and cast into plugs. The plugs were then digested 
overnight at 50°C with 1 mg/ml Proteinase K (Roche) in 10 mM Tris HCl pH 8.0, 
250 mM EDTA, 0.2% sodium deoxycholate and 1% sodium lauryl sarcosine. The 
next day, the plugs were washed five times for 1 h each with TE (1 mM PMSF 
was added to the fourth wash) and once with sterile water (20 min). DNA in the 
plugs was subsequently digested by AluI and MboI (NEB; 60 U of each per plug, 
in 500 μl cutSMART buffer) overnight at 37°C shaking. The next morning, plugs 
were washed once with 1 ml TE and equilibrated with 1 ml 0.5x TBE. The 
samples were loaded onto a 1% agarose/0.5x TBE gel and run on a CHEFTDRII 
pulse field electrophoresis apparatus (BioRad). The electrophoresis parameters 
were as follows: Initial pulse: 5 s, final pulse: 5 s, voltage: 6 V/cm, run time: 24 h. 
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The gel was then dried and pre-hybridized with Church mix for 1 h at 50°C. DNA 
in the gel was hybridized overnight at 50°C in Church mix with 50 ng of 32P end-
labeled [AACCCT]4 probe. After hybridization, the gel was washed three times 
30 min with 4x SSC at 55°C, once with 4xSSC/0.1% SDS and exposed to a 
phosphoimager screen overnight or longer. After exposure, the screen was 
scanned on a STORM phosphoimager (Molecular Dynamics) and the gel was 
denatured in 0.5 M NaOH, 1.5 M NaCl for 30 min, neutralized twice (15 min 
each) with 0.5 M Tris HCl pH 7.5, 3 M NaCl, pre-hybridized in Church mix (0.5 M 
Na+ phosphate pH 7.2, 1 mM EDTA, 1% BSA, 7% SDS) for 1 h at 55°C and 
hybridized overnight with the same probe as above at 55°C. The next day, the 
gel was washed and exposed as above. The ssDNA and dsDNA signals were 
quantified using ImageQuant software (Molecular Dynamics). The telomeric 3’ 
overhang signal was quantified based on the signal obtained after annealing a 
labeled CT strand telomeric oligonucleotide to native telomeric DNA. The ssDNA 
signal was normalized to the total telomeric DNA signal in each lane obtained 
after in situ denaturation of the DNA and re-hybridization with the same probe. 
The normalized signals are then compared between samples to determine the 
effect of genotypes or treatments on the relative normalized 3’ overhang signals.  
To determine if the telomeric ssDNA signal in the in-gel hybridization assay 
represented a bona fide terminal 3’ overhang structure, the DNA in agarose plugs 
were digested with the E. coli 3’ exonuclease ExoI prior to restriction digest. After 
the plugs had been washed 5x in TE as described above, they were washed with 
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ddH2O and 1x ExoI buffer (NEB) for 1 h each. The DNA in the plugs was 
digested with 100 units ExoI in 300 μl 1x ExoI buffer per plug overnight at 37°C. 
The next day, 60 units of fresh ExoI was added and the plugs were digested for 
an additional 2 h. After the digestion, the plugs were washed 2 times with TE for 
1 h each and loaded onto a 1% agarose gel as described above. 
 
6.2.8 Quantitative PCR analysis 
For qPCR analysis, RNA was isolated from MEFs using a Qiagen RNA 
isolation kit (invitrogen). cDNA was prepared from 1 µg of total RNA by using 
Thermoscript Reverse Transcriptase (Invitrogen). Quantitative PCR reactions 
were performed using Life Technologies SYBR Green Master Mix on an Applied 
Biosystems 7900HT Sequence Detection System. Differences between samples 
were calculated using QuantStudio software (Applied Biosystems) using the ΔCT 
method and were normalized to GAPDH. For Mus81, two different primers pairs 
were designed, both spanning an exon-exon junctions to prevent amplification of 





GAPDH_FW: GGGTGAGGCCGGTGCTGAGTAT (from H. Takai) 
GAPDH_RV: CCTTCCGTGTTCCTACCCCCAA (from H. Takai) 
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6.3 Imaging techniques 
6.3.1 IF and IF-FISH 
IF and IF-FISH were conducted as previously described (Dimitrova and de 
Lange, 2006). Briefly, cells grown on coverslips were fixated for 10 min in 3% 
paraformaldehyde and 2% sucrose in PBS at room temperature, followed by 
three PBS washes. Coverslips were incubated in blocking solution (1 mg/ml BSA, 
3% goat serum, 2% donkey serum, 0.1% TritonX-100, 1 mM EDTA in PBS) for 
30 min, followed by incubation with primary antibodies diluted in blocking solution 
for 1 h at room temperature. Cells were washed three times for 5 min with PBS 
and then incubated with secondary antibodies diluted in blocking solution for 30 
min at room temperature. For IF, samples were washed in three 5-min washes 
with PBS. DNA was stained with DAPI or Hoechst33342 (Tocris, Fisher 
Scientific) in the PBS washes and coverslips were mounted using antifade 
reagent ProLong Gold from Life Technologies. For IF-FISH, coverslips were 
washed after the secondary antibody incubation and fixed for an additional 10 
min in 3% paraformaldehyde. After 3 additional 5-min PBS washes, coverslips 
were dehydrated with 70%, 95% and 100% ethanol and allowed to dry. 
Hybridizing solution (70% formamide, 0.5% blocking reagent from Roche, 10 mM 
Tris-HCl pH 7.2 and 488-OO-[CCCTAA]3 or Cy3-OO-[TTAGGG]3 PNA or AF647-
OO-[TTAGGG]3  probe from Applied Biosystems) was added to each coverslip 
and denatured at 80ºC for 5 min, followed by a 1h incubation at room 
temperature. Two 15-min washes in 70% formamide/10 mM Tris-HCl pH 7.2 and 
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three 5-min washes with PBS were performed. DNA was stained with DAPI or 
Hoechst 33342 in the PBS washes and coverslips were mounted using antifade 
reagent ProLong Gold from Life Technologies. Images were captured using a 
Zeiss AxioPlan II microscope with a Hamamatsu C4742-95 camera using 
Volocity software from Perkin Elmer or with an image restoration system 
(DeltaVision; Applied Precision) equipped with a cooled charge-coupled device 
camera (CoolSnap QE; Photometrics), a PlanApo 60x 1.40 NA objective 
(Olympus America, Inc) and SoftWoRx software. 
Primary antibodies used for IF: Rif1 (de lange lab), 53BP1 (175933 Abcam or 
612522 BD Biosciences) FLAG epitope (M2 FLAG Sigma), MYC tag (9B11 Cell 
Signaling). Secondary antibodies used for IF: AF488 Goat-αMouse (Invitrogen), 
AF555 Goat-αRabbit (Invitrogen), AF647- Goat-αRabbit (Invitrogen). 
 
6.3.2 Chromatin bridge analysis 
To analyze chromatin bridges between nuclei, cells grown on coverslips were 
fixed for 10 min in 3% paraformaldehyde/2% sucrose at room temperature, 
followed by three PBS washes. Cells were either processed for regular IF as 
described in 6.3.1. Alternatively, coverslips were directly incubated for 5 min in 5 
μg/ml Hoechst 33342 or DAPI and washed three times in PBS. Coverslips were 
then mounted using antifade reagent ProLong Gold from Life Technologies. 
Coverslips were analyzed using a Zeiss AxioPlan II microscope with a 
Hamamatsu C4742-95 camera. Since the intensity of many bridges is too low to 
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capture by camera, bridges were counted manually at the microscope. For each 
coverslip, at least 200 cells were counted in fields next to each other and the 
percent of cells with a bridge was counted (every cell that has a bridge protruding 
from it is counted as positive, independent of whether the cell on the other end of 
the bridge was visible in the field of view). 
6.3.3 Metaphase telomeric FISH 
Telomeric FISH was conducted as previously described (van Steensel et 
al., 1998; Celli et al., 2006). Briefly, colcemid was added to cells 0.75-1 hour prior 
to harvest. Cells were collected by trypsinization, swollen in 0.075 M KCl and 
fixed overnight at 4ºC in methanol:acetic acid (3:1). Metaphase spreads were 
dropped on glass slides and aged overnight. Slides were hybridized with AF488-
OO-[CCCTAA]3 or Cy3-OO-[TTAGGG]3 PNA probe in hybridizing solution, 
denatured at 80ºC for 10 min and incubated for 2 h at room temperature. Two 15-
min washes in 70% formamide/10 mM Tris-HCl pH 7.2 and three 5 min PBS 
washes. Slides were dehydrated in 70%, 95%, and 100% ethanol and mounted 
using Vectashield mounting medium with DAPI from Vector Laboratories. Images 
were captured using a Zeiss AxioPlan II microscope with a Hamamatsu C4742-
95 camera using Volocity software from Perkin Elmer. 
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6.3.4 Isochromosome analysis 
Isochromosomes were counted on metaphase spreads based on their visual 
appearance. The details of the analysis are fully described in Chapter 4.2.4. 
 
6.3.5 Live-cell imaging for chromatin mobility analysis 
Dysfunctional telomeres were visualized using mCherry-BP1-2 (h53BP1, amino 
acid 1220-1711) as described previously (Dimitrova et al., 2008). Cre-treated 
TRF2F/F cells were plated onto MatTek glass bottom plates and grown for 2 days 
before imaging. An hour before imaging, cells were changed into Leibovitz’s L-15 
medium (Gibco) supplemented with 15% FBS, non-essential amino acids, L-
glutamine, penicillin/streptomycin and 50 mM β- mercaptoethanol, and allowed to 
equilibrate for one hour. Imaging was done at 37°C using an environmental 
chamber using a DeltaVision microscope system (Applied Precision) with a 
PlanApo 60x 1.40 NA objective lens (Olympus America, Inc.). 5 μm Z-stacks at 
0.5 μm steps were acquired using SoftWoRx software with 50 msec exposure 
time, every 30 sec over 10 min (t=20 frames) at 2 x 2 binning with 512 x 512 
pixels in final size. Images were deconvolved and 2D-maximum intensity 
projection images were obtained using SoftWoRx software. Tracking of mCherry-
BP1-2 foci was performed with ImageJ software for at least 10 cells per 
condition. Cells were registered by the StackReg plugin using Rigid Body 
(Thevenaz et al., 1998). Next, particles were detected and tracked using the 
Mosaic Particle Detector and Tracker plugin (Sbalzarini and Koumoutsakos, 
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2005) with the following parameters: radius=1-2 pixels; cutoff=1-2 pixels; 
percentile=1-6; link range=1; displacement=5 pixels. The x and y coordinates of 
each trajectory were output for further calculation. Per cell, all mCherry-BP1-2 
foci that were continuously tracked for at least 19 of the 20 frames were 
analyzed. The analysis of the eGFP-TRF1-marked telomeres was similarly 
conducted using the following parameters: radius=1 pixels; cutoff=1 pixels; 
percentile=8-12; link range=1; displacement=5 pixels. Distorted nuclei were 
discarded based on the methods described in Lottersberger et al. 2015 
(Lottersberger et al., 2015). 
6.3.6 Live-cell imaging for mitotic abnormalities 
Live cell imaging was performed as described in (Maciejowski et al., 2015). 
Briefly, cells were plated onto 35 mm glass bottom dishes (MatTek) 48 h before 
imaging. One hour before imaging, cell culture media was replaced with phenol 
red-free DMEM medium. Live cell imaging was performed using a CellVoyager 
CV1000 spinning disk confocal system (Yokogawa, Olympus) equipped with 445, 
488, and 561 nm lasers, a Hamamatsu 512 x 512 EMCCD camera. Pinhole size 
was 50 μm. Images were acquired at the indicated intervals using a UPlanSApo 
60x/1.3 silicone oil objective with the correction collar set to 0.17. The pixel size 
in the image was 0.27 μm. The following emission filters were used for image 
acquisition: 525/488 for Venus- tagged proteins, and 617/61 for RFP-tagged 
proteins. 12 μm z-stacks were collected at 2.0 μm steps. Temperature was 
maintained at 37°C in a temperature-controlled enclosure with CO2. Maximum 
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intensity projection of z-stacks and adjustment of brightness and contrast were 
performed using Fiji software. Image stitching was done with the Fiji plugin 
Grid/Collection stitching (Preibisch et al., 2009) with 20% tile overlap, linear 
blending, a 0.30 regression threshold, a 2.50 max/avg. displacement threshold, 
and a 3.50 absolute displacement threshold. Images were cropped and 
assembled into figures using Fiji and Photoshop CS5.1 (Adobe). 
6.4 Lists of cell lines used 
Genotype Source Cell line # 
293T ATCC 
Phoenix cells     ATCC 
TRF2F/F Rosa26 Cre-ERT2   De Lange lab 
TRF2F/F53BP1-/-Lig4-/-Rosa26 Cre-ERT2 De Lange lab 78600.1 
TRF2F/F53BP1-/-    De Lange lab 
TRF2F/F53BP1-/-Sun1-/-Sun2-/-  De Lange lab 60318.7 
TRF2F/F53BP1-/-Sun1+/+Sun2+/+  De Lange lab 53618.4 
TRF1F/F53BP1-/-late passage  De Lange lab 76565.5 
TRF1F/F53BP1-/-    This work 78882.3 
TRF1F/F53BP1-/-    This work 78882.5 
TRF1F/F     De Lange lab 9.3 
TRF1F/FGen1+/+ CRISPR   This work g3#13, g3#14 
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TRF1F/FGen1-/- CRISPR  This work  g3#17,g2#16,g2#17 
TRF1F/F     De Lange lab 39020.6 
 TRF1F/FGen1+/+ CRISPR  This work  g2#7 
 TRF1F/FGen-/- CRISPR  This work  g2#8, g3#11, g3#20 
TRF1F/FRif1F/F    De Lange lab 65.8 
 53BP1-/- CRISPR   This work  g3#3, g5#7 
TRF1F/FmTR+/-    De Lange lab 370.5 
TRF1F/FmTR+/+    De Lange lab 370.2 
TRF1F/FTIN2+/+Ku70-/-   De Lange lab 82263.2 
TRF1F/FTIN2+/+Ku70+/+   De Lange lab 82263.8 
TRF1F/FTRF2F/+Lig4-/-   De Lange lab 305-1 
TRF1F/Fp53-/-     De Lange lab 75023.9 
 
6.5 List of shRNA used 
 
Target  TRC   Backbone Target sequence 
CCDC9  TRCN0000250760 PLKO  GGACGTGAGTGAAGATGTTAC 
CCDC79  TRCN0000113325 PLKO  CGGTCCTTTGTTTGGACTCTT 
TRCN0000113326 PLKO  CCTGAGGTAATTCGACCTATA 
TRCN0000113327 PLKO  CCTGTAGAAGAAGACAACTTT 
CCDC124  TRCN0000181504 PLKO  GAAGGAGCTGGAAGATGCTTA 
TRCN0000181941 PLKO  GCTGGAAGATGCTTACTGGAA 
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TRCN0000181879 PLKO GCCACTGGAAGAGAACCTTAA 
TRCN0000181658 PLKO GAAACAGAAGGAGCTGGAAGA 
TRCN0000181793 PLKO GCTGATGCCAAGAAACAGAAG 
Gen1 TRCN0000246735 PLKO ATGTTGACTGTTACACGATAT 
TRCN0000246737 PLKO TGAACGTAATGGATGCATATT 
TRCN0000246738 PLKO GGCATCAGACAGACCATAATA 
PARP1 TRCN0000353959 PLKO GAGTACATTGTCTACGACATT 
TRCN0000325059 PLKO GCCCTTGGAAACATGTATGAA 
Mus81 TRCN0000241267 PLKO TAGTGCCTGGAAGTTCGAAAC 
TRCN0000241266 PLKO CCAGTCTGTGCGAGAAGTATT 
TRCN0000241264 PLKO CAGAAATGCTCCGAGAGTTAC 
Lig3 TRCN0000070979 PLKO GCAATGAAGAAGTGTCCCAAT 
TCRN0000070980 PLKO CCAGTGAAAGGTGCTTCGTTT 
Lig1 TRCN0000071154 PLKO CCTTGGATGTTGATGCCACTT 
TRCN0000071155 PLKO CCTTCCAAGAATAACTATCAT 
TRCN0000071157 PLKO CGAGAGTGATTCTCCAGTGAA 
TopBP1 TRCN0000124220 PLKO GCTCTTAGAAACTGCGAGAAT 
TRCN0000124223 PLKO GCCAGAAGAGTTTCCTTGTTT 
shBLM from Michal pSuperior GCATCCTAATAAAGAGTTA 
from Michal pSuperior GGAGGGTTATTATCAAGAA 
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